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Background: Autism spectrum disorder (ASD) is accompanied by comorbid sleep problems in 
40-80% of cases. Previous reports have shown relationships between circadian rhythm genes and 
sleep problems in ASD. This study aimed to (1) examine relationships between sleep problems 
and characteristics of children with ASD—age, sex, ASD severity, IQ, and medical conditions, 
and (2) explore genetic associations between 25 melatonin synthesis and suprachiasmatic 
nucleus (SCN) genes and sleep patterns in children with ASD. 
Methods: This secondary analysis used genotypic and phenotypic data on children aged 4-18-
years from the Simons Simplex Collection. An exploratory factor analysis and psychometric 
evaluation was performed on the Simons Simplex Collection Sleep Interview (SSCSI), 
consisting of Nighttime problems, Daytime problems, and Sleep duration problems subscales.  
Expression quantitative trait loci (eQTL) and single nucleotide polymorphisms (SNPs) were 
identified primarily from gene expression data for 25 melatonin/SCN genes. Student’s t-tests, 
Chi-square, and Kruskal-Wallis or Mann-Whitney U tests were performed to detect differences 
between age groups, sexes, and sleep problem groups. Associations between sleep problems and 
child characteristics were assessed using logistic regression.  Relationships between sleep 
problems and gene variants were tested with logistic regression and transmission disequilibrium 
tests. 
Results: Approximately 41% of children were categorized as having sleep problems. In the full 
sample, and in age subgroups, GID and age were the variables most frequently associated with 
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composite sleep problems, Nighttime problems, Daytime problems, and Sleep duration problems, 
followed by NVIQ and male sex. Seizures were associated with composite sleep problems and 
Nighttime problems. ASD severity was not associated with sleep problems in this sample. No 
significant associations were found between sleep problems and any gene variants after 
correction for multiple testing. 
Conclusions: This study advances our understanding of sleep in ASD by showing that GID, 
NVIQ, age, sex, and seizures increased the odds of sleep problems; but that the gene expression-
related variants in the melatonin synthesis and SCN pathways do not have a notable impact on 
sleep problems in children with ASD. These results reinforce that healthcare professionals 
should screen for sleep problems in children with ASD and suggest future lines of inquiry.  
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DEFINITIONS OF TERMS 
Proband: individual under study, often the first individual affected in a family who is brought to 
 medical attention  
Simplex family: family in which only one member has the condition under study; in this study, a 
 family  in which the proband is the only member of the family with ASD up to third 
 degree relatives affected with ASD 
Sleep efficiency: portion of sleep episode taken up by sleep (total sleep time/time in bed) 
Sleep latency: period of time from beginning to try to fall asleep to onset of sleep; also known as 
 sleep  onset latency 
Sleep quality: subjective satisfaction with one’s sleep, including falling asleep, staying asleep, 
 length  of sleep, and refreshment on waking 
Time in bed: time one spends in bed, from laying down to rising for the final time 
Total sleep time: amount of time asleep during a sleep episode; equal to duration of sleep 
 episode minus time awake 
Wake after sleep onset: awakenings after initially falling asleep in which the sleeper returns to a 
 relatively alert state 
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1.0  PROPOSAL INTRODUCTION 
Autism spectrum disorder (ASD) is a pervasive developmental disorder characterized by deficits in social 
communication, and restricted, repetitive interests and behaviors (American Psychiatric Association, 
2013). ASD presents early in life, persisting through the lifespan, and is termed a spectrum because 
symptoms of the disorder vary widely in severity. In addition to core communication and behavior 
difficulties, children with ASD may suffer from a range of other medical and behavioral comorbidities, 
such as anxiety, gastrointestinal disorders, seizures, and sleep problems. Sleep problems are estimated to 
affect 40-80% of children with ASD, and include difficulty falling asleep (Goldman et al., 2017) and 
staying asleep (Souders et al., 2009), shorter total sleep time (sleep beginning to end– awakenings after 
sleep onset; Elrod & Hood, 2015), poorer sleep efficiency (total sleep time/time in bed; Fletcher et al., 
2016; Giannotti et al., 2011). Several studies have also suggested that intellectual ability (Mazurek & 
Petroski, 2015; Veatch et al., 2017) and ASD severity may contribute to sleep problems in children with 
ASD (Zachor & Ben-Itzchak, 2016). However, the studies of sleep problems in ASD that have been 
performed thus far have used relatively small samples in a restricted age range, examined a single or 
select few sleep problems, or did not account for variables such as IQ, ASD severity, or medical 
problems. 
Recent studies have suggested that disrupted levels of melatonin and/or alterations of genes in the 
suprachiasmatic nucleus, two components of circadian rhythm regulation, may play a role in sleep 
problems in ASD. Using data from the Simons Simplex Collection (SSC), a large, national ASD 
consortium genome-wide association study (GWAS) that collected information about sleep patterns, 
intellectual abilities, ASD symptoms, and medical history, the proposed study seeks to fill these gaps in 
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knowledge by (1) examining associations between nighttime and daytime sleep problems and sleep 
duration problems and characteristics of children with ASD (sex, age, IQ, ASD severity, and medical 
conditions), and (2)  relate variation in and around 25 melatonin synthesis and SCN genes to their 
influence on sleep problems in children with ASD. Genetic variants have been chosen for association 
analysis based on their impact on gene expression, as measured by RNA-sequencing (RNASeq) and 
single nucleotide polymorphism (SNP) data. Sleep patterns to be examined include difficulty going to bed 
and falling asleep, frequent/prolonged night wakings, difficult morning waking, long/frequent naps, 
excess daytime sleepiness, irregular bedtime and waketime, and irregular sleep duration. This study 
helped to distinguish subgroups in ASD; address the question of whether and to what extent IQ, ASD 
severity, medical conditions, and melatonin-related genes impact sleep patterns; and eventually may even 
contribute to the search for targeted therapies to improve the quality of life, health, and treatment efficacy 
of children and families affected by ASD. 
1.1 SPECIFIC AIMS 
Specific Aim 1: Examine the relationship between sleep patterns and characteristics of children with 
ASD—age, sex, ASD severity, IQ, and medical conditions. We hypothesize that IQ, more severe ASD 
symptoms, and presence of medical conditions will increase the likelihood of a child having certain sleep 
patterns. 
 
Specific Aim 2: Explore genetic associations between 25 melatonin synthesis and SCN genes and sleep 
patterns in children with ASD. We hypothesize that relationships will exist between sleep patterns and 
variants in the melatonin/SCN genes. 
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1.1.1 Conceptual models 
The conceptual model for aim 1 (Figure 1) demonstrates relationships between child characteristics, 
measured by the Autism Diagnostic Observation Schedule, four well-validated intelligence tests, and the 
SSC medical history; and sleep patterns, measured by the Simons Simplex Collection Sleep Interview. 
 
 
 
Figure 1: Aim 1 Conceptual Model 
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The conceptual model for aim 2 (Figure 2) demonstrates relationships between 25 genes related to 
melatonin synthesis and SCN circadian function, measured by genotypes from a SNP genotyping array 
that covered the genome; and sleep patterns, measured by the Simons Simplex Collection Sleep 
Interview; controlling for child characteristics, measured by the Autism Diagnostic Observation Schedule, 
four intelligence tests, and the SSC medical history. The model also depicts the interaction between the 
pineal gland and SCN. 
 
 
 
Figure 2: Aim 2 Conceptual Model 
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1.2 SIGNIFICANCE, INNOVATION, AND BACKGROUND 
1.2.1 Significance 
Roughly half of children diagnosed with ASD have abnormal sleep patterns (Liu, Hubbard, Fabes, & 
Adam, 2006; Malow et al., 2006; Souders et al., 2009), which are worsened in children with severe ASD 
and/or low IQ (DeVincent, Gadow, Delosh, & Geller, 2007; Gail Williams, Sears, & Allard, 2004; 
Schreck, Mulick, & Smith, 2004; Veatch et al., 2017; Zachor & Ben-Itzchak, 2016). Adequate sleep is 
vital for all children for optimal physical and mental health, growth, learning and memory, and peak 
academic performance. The proposed study aims to describe sleep patterns within the context of ASD, 
and to determine whether these patterns can be ascribed, in part, to genotypes of children with ASD. The 
study lays the groundwork to understand from a biological perspective why and how sleep patterns are 
abnormal in children with ASD. With this firm foundation, it should be possible to build further studies 
and interventions aimed at making sleep patterns more typical, thereby improving the quality of life for 
individuals with ASD and their families. Insofar as we are aware, this will be the largest study to 
statistically characterize patterns of sleep in ASD, and the relationship of those patterns to attributes of 
ASD subjects. We anticipate that this study will be of keen interest to the field, could form the foundation 
to understand why these patterns emerge, and will be the essential first step toward understanding the 
biology of abnormal sleep patterns in ASD. 
1.2.2 Innovation 
The proposed study is innovative in several ways: (1) previous research has not sufficiently explored how 
biological factors, some affected by genetic variation, influence sleep patterns in ASD. (2) The study 
takes advantage of a large sample of strictly phenotyped children, from whom data on sleep patterns and 
genome-wide data are available, to examine an entirely new question. (3) Genetic variants have been 
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chosen for association analysis based on their impact on gene expression in the brain, as measured by 
RNA-Seq and SNP data, providing a closer link to SCN gene expression than other methods for SNP 
selection. (4) Findings could help to distinguish genetic subgroups within ASD and contribute to sleep 
research in other closely related neuropsychiatric disorders. 
1.2.3 Background 
1.2.3.1  Sleep and development in the healthy child 
Adequate sleep quantity and quality are essential for healthy growth and development from birth through 
adolescence (Carskadon, 2002; Dahl & Lewin, 2002; Hobson, 1989; Sadeh, Mindell, & Rivera, 2011), 
and for good health and functioning throughout the lifespan. Most researchers now agree that sleep is an 
active neurologic process in which chemical and hormone levels are restored (Carter, 2005), epigenetic 
changes occur, psychological homeostasis is restored (Agnati et al., 2011), memories are consolidated and 
reorganized (Diekelmann, Wilhelm, Wagner, & Born, 2013), and growth and maturation take place 
(Carskadon, 2002; Dahl & Lewin, 2002). Children and adolescents also need to have satisfactory sleep 
quantity and quality to convert new learning to long-term memory (Diekelmann et al., 2013).          
Healthy sleep is comprised of two physiologically distinct phases, non-rapid eye movement 
(NREM) and rapid eye movement (REM) sleep, that cyclically alternate throughout the sleep period. 
NREM is made up of four progressively deeper stages, ranging from stage 1 when the sleeper may be 
easily awakened and may not realize they had fallen asleep, to stages 3 and 4, referred to as slow wave 
sleep (SWS) because of characteristically slow delta waves. During NREM, the body has low muscle tone 
and negligible psychological activity. REM sleep is the stage in which individuals dream, and is 
distinguished by dyssynchronous electroencephalogram (EEG) waves and atonic muscles. The first REM 
stage of sleep typically occurs 80 to 100 minutes after sleep onset. Over the sleep period, SWS episodes 
become progressively shorter and REM episodes progressively longer. Sleep quantity and quality may be 
affected by homeostatic sleep need, circadian phase, environmental temperature and light, medications, 
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and sleep or medical disorders (Carskadon & Dement, 2017). 
The two-process model is a biologic conceptual model commonly used to describe the 
components of the circadian clock that interact to regulate sleep propensity.  Sleep homeostasis, or 
Process S, represents sleep need or sleep debt, and is dependent on previous amounts of sleep and wake 
time. This process, also referred to as sleep pressure, increases during wakefulness and decreases during 
sleep. When Process S nears the lower end of its range, it triggers awakening; and when it approaches the 
upper end of its range, it triggers sleep. Circadian rhythm, or Process C, is controlled by the SCN and is 
independent of previous sleep or wakefulness. The Process C alertness signal has a regular diurnal rhythm 
with a peak in the early evening, and a trough in the early morning. These two processes antagonize each 
other to produce a balanced sleep/wake propensity (Borbély, Daan, Wirz-Justice, & Deboer, 2016), and 
may also be responsible for the cyclic alternation of REM and NREM sleep stages.  The rate at which 
sleep propensity builds up changes across childhood, with the greatest change around puberty.   
 The structure and characteristics of sleep patterns change considerably from birth to adolescence, 
and a number of sleep problems may be seen in different age groups. From the fetal period through 
adolescence, sleep evolves to meet particular needs during developmental processes including memory 
consolidation (Stickgold, 2005), synaptic growth and pruning (Tononi & Cirelli, 2006), and formation of 
white matter connectivity (Yoo, Gujar, Hu, Jolesz, & Walker, 2007).   
Fetuses and infants 
A recognizable pattern of activity and quiet behavior can be seen in fetuses as early as 20 weeks 
gestation. Newborns (birth to 1-month) sleep about 70% of a 24-hour period, or approximately 16.8 
hours. Sleep in newborns occurs in multiple periods throughout the day and night, not cued by circadian 
indicators like light and dark. Sleep periods tend to be around 4-hours long, with 1-2 hour wake periods in 
between. Infant (1- to 12-months) sleep is comprised of two stages, quiet sleep characterized by relaxed 
muscles and even breathing; and active sleep, characterized by muscle twitches and flickering eyelids. As 
infants age, quiet sleep will differentiate into the stages of NREM sleep, and active sleep will become 
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REM sleep. In the neonatal period, active sleep makes up more of total sleep time than quiet sleep, but 
quiet sleep increases in length until it predominates by around 3-months-old.  In contrast to newborns, 
who generally enter sleep through active or REM, infants around 4-months begin transitioning to entering 
sleep predominantly through quiet or NREM sleep.  Sleep onset latency is typically less than 15 minutes. 
By 3-4 months old, a diurnal pattern of sleep and wake can be seen in infants’ activity, and recognizable 
NREM sleep stages begin to appear. Consolidation of sleep into nighttime sleep and daytime naps, and 
entrainment of sleep to environmental cues develops during the first 6-months of life. The age at which an 
infant can sleep through the night varies widely and is largely determined by a child’s temperament 
(Mindell, Leichman, & Composto, 2016; Sheldon, 2014). Recommended sleep time for newborns is 
between 14- and 17-hours per 24-hour period, and for infants is between 12– and 15-hours per 24-hour 
period (Hirshkowitz et al., 2015).   
A major sleep-related task in infancy is learning to self-soothe, or the ability to fall back to sleep 
independently. Infants placed in their crib drowsy but awake tend to be better and self-soothing and 
falling asleep by themselves. Since sleep onset latency lengthens as children age and nighttime wakings 
continue to be common through the toddler years, the ability to self-soothe becomes more important for 
parents (Mindell, Sadeh, Kohyama, & How, 2010). 
Toddlers 
Compared with infants, sleep pattern changes in toddlers occur steadily, but more gradually. As 
children move into the toddler years (1-3 years), sleep continues to consolidate into one long period at 
night and one or two naps during the day (Mindell et al., 2016). Sleep onset latency increases to 15-30 
minutes as toddlers age. At the beginning of the first year, REM periods tend to be uniform in length and 
spaced evenly throughout the night.  As the child ages, REM periods become shorter at the beginning of 
the night and gradually longer throughout the sleep period. Slow wave sleep periods exhibit the opposite 
trend, longer in the early night and shorter as the night proceeds (Sheldon, 2014). The recommended sleep 
duration for toddlers is 11-14 hours per 24 hour period (Hirshkowitz et al., 2015). 
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A number of behavioral sleep problems may emerge in the toddler years as regular sleep routines 
are being established. Two common and related problems are bedtime resistance and separation anxiety. 
Children may fight going to bed because of fear of being separated from caregivers, or as children 
develop independence and begin testing their limits. Bedtime resistance may manifest as refusing to lay 
down in bed and stay in bed, or frequently calling out after they have been put to bed. Another common 
problem seen in toddlers is nighttime wakings, reported in 25-50% of parents. These may be due long 
naps, delayed bedtime, not enough sleep overall, sleep disordered breathing (snoring, sleep apnea), or a 
sleep environment not conducive to sleep (noise, light, temperature). Although wakings throughout the 
night are normal at all ages, they become a problem when the child is not able to go back to sleep 
independently. These three common problems may be helped by a regular bedtime routine and consistent 
limit setting (Mindell & Moore, 2014).  
Pre-schoolers 
Sleep patterns in preschool-aged children (3-5-years) steadily continue toward mature, adult 
patterns. A distinct process occurring in this period is a decline in the percentage of REM sleep to total 
sleep time from about 30% in toddlers to a more adult level of 20-25%. The age at which naps are given 
up varies among children but is most often by 3- to 4-years-old, especially as children enter school. A 
strict bedtime routine is particularly important when preschoolers are attending school because they need 
to wake up in time for school while still needing 10-13 hours of sleep per night (Licis, 2018).   
The preschool age period is the peak time for sleep disordered breathing (SDB) to emerge. 
Including obstructive sleep apnea syndrome, SDB ranges from snoring to periodic obstruction of the 
airway, and has been identified as a risk factor for neurocognitive and behavioral problems in children 
(Biggs et al., 2014). SDB may be indicated by other symptoms such as enuresis (Su et al., 2011), daytime 
hyperactivity or excess sleepiness (Ren & Qiu, 2014), and decreased physical, emotional, and social 
functioning (Jackman et al., 2013). The majority of SDB cases in children are due to adenotonsillar 
hypertrophy, treated most often with adenotonsillectomy (Mitchell, Pereira, & Friedman, 2006). 
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Other behavioral sleep problems that may occur in preschool-aged children include “curtain 
calls” and parasomnias—sleep walking, confusion arousals, or sleep terrors. Curtain calls are repeatedly 
calling for a caregiver to come back into the room or the child repeatedly leaving the bedroom. Children 
are usually seeking reassurance that they are safe and a caregiver is nearby. While children are still 
learning the difference between reality and imagination, children may need to have a caregiver look in 
closets, under the bed, and in the toy box to assure the child that they are safe. Parasomnias, also known 
as disorders of arousal, are a group of disorders that involve abnormal or unusual behavior during sleep. 
A child having a parasomnia may display misperception of or unresponsiveness to the environment, 
difficulty being aroused, autonomic arousal, automatic behavior, and amnesia to the event after waking. 
Parasomnias usually occur while transitioning out of slow wave sleep, typically 60-90 minutes after 
falling asleep, and may last less than one minute to more than 30 minutes. Sleep terrors are typically seen 
in older children and adolescents. The majority of children naturally grow out of parasomnias (Rosen, 
2014). Enuresis in the absence of SDB is common in preschool children while stable bladder control is 
still being established. In a study of over 16,000 children, an estimated 16% of 5-year-old children 
experienced one episode of enuresis over three-months. Boys were found to be three times more likely to 
experience enuresis than girls (Yeung, Sreedhar, Sihoe, Sit, & Lau, 2006). 
School-aged children 
Sleep patterns in school age children (6-12-years) resemble that of adults, with the exception of 
sleep duration. The recommended sleep duration for school age children is 9-11 hours per night, while 
adults are advised to sleep 7-9 hours per night. The additional time these children sleep is distributed 
evenly across sleep stages, so that each stage is slightly longer but proportion of each sleep stage to total 
sleep resembles adults. Distinctively, prepubertal school aged children have the most energy and alertness 
they have had or will have in their life.  Because of this, most school-aged children do not nap, and 
daytime sleepiness may signal a problem with nighttime sleep duration or quality (Sheldon, 2014).  
Some sleep problems—parasomnias, enuresis, SDB—may continue from the preschool period 
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into the early school-aged period.  School-aged children may increasingly have problems with getting the 
recommended sleep duration because wake time during the week is dictated by school start time. Children 
in this age group are also becoming more involved with electronic devices and consumption of caffeine 
during the day, which have been show to disrupt sleep patterns and next day function (Cain & Gradisar, 
2010; Lamontagne, Singh, & Palosky, 2010). Parents, however, may not be as aware of sleep problems in 
school-aged children, because children at this age are more likely to put themselves to bed in the evening, 
and fall back to sleep themselves if they wake in the night. 
Adolescents 
As children move into puberty, considerable changes in sleep patterns take place. In natural 
conditions (no set bedtime or waketime), the amount of slow wave sleep decreases significantly from pre- 
to post-puberty. Pubertal children also experience a delayed sleep phase, naturally falling asleep later and 
waking later than pre-pubertal children. Based on study of natural and recovery sleep after sleep 
deprivation, Jenni et al. (2005) propose that homeostatic sleep pressure during the day accumulates more 
slowly in post-pubertal children, but that the waning of Process S remains comparable to pre-pubertal and 
pubertal children. Research has also found that total sleep time and REM sleep time needed remain 
constant across the pubertal process.  
The primary sleep problem encountered in adolescence is daytime sleepiness, and cumulative 
sleep debt because of nighttime sleep restriction. As adolescents progress through puberty, daytime 
sleepiness increases, even in the absence of nighttime sleep deprivation. Post-pubertal adolescents tend to 
be sleepiness during the early to mid-afternoon (Carskadon et al., 1979; Crowley, Tarokh, & Carskadon, 
2014). Daytime sleepiness is compounded by the effects of sleep debt commonly seen in contemporary 
adolescents. As adolescents begin to exercise more independence, become more involved in social 
activities and sports, and receive more homework, bedtimes are often pushed later in the night. However, 
they must then wake up in time for early school start times. Reduced total sleep time in combination with 
natural daytime sleepiness can put adolescents at risk for serious attentional impairment. In addition to the 
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detrimental effects this attentional impairment may have on academic achievement, it can have deadly 
consequences for young adults who are learning to drive.    
1.2.3.2  Measurement of sleep patterns 
Sleep patterns and the EEG structure of sleep may be studied with polysomnography (PSG), actigraphy 
(ACT), validated sleep instruments, or sleep diaries. The in-laboratory PSG is considered the “gold 
standard” for the evaluation of sleep according to the American Association of Sleep Medicine (Kushida, 
Littner, & Morgenthaler, 2005). Before an in-laboratory PSG, a detailed history and physical examination 
is performed to evaluate normal sleep patterns and symptoms of sleep disorders. A PSG is performed by a 
trained polysomnographic technologist, and usually includes central EEG, respiratory effort, nasal and 
oral airflow, a microphone to record snoring, pulse oximetry, electrocardiogram, and video recording to 
document body positions during sleep. This recording can determine the total time in each sleep stage, 
total sleep time, sleep efficiency, sleep onset latency (time to fall asleep), REM sleep latency, wake after 
sleep onset, and arousals (Krishna, 2014; Roland et al., 2011). A disadvantage of PSG is that sleep quality 
is often poorer in the sleep lab with its associated equipment than at home. For example, the “first-night 
effect” occurs when sleep quality is poorer on the first night of a two night study in the PSG lab (Buckley 
et al., 2013).  
Actigraphy uses a device about the size of a wristwatch to quantify sleep-wake patterns by 
measuring movement. The actigraph is worn on the wrist or ankle for several days and nights as 
individuals go about their regular activities. The actigraph registers frequency and amplitude of 
movements in 30- or 60-second periods. One benefit of ACT is that it’s objectively measured activity 
patterns may estimate habitual sleep patterns more effectively than PSG because of being worn by an 
individual in their natural environment, avoiding the first-night phenomenon. ACT can be used to 
measure sleep latency, total sleep time, wake time after initial sleep onset, sleep efficiency (total sleep 
time/total time in bed) by recording episodes of activity and inactivity (Ancoli-Israel et al., 2003). 
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Sleep questionnaires have been developed to specifically evaluate overall sleep, sleep initiation 
and maintenance, daytime sleepiness, sleep habits and sleep hygiene, beliefs about sleep, and multiple 
sleep dimensions (Lewandowski, Toliver-Sokol, & Palermo, 2011). The most commonly used sleep 
questionnaire in the pediatric population is the Children’s Sleep Habits Questionnaire (CSHQ), a 35-item, 
well-validated and commonly used parent-completed multidimensional instrument that assesses bedtime 
routine, sleep behavior, waking during the night and in the morning, and daytime sleepiness. Each item is 
scored on a 1 to 3 scale indicating how frequently a behavior occurs, with 1 corresponding to usually (5-7 
days/week), 2 to sometimes (2-4 times/week), and 3 to rarely (0-1 time/week). Thus, a high score 
indicates more sleep problems than a low score. The CSHQ addresses sleep latency as how often the child 
falls asleep within 20 minutes of going to bed (Owens, Spirito, & McGuinn, 2000).  
Sleep diaries record information about time to bed, sleep onset latency, and number and length of 
night wakings, final awakening time in the morning, and subjective evaluation of sleep quality. Sleep 
diaries may take the form of simply writing information in a journal, shading in a bar graph with sleep 
time, or the standardized Consensus Sleep Diary (CSD). The CSD gathers the above information, and 
may also ask if final awakening time was earlier than planned, excess daytime sleepiness and napping 
during the day, caffeinate consumption during the day, and sleep medications taken (Carney et al., 2012; 
Luyster et al., 2015).  It is recommended that sleep diaries capture at least five weekday nights to most 
accurately record adolescent bedtimes, sleep onset latency, and sleep duration (Short, Arora, Gradisar, 
Taheri, & Carskadon, 2017). Sleep diaries may underestimate length of night awakenings, and 
overestimate total sleep time when compared with ACT recordings, although ACT may record 
movements during sleep as activity and quiet time while awake as sleep (Short, Gradisar, Lack, Wright, & 
Carskadon, 2012).    
1.2.3.3 Support for investigation of sleep patterns in autism spectrum disorder 
Abnormal sleep patterns in ASD have long been recognized by researchers (Ornitz et al., 1969; Tanguay, 
Ornitz, Forsythe, & Ritvo, 1976). Polysomnography studies have shown that, compared with typically 
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developing [TD] peers, children with ASD have significantly lower average time in bed (mean: 
9.2±0.56hrs vs. 8.4±0.45hrs), sleep period time (sleep onset to sleep end, mean: 8.9±0.45hrs vs. 
7.7±0.75hrs), and total sleep time (sleep period time – wake after sleep onset + movements, mean: 
8.7±0.40hrs vs. 7.5±0.83hrs, all p ≤ 0.02; Elia et al., 2000). Krakowiak, Goodlin-Jones, Hertz-Picciotto, 
Croen, & Hansen (2008) developed and performed factor analysis on the CHARGE Sleep History, their 
parent-report, 30-item sleep questionnaire for children with ASD similar to the well-validated Children’s 
Sleep Habits Questionnaire (Owens et al., 2000), revealed two factors: sleep onset problems (7 items, 
ɑ=0.79) and night waking (4 items, ɑ=0.81). The most common sleep onset problem was trouble falling 
asleep (p<0.0001), and the most common night waking problem was parasomnias, particularly waking up 
screaming during the night (p=0.0014).  
 Multiple ASD studies have confirmed that the most common complaints about sleep patterns in 
ASD are problems settling to bed, also referred to as Behavioral Insomnia of Childhood (Goldman et al., 
2010; Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014; Mazurek & Petroski, 2015), trouble falling 
asleep (Aldinger, Lane, Veenstra-VanderWeele, & Levitt, 2015; Allik et al., 2008; Fadini et al., 2015; 
Suzanne E Goldman et al., 2010; Krakowiak et al., 2008; Miano et al., 2007), frequent and/or long night 
wakings (Giannotti et al., 2008; Goldman et al., 2010; Hodge, Carollo, Lewin, Hoffman, & Sweeney, 
2014), early morning waking (Cotton & Richdale, 2006; Gail Williams et al., 2004; Wiggs & Stores, 
2004), decreased sleep duration (Aldinger et al., 2015; Elrod & Hood, 2015; Giannotti et al., 2011; 
Goldman et al., 2010) and daytime sleepiness (Giannotti et al., 2011; Goldman et al., 2010; May, Cornish, 
Conduit, Rajaratnam, & Rinehart, 2015). 
1.2.3.4 Comparison of sleep in children with ASD and TD children 
A variety of objective and subjective measures reveal that bedtime difficulties—bedtime resistance, sleep 
anxiety, difficulty falling asleep—are significantly more common in children with ASD than their TD 
counterparts (Table 10). Significantly higher (worse) bedtime resistance, sleep anxiety, and sleep onset 
delay subscale scores on the CSHQ have been reported by numerous research groups in ASD samples 
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when compared to TD samples (Flavia Giannotti et al., 2008, 2011; Hodge et al., 2014; May et al., 2015; 
Souders et al., 2009). Children in these samples range from 2.5- to 17-years-old, demonstrating the 
presence of sleep problems throughout childhood and adolescence. Giannotti et al. (2008) divided their 
ASD sample of children 2.5- to 8-years-old into developmentally regressed (n=70; lost developmental 
skills after period of typical or mildly delayed development) and non-regressed children (n=34, symptoms 
apparent early in life with delayed developmental milestones; TD n=162; Williams, Brignell, Prior, 
Bartak, & Roberts, 2015). They found that regressed children had significantly greater scores on the 
CSHQ bedtime resistance and sleep onset delay subscales than non-regressed children with ASD and TD 
children (p<0.01). Regressed children also were found on parent-report sleep diaries to have significantly 
longer sleep onset latency than non-regressed children with ASD and TD children (p < 0.01). Using 
objective measures of sleep onset latency, several research groups have reported greater sleep onset 
latency in children with ASD than TD children aged 2- to 19-years, again demonstrating persistence of 
sleep problems through childhood and adolescence (ACT: Goldman et al., 2017; Lambert et al., 2016; 
Souders et al., 2009; PSG: Elrod & Hood, 2015; Giannotti et al., 2011; Lambert et al., 2016). In a meta-
analysis of ten studies, Elrod and Hood (2015) found a significant pooled mean delay in sleep onset 
latency of 10.9 minutes (95% CI: 6.7 to 15.0) in children with ASD compared to TD children. 
Children with ASD are also reported to have significantly more nighttime sleep problems than 
their TD peers. Using the CSHQ, children with ASD are reported to have significantly worse scores on 
night waking, parasomnia, and sleep duration subscale scores than TD children 2.5- to 17-years-old 
(Flavia Giannotti et al., 2008, 2011; Hodge et al., 2014; May et al., 2015; Souders et al., 2009). A 
common complaint of parents who have children with ASD, waking after sleep onset (WASO) was 
confirmed to be a significantly greater problem in children with ASD than TD children. 
Polysomnography revealed a greater percentage of total sleep time spent awake after sleep onset in 
children with ASD 5- to 10-years-old, and worse in regressed than non-regressed ASD (p < 0.05; 
Giannotti et al., 2011); and ACT showed a greater number and length of WASO in children with ASD 
aged 4- to 15.5-years-old (p < 0.05; Allik, Larsson, & Smedje, 2008; Souders et al., 2009). Sleep 
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efficiency (total sleep time/time in bed) is reported to be significantly lower in children with ASD using 
ACT in children greater than 6-years-old (p<0.05; Fletcher et al., 2016; Goldman et al., 2017); and using 
PSG in children 5- to 10-years old (p < 0.05; Giannotti et al., 2011). Overall, total sleep time has been 
shown to be significantly less in children with ASD than TD children throughout childhood and 
adolescence using parent-report sleep diaries (Flavia Giannotti et al., 2011; Hodge et al., 2014), CSHQ 
(Flavia Giannotti et al., 2008, 2011; Hodge et al., 2014; Souders et al., 2009), ACT (Goodlin-Jones, Tang, 
et al., 2008), and PSG (all p < 0.05; Buckley et al., 2010; Giannotti et al., 2008, 2011; Miano et al., 2007) 
Nighttime sleep problems are often followed by daytime sleepiness in all children, although less 
is published comparing ASD to TD. Children with ASD of all ages have received worse daytime 
sleepiness scores on the CSHQ daytime sleepiness subscale (2.5-12-years-old; p<0.05; Giannotti et al., 
2008; May et al., 2015) and on the Sleep Disturbance Scale (3.7-19-years-old; p < 0.05; Miano et al., 
2007). Souders et al. (2009), however, did not find a significant difference between children with ASD 
and TD on the CSHQ daytime sleepiness subscale. 
The notable shifts in sleep patterns that occur around puberty in TD children are believed to occur 
in adolescents with ASD as well. Allik et al.(2008) observed over the course of 2-3 years that a sample of 
adolescents with ASD (mean age time 1=11.1 years, time 2=13.7 years) developed significantly later 
sleep onset time (difference= 40.2±57.3 minutes, p=0.01) and wake time (difference=38.8±69.2 minutes, 
p<0.01). The same pattern was observed in age- and gender-matched TD controls. The amount of sleep 
needed appears to remain constant across pubertal stages (Carskadon et al., 1979). The average age of 
puberty (Tanner stages 2-4) in the United States is between 8-13-years for girls, and 9-14-years for boys; 
mean age of menarche is 12.2-12.8-years (Al-Sahab, Ardern, Hamadeh, & Tamim, 2012; Cabrera, Bright, 
Frane, Blethen, & Lee, 2014). Pubertal development was not well characterized in the SSC. For these 
reasons, children in SSC sample will be divided into three age groups: early childhood (4-8-years), 
middle childhood (9-13- years), and late childhood (14-18-years). 
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1.2.3.5   Intellect, ASD severity, and sleep 
It has been suggested that intellectual disability (ID; Full scale IQ < 70 with functional deficits; World 
Health Organisation, 1996) may alter sleep patterns in children with ASD. Two recent studies have noted 
that ASD with ID was associated with sleep anxiety in children 2- to 5-years-old (p<0.001), bedtime 
resistance and night wakings in children 6- to 18-years-old (p < 0.05; Mazurek & Petroski, 2015), and 
short sleep duration in children 4- to 18-years-old (p < 0.001; Veatch et al., 2017). A meta-analysis of ten 
studies revealed that children with ASD and comorbid ID had significantly lower total sleep time than TD 
children (pooled difference of means = -45 minutes; 95% CI: -62.6 to -28.6, p < 0.001), while there was 
no significant difference in total sleep time between children with ASD and no ID compared to TD 
children (p = 0.316).  
Severity of ASD may also contribute to abnormal sleep patterns in children. In a population of 
1,224 children, those with parent-reported sleep problems (falling asleep and staying asleep) were 
observed to have higher ASD severity scores on the Autism Diagnostic Inventory-Revised social 
interaction, communication, and restricted, repetitive behavior subscales (Lord, Rutter, & Le Couteur, 
1994); and on the Vineland Adaptive Behavior Scale (Sparrow, Balla, Cicchetti, Harrison, & Doll, 1984) 
communication, socialization, daily living skills, and motor skills subscales than children without sleep 
problems (Zachor & Ben-Itzchak, 2016; p < 0.02). Using the Autism Diagnostic Observation Scale 
(ADOS; Hus, Gotham, & Lord, 2014; Lord et al., 1989) as an indicator of ASD severity, Veatch et al. 
(2017) observed that short sleep duration was significantly negatively correlated with ADOS social affect 
severity scores (ρ= -0.06, p < 0.02), though not with total ADOS severity score.  
The correlations between sleep patterns and behavior are striking in children with ASD. Using the 
Pediatric Behavior Scale and the Checklist for Autism Spectrum Disorder, sleep problems—difficulty 
falling asleep and staying asleep, restlessness, parasomnias, waking too early, and less total sleep time—
were significantly related to oppositional behavior, aggression, explosiveness, attention deficit and 
hyperactivity, anxiety, depression, and mood variability (r = 0.26-0.42, p < 0.01; Mayes & Calhoun, 
2009). By contrast, greater total sleep time significantly predicted better adaptive behavior, motor skills, 
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socialization, and daily living skills on the Scales of Independent Behavior-Revised and the Vineland 
Adaptive Behavior Scale. It was even suggested that more hours of sleep per night may translate into 
higher full-scale IQ scores on age-appropriate Stanford-Binet or Wechsler Intelligence scales (Taylor, 
Schreck, & Mulick, 2012). Some uncertainty exists, however, about whether behavior problems predict 
sleep patterns or the other way around. 
1.2.3.6   Medical conditions and sleep 
Two medical comorbidities that have been associated with sleep problems in children with ASD are 
gastrointestinal disturbance (GID: diarrhea, constipation, vomiting or reflux, abdominal pain, bloating, 
etc.) and seizures. Presence of epilepsy and epileptiform EEG abnormalities have both been reported as 
predictors of sleep problems (Giannotti et al., 2008; p < 0.01). Aldinger, Lane, Veenstra-VanderWeele, 
and Levitt (2015) report that, among children with ASD and sleep problems in the SSC, the odds of 
having GID (23% of sample) were almost two times higher than for children without sleep problems 
(OR=1.8, 95% CI: 1.5-2.3), and the odds of having both GID and seizures (2.6% of sample) was twice as 
high as children without sleep problems (OR=2.0, 95% CI: 1.3-3.1).  In the Autism Genetic Resource 
Exchange, Aldinger et al. also report that children with sleep problems, seizures, and GID had a two 
standard deviation lower Vineland Adaptive Behavior Scale composite score than children with none of 
the three comorbidities. 
1.2.3.7  Support for investigation of circadian genes and sleep patterns 
Components of sleep, such as onset, duration, and sleep stages, appear to be highly heritable based on 
monozygotic and dizygotic twin studies (Ambrosius et al., 2008; De Gennaro et al., 2008). Studies of 
twins have also revealed that diurnal preference—morning or evening—is about 50% heritable 
(Koskenvuo, Hublin, Partinen, Heikkila, & Kaprio, 2007), and habitual bedtime is about 22-25% heritable 
(Gottlieb, O’Connor, & Wilk, 2007). Multiple gene/hormone pathways expressed throughout the brain 
may contribute to regulation of sleep patterns. These include serotonin (Frank, Stryker, & Tecott, 2002; 
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Popa, El Yacoubi, Vaugeois, Hamon, & Adrien, 2006), dopamine (Goel, Banks, Lin, Mignot, & Dinges, 
2011; Kume, Kume, Park, Hirsh, & Jackson, 2005), histamine (Anaclet et al., 2009), adenosine (Bjorness, 
Kelly, Gao, Poffenberger, & Greene, 2009; Stenberg et al., 2003), ɣ-aminobutyric acid (GABA; Winsky-
Sommerer, 2009); cytokines (Clinton, Davis, Zielinski, Jewett, & Krueger, 2011; Darko et al., 1995); 
orexin (Anaclet et al., 2009; Mochizuki et al., 2004); and melatonin/SCN (Isobe & Nishino, 2004; Moore, 
Speh, & Leak, 2002; Pandi-Perumal, Srinivasan, Spence, & Cardinali, 2007). Some pathways, such as 
orexin (Anaclet et al., 2009; Ebrahim, Howard, & Kopelman, 2002), dopamine (Andretic, van Swinderen, 
& Greenspan, 2005; Kume et al., 2005), and histamine (Parks et al., 2014; Thakkar, 2011) provide arousal 
cues; while others, such as GABA (Alam et al., 2005; Goutagny, Luppi, Salvert, Gervasoni, & Fort, 
2005), adenosine (Basheer, Porkka-Heiskanen, Strecker, Thakkar, & McCarley, 2000; Porkka-Heiskanen 
et al., 1997), and the cytokines, interleukin-1β and tumor necrosis factor promote sleep (Krueger, Rector, 
& Churchill, 2007).  
The most thoroughly studied and well-replicated pathway regulating timing, onset, and 
maintenance of sleep are the melatonin/SCN pathways (Table 1; Dardente & Cermakian, 2007; Ko & 
Takahashi, 2006). The SCN, the circadian pacemaker of the body, is a small group of compact neurons 
sitting atop the optic chiasma in the hypothalamus. The SCN is responsible for controlling the sleep-wake 
cycle, and coordinating physiologic functions according to circadian phase. When signaled by decreasing 
light through the retinohypothalamic pathway, the SCN stimulates the pineal gland to produce melatonin 
(Moore, 1996; Moore et al., 2002). The melatonin synthesis pathway is a four-step process carried out in 
the pineal gland via the expression of TPH2 (Carkaci-Salli et al., 2006; Zhang, Beaulieu, Sotnikova, 
Gainetdinov, & Caron, 2004), DDC (Lauritsen et al., 2002; National Center for Biotechnology 
Information, 2014b; Sumi-Ichinose, Ichinose, Takahashi, Hori, & Nagatsu, 1992),  AANAT (Blomeke, 
Golka, Griefahn, & Roemer, 2008; Coon et al., 1996), and ASMT (Huafang, Donohue, Klein, & Mcbride, 
1992; National Center for Biotechnology Information, 2014b; L. Wang et al., 2013). When melatonin 
binds to the SCN’s MTNR1A and MTNR1B receptors, it entrains the circadian rhythm to 24-hours. In 
general, MTNR1A suppresses SCN neuronal excitability at night, whereas MTNR1B receptors shift phase 
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by switching the SCN from daytime high-electrical, low hormone mode to nighttime low-electrical, high 
hormone mode (Dubocovich, Benloucif, & Masana, 1996; Liu et al., 1997).  
Oscillations in the expression of core SCN genes influence sleep by driving phase shifts in two 
main autoregulatory feedback loops. At the center of both loops are the core transcriptional regulators 
CLOCK and ARNTL. In the first loop, CLOCK and ARNTL heterodimerize to activate the rhythmic 
transcription of PERIOD (PER1, PER2, PER3) and CRYPTOCHROME (CRY1, CRY2) genes (King et al., 
1997; Kondratov et al., 2003; National Center for Biotechnology Information, 2014a, 2014a).  DBP, 
although not necessary for maintenance of circadian rhythm, enhances CLOCK:ARNTL activation of PER 
(Lopez-Molina, Conquet, Dubois-Dauphin, & Schibler, 1997). Activated by the CLOCK:ARNTL 
heterodimer, PER and CRY proteins accumulate in the cytoplasm throughout the day and then form 
PER:CRY heterodimers that enter the nucleus and repress the CLOCK:ARNTL complex (Nieto et al., 
2015; UniProtKB, 2014a, 2014b). This repression may be aided by TIMELESS (Sangoram et al., 1998).  
Degradation of PER and CRY by casein kinase (CSNK1D, CSNK1E) phosphorylation allows the feedback 
loop to begin again (National Center for Biotechnology Information, 2014). 
The second loop regulates expression of ARNTL and activates genes that carry messages within 
and out of the SCN. The nuclear orphan receptor genes, RORA/B upregulate, and NR1D2 downregulates, 
expression of ARNTL. BHLHE40/41 (Kawamoto et al., 2004; Nakashima et al., 2008; Sato et al., 2004)  
and CIART (Goriki et al., 2014) interfere with the activation of core circadian genes by ARNTL. The SCN 
distributes its circadian message to receptors in the brain and peripheral tissues using several 
neurotransmitters (Born, Kellner, Uthgenannt, Kern, & Fehm, 1992; Scheer, Ter Horst, Van der Vliet, & 
Buijs, 2001; Vázquez-Palacios, Retana-Márquez, Bonilla-Jaime, & Velázquez-Moctezuma, 2001) or 
autonomic nerves to deliver electrical messages directly to targeted tissues (Bamshad, Song, & Bartness, 
1999; Buijs et al., 1999; Buijs, Chun, Niijima, Romijn, & Nagai, 2001; Gerendai, Toth, Boldogkoi, 
Medveczky, & Halasz, 2000; Kalsbeek, Fliers, Franke, Wortel, & Buijs, 2000). PROK2 acts as a key 
signaling molecule within the SCN and to other regions of the brain (Cheng et al., 2002; Masumoto et al., 
2006). The primary neurotransmitter carrying messages from the SCN to the pineal gland is GABA, 
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encoded by the GAD1 and GAD2 genes (Erlander, Tillakaratne, Feldblum, Patel, & Tobin, 1991; Liu & 
Reppert, 2000; O’Hara, Andretic, Heller, Carter, & Kilduff, 1995).  
 
 
Table 1: Melatonin and SCN Genes 
Gene Name Function Associations 
TPH2*  tryptophan hydroxylase 2  5-hydroxylation of L-tryptophan to  5HTP  
DDC*  dopa decarboxylase  Decarboxylation of 5HTP to 5HT  
AANAT  aralkylamine N  acetyltransferase 
 N-acetylation of 5HT to N 
 acetylserotonin 
 DSPS (Hohjoh et al., 2003), 
 short sleep duration (Wang, 
 Lee, & Lee, 2004) 
ASMT*  acetylserotonin O  methyltransferase 
 O-methylation of N-acetylserotonin to 
 melatonin 
 Sleep efficiency in ASD 
 (Melke et al., 2008) 
MTNR1A*  melatonin receptor 1A  Suppresses SCN neuronal firing  
MTNR1B*  melatonin receptor 1B  Induces circadian phase shifting  Insomnia in ASD (Yang et  al., 2016) 
CLOCK*  clock circadian regulator 
 Transcription factor, with ARNTL 
 activates transcription of PER, CRY, 
 NR1D2, RORA/B, PROK2, 
 TIMELESS 
 Narcolepsy (Moreira et al., 
 2005), sleep duration 
 (Allebrandt et al., 2010) 
ARNTL  aryl hydrocarbon receptor  nuclear translocator-like 
 Transcription factor, with CLOCK 
 activates transcription of PER, CRY, 
 NR1D2, RORA/B, PROK2, 
 TIMELESS 
 Altered sleep patterns, later 
 sleep onset and wake time in 
 elderly (Evans et al., 2013) 
PER1*  period circadian clock 1  Feedback regulation of  CLOCK:ARNTL 
 Extreme diurnal preference 
 (Carpen, von Schantz, Smits, 
 Skene, & Archer, 2006) 
PER2  period circadian clock 2  Maintains clock gene RNA rhythms 
 FASPS (Shanware et al., 
 2011), DSPS (Hamet & 
 Tremblay, 2006) 
PER3*  period circadian clock 3  Maintains cycle length 
 DSPS (Archer et al., 2010), 
 extreme diurnal 
 preference (Archer et al., 
 2003) 
CRY1  cryptochrome 1  Repression of CLOCK:ARNTL;   translocation of PER to nucleus  
CSNK1D*  casein kinase 1, delta  Phosphorylates PER induces  translocation of PER3 to nucleus  FASPS (Brennan et al., 2013)  
CSNK1E  casein kinase 1, epsilon  Ubiquinates, translocates PER3 to  nucleus; phosphorylation of PER 
 DSPS, non-24h sleep–wake 
 syndrome (Takano et al., 
 2004) 
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RORA*  RAR-related orphan receptor  A  
Activates CLOCK and ARNTL 
 expression  
 Rigid circadian type (Etain et 
 al., 2014), early 
 morning awakening in 
 depression (Utge et al., 2010) 
RORB  RAR-related orphan receptor  B  Activates ARNTL expression 
 Free-running rhythmicity 
 (André et al., 1998) 
NR1D2  Nuclear receptor subfamily  1 group D member 2 
 Transcription factor, represses ARNTL 
 expression  
BHLHE40  Basic HLH family member  E40 
 Represses CLOCK:ARNTL activation 
 of PER1 
 Non-24 hour sleep-wake 
 syndrome (Kripke et al., 
 2014) 
BHLHE41 
 
 Basic HLH family member 
 E41 
 Represses CLOCK:ARNTL activation 
 of PER1 
 Short sleep duration (He et 
 al., 2009) 
CIART  Circadian associated  repressor of transcription 
 Interferes with ARNTL to repress 
 CLOCK:ARNTL activity  
GAD1*/2  Glutamate decarboxylase  Catalyze production of GABA, the  main SCN output neurotransmitter  
PROK2  Prokineticin 2  Transmits circadian signals from SCN 
 Sleep duration (Gottlieb et 
 al., 2007), reduced 
 rhythmicity (J. Li et al., 
 2006) 
DBP 
 D Site of Albumin Promoter 
 (Albumin D-Box) Binding 
 Protein 
 Enhances activation of PER regulates 
 clock output signals 
 Sleep consolidation (Franken, 
 Lopez-Molina, Marcacci, 
 Schibler, & Tafti, 2000), 
 sleep duration (Yamajuku et 
 al., 2011) 
TIMELESS*  Timeless Circadian Clock  Interacts with PER to repress  CLOCK:ARNTL 
 Sleep disturbance in 
 depression (Utge et al., 2010) 
 and ASD (Yang et al., 2016), 
 later sleep onset (Etain et al., 
 2014) 
DSPS=delayed sleep phase syndrome; FASPS=familial advanced sleep phase syndrome; * significant variants 
identified in ASD risk; bold print designates genes with significant expression in CMC data 
 
 
Variations in core melatonin and SCN genes have been correlated with abnormal sleep patterns in 
individuals with ASD. Spurred by reports of abnormal melatonin levels in individuals with ASD, 
(Kulman et al., 2000; Leu et al., 2011; Nir, Meir, Zilber, Knobler, & Hadjez, 1995; Tordjman, Anderson, 
Pichard, Charbuy, & Touitou, 2005) Melke et al.(2008) examined variations in ASMT in 250 individuals 
with ASD, and 255 controls. Two promoter polymorphisms were found significantly more frequently in 
individuals with ASD (rs4446909 and rs5989681, p<0.000) leading to a substantial decrease in ASMT 
activity (p=2x10-12) and melatonin level (p=3x10-11) in two triads (mother, father, child). In addition, a 
splice-site mutation (IVS5+2T>C) was correlated in ASD with decreased sleep efficiency (70-82% vs. 
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>85% in controls) and increased night wakings (17-22 times/hr vs. <10 times/hr in controls) in one triad. 
More recently, Veatch et al. (2015) confirmed a high frequency of two ASMT polymorphisms previously 
reported by Melke et al. (rs4446909 and rs5989681) in a group of fifteen unrelated children with ASD 
and sleep onset delay. Yang et al.(2016) took a broader approach, examining 18 melatonin and SCN 
genes in individuals with ASD with (n=14) and without self-reported abnormal sleep patterns (n=14) and 
controls (n=23). Six missense changes found exclusively in individuals with ASD and abnormal sleep 
problems were observed in CLOCK (c.2551A>G), MTNR1B (c.974G>A), PER3 (c.1447C>T, 
c.1361G>A), NIR1D1 (c.58A>C), and TIMELESS (c.1493T>C). These studies are limited in their ability 
to identify meaningful associations between genomic and biochemical variants and sleep patterns by their 
small sample sizes and choice of only one gene. 
Intriguingly, and in support of an abnormality in melatonin synthesis or use by the body, a 
multitude of studies have shown that exogenous melatonin supplementation in children with ASD 
significantly improves sleep latency, duration of sleep, and sleep efficiency (Cortesi, Giannotti, 
Sebastiani, Panunzi, & Valente, 2012; Gringras, Nir, Breddy, Frydman-Marom, & Findling, 2017;  
Malow et al., 2012; Wirojanan et al., 2009; Wright et al., 2011). In a recent meta-synthesis of eight 
systematic reviews examining melatonin supplementation in children with ASD, it was concluded that 
there is strong evidence for a positive effect of melatonin on sleep latency, total sleep time, bedtime 
resistance, and need for co-sleeping; and moderate evidence for a positive effect on night wakings, 
activity during the night, and the longest sleep episode without waking (Cuomo et al., 2017). Rossignol 
and Frye (2011; included in Cuomo et al. meta-synthesis) showed in a meta-analysis of five randomized, 
double-blind, placebo-controlled studies of melatonin supplementation revealed significant improvements 
from baseline in total sleep time (73 min greater vs. 44 min with placebo) and sleep latency (66 min less 
vs. 39 min with placebo; both p<0.01).  An open-label trial of controlled-release melatonin 
supplementation report sustained improvements in sleep latency, bedtime resistance, total sleep time, 
night wakings, and need for a parent to co-sleep up to 2-years after starting melatonin (p < 0.001), and a 
relapse in sleep problems when taken off the melatonin (NS; Giannotti, Cortesi, Cerquiglini, & Bernabei, 
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2006).  These studies report that melatonin supplements were well-tolerated with mild to no adverse 
effects. 
1.3 PRELIMINARY STUDIES 
1.3.1 Simons Simplex Collection Sleep Interview 
In order to study sleep patterns in the SSC sample, psychometric evaluation was performed on items 
pertaining to sleep from the SSC medical history form. The medical history form used 18 questions 
(“Does your child currently or has your child ever had…”) to investigate sleep habits—bedtime, 
waketime, sleep duration; daytime problems as a result of sleep patterns—difficulty waking, naps, 
daytime sleepiness; and associated symptoms—sleep disordered breathing, parasomnias, enuresis. 
Correlational analyses and exploratory factor analysis was executed on this data from the sample of 2,737 
children with ASD aged 4-18 years to develop the Simons Simplex Collection Sleep Interview (SSCSI; 
Table 10). The resulting cross-sectional, parent-report questionnaire is comprised of ten dichotomous 
(yes/no) items in three subscales: Nighttime Problems (bedtime problems, need to lay down with child, 
difficulty falling asleep, frequent/prolonged awakenings), Daytime Problems (difficulty waking, excess 
daytime sleepiness, long/frequent naps, regular duration is not enough), and Sleep Duration Problems 
(irregular bedtime and/or waketime, no regular duration). An eleventh question asks for the child’s 
regular sleep duration in hours.  The SSCSI is scored by giving one point for each “yes” response to the 
ten dichotomous items, and also one point if the regular sleep duration is outside the duration 
recommended by the National Sleep Foundation for the child’s age (Hirshkowitz et al., 2015). The points 
for these eleven questions are summed to yield a composite score (range = 0-11), and three subscale 
scores (Nighttime Problems and Daytime Problems: range = 0-4; Sleep Duration Problems: range = 0-2). 
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These scores will be used as the dependent variables in the proposed dissertation project. (See Manuscript 
1, Psychometric properties of the Simons Simplex Collection Sleep Interview, for a full description.) 
1.4 RESEARCH DESIGN AND METHODS 
This study was a secondary analysis of data from the SSC, a large and very well characterized GWAS of 
physical, behavioral, and cognitive correlates of ASD. Due to the nature of this sample, we were able to 
test for association using quantitative trait techniques to examine associations between child 
characteristics (age, sex, intellect, ASD severity, and medical conditions) and sleep patterns, and between 
gene variants and sleep patterns in children with ASD.  
1.4.1 Parent study design and sample 
The Simons Foundation Autism Research Initiative (SFARI) began in 2003 with the goal of improving 
the scientific understanding of ASD. One of their major projects was the SSC, a sample of 2,744 simplex 
families from 12 sites in the United States. (Simplex means only one subject with ASD, termed the 
proband, in a nuclear family; and, for the SSC, no other family member up to third degree relatives 
affected with ASD.) The goal of the SSC was to identify highly penetrant, rare de novo mutations and 
copy number variants associated with ASD. Its data have been used to study genomics of cognition and 
behavior in ASD (Frazier, Georgiades, Bishop, & Hardan, 2014), intellectual disability (Gamsiz et al., 
2013), the broad autism phenotype (Davidson et al., 2014), and the impact of copy number variants on 
ASD (Luo et al., 2012). More than thirty instruments were used, or interviews conducted, to collect many 
other variables with which we can study ASD in the future. These include demographics; family health, 
psychiatric, developmental, and environmental exposure histories; proband medical, developmental, 
treatment, school, and ASD histories; and current proband comorbidities, intelligence, behavior, motor 
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skills, and speech. Blood samples were taken from biological parents, the proband, and one full sibling, if 
available (Fischbach & Lord, 2010; Simons Foundation Autism Research Initiative, 2014). 
Families were recruited from clinics at the University of Michigan, Yale University, Emory 
University, Columbia University, Vanderbilt University, McGill University, Harvard University 
(Children’s Hospital of Boston), the University of Washington, the University of Illinois (Chicago), the 
University of Missouri, the University of California-Los Angeles, and the Baylor College of Medicine. 
Local service providers and parent and advocacy groups were enlisted to aid in recruitment, in addition to 
web postings and radio and television ads.  
Children were included if they were between 4- and 18-years-old; met the criteria for ASD based 
on the Autism Diagnostic Observation Schedule [ADOS], Autism Diagnostic Interview-Revised [ADI-
R], and Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revised; and had a non-verbal 
mental age of at least 24-months (in probands 4- to 7-years-old), or 30-months (in probands ≥7-years-
old). Probands were excluded if they were born at < 36-weeks and had a birth weight <2,000 grams; were 
born with a significant injury, abnormality, or disorder affecting the brain; had extended prenatal or birth 
complications; had fragile X or Down syndrome; had sensory or motor disorders that would confound 
diagnostic measures; had a history of severe nutritional or psychological deficiency; or were not fluent in 
English (Simons Foundation Autism Research Initiative, 2014). Informed consent was obtained for the 
SSC study from parents or caregivers, and assent was obtained from children as required by local 
institutional review boards. 
Probands were strictly phenotyped through parent interview, medical history, and multiple well-
validated instruments. Children were given a clinical best estimate diagnosis of autism or ASD based on 
observation, medical history and chart review, and ADOS and ADI-R scores. Diagnoses were based on 
the Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revised [DSM-IV-TR] (Simons 
Foundation Autism Research Initiative, 2014).  
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1.4.2 Study procedures 
Approval was obtained from the University of Pittsburgh Institutional Review Board for the current 
study. Data was de-identified by the SFARI prior to receipt by the present researchers. All phenotypic and 
genomic data were obtained from the SSC through the SFARI software platform, SFARI Base. 
Demographic data (age, sex, etc.) were collected when families entered the SSC study. The present study 
tried to capture normal changes in sleep patterns by dividing the sample into three age groups called early 
(4-8-years), middle (9-13- years), and late (14-18-years) childhood. As analysis of the sample (Johansson, 
Feeley, Dorman, & Chasens, n.d.), revealed associations between sleep problems and presence or absence 
of GID, non-verbal IQ (NVIQ), and ADOS total score, these variables, with the addition of seizures, will 
be used as covariates in analysis. The medical condition, GID, was defined as parent reports of 
bloating/excess gas, celiac disease, constipation, diarrhea, ulcers, gastroesophageal reflux disease, 
inflammatory bowel disease (Crohn’s disease, ulcerative colitis), irritable bowel syndrome, abdominal 
pain, unusual stools, vomiting, and/or other GID; and seizures as parent reports atonic drop, infantile 
spasms; or partial complex, grand mal, petit mal, simple partial, and/or other seizures. Presence or 
absence of GID and seizures was determined using data from the medical history interview conducted by 
the parent study at baseline. Participants were excluded from the present study if more than two SSCSI 
items were missing or coded unknown, or if the child was missing both ADOS and IQ measures. 
1.4.2.1 Genotype data collection 
Variants used in analysis of genes and sleep problems were identified using gene expression data from the 
CommonMind Consortium (CMC; Fromer et al., 2016), the Genotype-Tissue Expression project (GTEx; 
The GTEx Consortium, 2015), HaploReg v.4 (Ward & Kellis, 2016), and previous literature (Melke et al., 
2008; Veatch et al., 2015; Yang et al., 2016) (Table 12). The CMC used RNA Seq data from dorsolateral 
prefrontal (DLPFC) brain tissue of 279 control individuals and 258 adult individuals diagnosed with 
neuropsychiatric disorders. Using the RNA sequencing data and genotypes from the same subjects, gene 
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expression and how it relates to genetic variation in candidate genes was assessed at almost 10 million 
loci using regression methods. This identified expression quantitative trait loci (eQTLs), SNPs or 
genomic variants that affect the expression of one or more genes (Albert & Kruglyak, 2015).  
Figure 3 displays the flow of variant selection from the CMC, GTEx, HaploReg, and variants 
previously identified by other groups as related to sleep in ASD. For the current study, gene expression 
was analyzed in cis- (within 1Mb of gene) variants with a false discovery rate threshold FDR ≤ 0.05. This 
revealed that 17 of the 25 genes are expressed in substantial quantities in the CMC DLPFC data (TPH2, 
CLOCK, ARNTL, PER1/2/3, BHLHE40/41, DBP, GAD1/2, NR1D2, RORA/B, CSNK1D/E, CRY1), and 
identified 5,133 cis-eQTLs whose genotypes correlate with the total abundance of transcripts of its nearby 
gene. From this list, all eQTLs with a p-value < 0.001 were chosen. Using genotypes from 1000 Genomes 
(Auton et al., 2015), the eQTLs were analyzed using the independent pairwise function in Plink, which 
prunes the list based on linkage disequilibrium (LD). The settings used were a window of 50 SNPs, 
moving by 5 SNPs at each step, and an r2 = 0.5. When eQTL were not present in the SSC data, proxy 
eQTL in significant LD were substituted; SNAP Proxy Search was used to find proxy eQTLs (Broad 
Institute, 2015). This resulted in 72 eQTL; 49 were available in SSC data (32 proxy eQTL were 
substituted). eQTLs were not found in the CMC analysis for CRY1. 
To identify eQTLs for 7 of the remaining 8 genes (MTNR1B, CRY1, DDC, AANAT, PROK2, 
CIART, TIMELESS), data was used from the GTEx project (The GTEx Consortium, 2015). The GTEx 
project aimed to further the understanding of functional genomic variation, including how this variation 
impacts human disease and traits, by identifying eQTLs for all genes in a variety of human tissue types. 
For the 7 genes, 1,051 eQTLs were available in the GTEx database; 556 of these were unique (not 
repeated). Using genotypes from 1000 Genomes, Plink pruned these down to 40 eQTLs. The settings 
used were a window of 50 SNPs, moving by 5 SNPs at each step, and an r2 = 0.5. Of the 40 eQTLs, 16 
were available in the SSC data (12 proxy eQTLs were substituted). 
HaploReg acquired SNP and eQTL results from GTEx pilot analysis v.6 (The GTEx Consortium, 
2015), the GEUVADIS project (Lappalainen et al., 2013)s, the GRASP database (Eicher et al., 2015), and 
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a dozen studies (Fairfax et al., 2014; Gibbs et al., 2010; Grundberg et al., 2011; Hao et al., 2012; 
Koopmann et al., 2014; Q. Li et al., 2014; Montgomery et al., 2013; Ramasamy et al., 2014; Schadt et al., 
2008; Stranger et al., 2009; Westra et al., 2013; Zou et al., 2012). For MTNR1A, 2,149 SNPs were found 
in the Haploreg v.4.1 program using the location of the gene plus 50KB on each side (chr4:187404809-
187526537). Of these, 12 variants had data for expression. The 12 eQTLs were analyzed using the 
independent pairwise function in Plink, using the previous settings. This resulted in 8 eQTL; 3 were 
available in SSC data (1 proxy eQTL was used).  
From previous literature on sleep patterns in individuals with ASD, 26 variants were identified 
from 10 genes (ASMT, CLOCK, CSNK1D/E, MTNR1A/B, NR1D1, PER1/2/3, TIMELESS). Four of these 
variants were available in the SSC data (2 proxies were used): ASMT rs4446909 was identified by Melke 
et al. (2008) and Veatch et al. (2015); PER2 rs934945, PER3 rs10462020 (proxy: rs10462021), and 
PER3 rs228697 (proxy: rs228690) were identified by Yang et al. (2016).  
In all, 72 independent eQTLs or SNPs were identified (Table 12: CMC = 50, GTEx = 16, 
Haploreg = 3, literature = 4). The variants from CMC, GTEx, and Haploreg are eQTLs or putative 
eQTLs; the four variants from literature are SNPs for which their effect on expression was not 
investigated. The 72 eQTLs and SNPs will henceforth be referred to as “variants.” When proxy eQTL 
were required, SNAP Proxy Search was used to find proxy eQTLs (Broad Institute, 2015).   
Individuals in the SSC sample were genotyped using either Illumina 1Mv1 (approximately 325 
families), Illumina 1Mv3 Duo (approximately 1,160 families), or Illumina HumanOMNI 2.5 
(approximately 625 families) arrays. The same array version was used to analyze all members of a family. 
 
 
 
 
 
 
 30 
 
Figure 3: Flowchart of Genetic Variant Selection 
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1.4.3 Instruments 
1.4.3.1  Sleep 
The SSCSI, an 11-item parent-report questionnaire, was used for assessing bedtime and nighttime sleep 
problems, daytime function, and sleep duration problems (Table 10).  The instrument was developed from 
questions in the SSC medical history that were asked at a clinic visit or by telephone interview of parents 
within three months of study initiation. The SSCSI is comprised of three subscales: Nighttime Problems, 
Daytime Problems, and Sleep Duration Problems. The scoring rubric consists of individual items that are 
scored as 0 for “no” and 1 for “yes”.  A continuous composite score is made by summing the ten 
dichotomous items and adding one point for sleep duration that was outside the National Sleep 
Foundation recommendations for the child’s age (Hirshkowitz et al., 2015). Composite scores range from 
0 to 11, with higher scores indicating worse sleep.  Scores for the Nighttime Problems and Daytime 
Problems subscales range from 0 to 4, and scores for the Sleep Duration Problems subscale range from 0 
to 2 (reviewed in Johansson, Feeley, Chasens, in press).   
1.4.3.2  IQ measures 
Intelligence is operationalized by the IQ measures as characteristics of cognitive abilities (verbal 
receptive and expressive abilities, nonverbal reasoning, and spatial abilities) and functional skills 
(processing speed, working memory, motor skills). Four norm-referenced instruments were used to 
quantify IQ in the SSC sample depending on chronologic and mental age (Table 11).  Norm-referenced 
measures are those standardized by the developers of the measure on a group of individuals chosen to 
represent the general characteristics (ex. age, sex, ethnicity/race, socioeconomic status, geographical 
region) of those who will be measured with the instrument. Norm-referenced measures are mapped onto a 
scale so that scores are a rank that indicate the test-taker’s performance relative to the normalization 
sample. Instruments are then standardized so that, although raw scores are comparable between 
instruments, standardized scores are on a common metric across instruments. This is done by mapping 
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raw scores from the individual test onto a common scale with a total score mean = 100 and standard 
deviation = 15.  Thus, each scale produces a common standardized verbal IQ (VIQ), nonverbal IQ 
(NVIQ), and full-scale IQ (FSIQ) score that can be used to quantify and compare IQ across instruments.  
The established cut-off for intellectual disability (ID), described by the Autism and Developmental 
Disabilities Monitoring Network as, a condition in which “a person has difficulty learning at an expected 
level and functioning in daily life” (Centers for Disease Control and Prevention, 2016), is an IQ test score 
≤ 70. 
There are limitations to the standardization and measurement process for intellegence measures. 
Each measure uses different items to quantify IQ, although they are generally in common domains. IQ is 
often underestimated in individualas with ASD,  frequently because of difficulty completing a 
standardized test (Bolte, Dziobek, & Poustka, 2009). Discrepencies also often occur between nonverbal 
and verbal IQ scores in individuals with ASD. A primary reason for this is because of verbal and/or 
language deficits inherent in the disorder. Thus, tests that rely on language skills may not accurately 
reflect the child’s actual intelligence and functional abilities (Joseph, Tager-Flusberg, & Lord, 2002). For 
this reason, NVIQ scores were utilized in the present study, and scores were categorized into five groups. 
Nonverbal IQs above 70 were divided by the population mean (mean=100). Those below 70 were divided 
by population standard deviation (SD=15) down to NVIQ=40. Based on recommendations from the 
American Association of Intellectual and Developmental Disabilities (Tasse, Luckasson, & Nygren, 
2013), NVIQ scores below 40 were condensed into one category. 
The Differential Ability Scales-II (DAS-II) is a standardized battery of tests measuring a range of 
cognitive abilities in children with mental age 2 years 6 months through 17-years-old. The DAS-II 
consists of 20 independent subtests within 3 item clusters measure verbal comprehension, nonverbal 
reasoning skills, and spatial abilities yielding norm-referenced ability scores, t-scores and confidence 
intervals, cluster scores, and percentile ranks. Six core subtests contribute to an overall General 
Conceptual Ability score.(Elliott, 2012; PsychCorp, 2016) The DAS-II has two versions used for younger 
children and school-aged children. The DAS-II Early Years is divided into a lower level for children with 
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mental age 2 years 6 months to 3 years 5 months with 4 core subtests, and an upper level for children with 
mental age 3 years 6 months to 6 years 11 months, and has 6 core subtests. The DAS-II School Age is 
used for children with mental age 7 years to 17 years 11 months, and has 6 core subtests. Additional 
subtests are available for each of the three levels to measure things like school readiness, working 
memory, and processing speed. The SSC primarily used the DAS-II (85.0%), with almost equal 
proportions using the Early Years (50.9%) and School-Age (49.1%) versions (Elliott, 2012; PsychCorp, 
2016).  
The Weschler Intelligence Scale for Children-Fourth Edition (WISC-IV) is a standardized 
intelligence test used in children with mental age 6 years to 16 years 11 months. The WISC-IV measures 
intellectual ability and cognitive processing with ten core and five supplemental subtests resulting in four 
index scores: verbal comprehension, perceptual reasoning, working memory, and processing speed. The 
scale has good reliability in standard samples (Full scale: α=0.88-0.97, subtests: α=0.70-0.90) and special- 
education samples (full-scale not calculated, subtests: α=0.82-0.93; Williams, Weiss, & Rolfhus, 2003). 
The scale has been used in ASD samples (Khor, Gray, Reid, & Melvin, 2014; Oliveras-Rentas, 
Kenworthy, Roberson, Martin, & Wallace, 2013; P. E. Williams et al., 2003).   
The Wechsler Abbreviated Scale of Intelligence (WASI) is a standardized intelligence test used in 
individuals with mental age 6 years to 90 years 11 months. The WASI is a shortened version of the 
WISC-IV and Wechsler Adult Intelligence Scale, and has the same standardized scoring as the WISC-IV. 
The WASI has a 2-scale version resulting in VIQ, PIQ, and FSIQ; and a 4-scale version resulting in just 
FSIQ (Axelrod, 2002; Canivez, Konold, Collins, & Wilson, 2009; Goldstein & Mazefsky, 2013; 
McCrimmon & Smith, 2012). The WASI has good reliability in a standard sample of children (α=0.81-
0.97) and adults (α=0.84-0.98; The Psychological Corporation, 1999), and excellent reliability in a sample 
of adults with neurologic or psychiatric disorders (α=0.96-0.98; Axelrod, 2002). 
The Mullen Scales of Early Learning (MSEL) is a standardized cognitive test used with children 
from birth to a mental age of 5 years 8 months. The MSEL produces an Early Learning Composite score 
which measures cognitive abilities with five subscales: Gross Motor, Visual Reception, Fine Motor, 
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Receptive Language, and Expressive Language. The Gross Motor subscale is only used for children up to 
33 months. Scores are reported as T scores for subscales (mean=50, SD=10) and standardized scores for 
the full scale (mean=100, SD=15; Bradley-Johnson, 1997). The MSEL has been used with TD children 
and those with ASD (Akshoomoff, 2006; Bishop, Guthrie, Coffing, & Lord, 2011). The Early Learning 
Composite has good reliability (α=0.83-0.95; Dumont, Cruse, Alfonso, & Levine, 2000). 
1.4.3.3 ASD severity measures 
ASD severity was measured with the ADOS, a semi-structured observational instrument used for 
diagnosis of ASD and classification of severity.  The measures that make up the ADOS total score are 
operationalized as characteristics of social responsiveness, communication, language delay, and spatial 
ability.  Four modules are available with developmentally appropriate tasks for testing individuals with 
different language abilities: (1) “Preverbal/single words/simple phrases,” (2) “Flexible phrase speech,” (3) 
“Fluent speech child/adolescent,” and (4) “Fluent speech adolescent/adult (Lord et al., 2000).” Items are 
scored on a 4-point Likert-type scale from 0 (no abnormality) to 3 (moderate to severe abnormality), and 
fall into measures of either social affect (SA) or restricted repetitive behavior (RRB).  Calibrated severity 
scores (CSS), standardized for age and language level, are calculated for SA items (CSS-SA) and RRB 
items (CSS-RRB), and a total ADOS-CSS is the sum of these scores. Children with a total ADOS-CSS 
score from four to five are classified as having “autism spectrum,” and those with a score of six or more 
are classified as having “autism”  (Gotham, Pickles, & Lord, 2009; Gotham et al., 2008; Hus et al., 2014). 
The present research team performed standardization of module 4 scores to match prior standardization of 
modules 1-3 by mapping raw social affect and restricted, repetitive behavior scores onto total, social 
affect, and restricted repetitive behavior severity scores (V. Hus Bal, personal communication, March 24, 
2017). 
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1.4.4 Analysis for Aim 1 
Analysis for the SSCSI factor analysis can be found in the instrumentation manuscript, Psychometric 
properties of the Simons Simplex Collection Sleep Interview (section 4). The ten dichotomous SSCSI 
items, SSCSI composite score and subscale scores, NVIQ, ADOS severity score, and sex were described 
using frequency counts and percentages. Regular sleep duration in hours per night and age in years were 
described using mean, standard deviation, and range. Outliers in regular sleep duration—reported sleep 
duration less than 3 standard deviations below the population mean—were replaced with the 3rd standard 
deviation below the mean (4.85 hours). Correlations between age, sex, NVIQ, ADOS severity score, GID, 
and seizures were compared with Student’s t-test, chi-square, or Mann-Whitney U analysis. Descriptive 
and correlational analyses were performed with SPSS version 23 (SPSS Inc., Chicago, IL). 
SSCSI composite sleep scores have been categorized into three levels of sleep problems: 
none/minimal (scores 0-1), mild (2-3), moderate/severe (> 4). Baseline and adjacent category logistic 
regression analyses were performed to explore and compare the association between SSCSI composite 
and factor scores, and child characteristics. This method uses maximum likelihood estimation to compare 
the log odds of being in one group versus another. Six independent variables were included: age, ADOS 
severity score (range: 4-10), sex (male=0, female=1), NVIQ (<40=1, 40-54=2, 55-70=3, 71-100=4, 
>100=5), GID (no=0, yes=1), and seizures (no=0, yes=1). Where total ADOS severity score was 
significant, social affect and restricted, repetitive behavior severity scores were analyzed. Analyses were 
performed by building models with no sleep problems versus sleep problems (mild and moderate/severe) 
as the outcome variable, and then looking between sleep problem severities (none/minimal vs. mild, mild 
vs. moderate/severe, none/minimal vs. moderate/severe). The most parsimonious model in each case was 
chosen using the Akaike information criterion (AIC). Because of small proportions of children in the 
female, and middle and late childhood subgroups, only baseline (none/minimal sleep problems vs. sleep 
problems) analyses were performed in subgroups. Logistic regression analyses were done with the full 
sample, and then stratified by age group and sex. Logistic regression was performed with the MASS 
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package in the R suite (R Core Team, 2016). Level of significance was set at p < 0.05. Power to detect 
factors associated with sleep patterns was calculated assuming 20 independent tests, resulting in a 
corrected significance level of 0.05/20.  With over 2,600 subjects assessed, we will have good power 
(>80%) to detect an effect of size 0.06 SD.  Of the full sample, 2,619 have complete data on the ADOS, 
IQ scales, and SSCSI and were used for the analyses. 
1.4.5 Analysis for Aim 2 
1.4.5.1  Logistic regression analysis 
The SSCSI items, composite score and subscale scores, and sex were described using frequency counts 
and percentages. Parent reported regular sleep duration (hours per night) and age (years) were described 
using mean, standard deviation, and range. Regular sleep duration less than 3 standard deviations below 
the population mean, were replaced with the 3rd standard deviation below the mean (4.85 hours). Mann-
Whitney U was used to compare SSCSI composite and subscale scores between age groups, and chi-
square analyses to compare between sexes. Descriptive and correlational analyses were performed with 
SPSS version 23 (SPSS Inc., Chicago, IL). 
SSCSI composite and subscale scores were dichotomized into none/minimal (scores 0-1) or sleep 
problems present (≥2). Logistic regression analyses were performed to estimate associations between 
SSCSI composite and factor scores, and individual variant reference allele dosage (0, 1, 2 alleles). Hardy-
Weinberg equilibrium (HWE) was assessed in participants of non-Hispanic European Ancestry using the 
HardyWeinberg package in the R suite (R Core Team, 2016) and a p < 0.00023 (Bonferroni correction).  
All variants were in HWE. All models were adjusted for age (years), ADOS severity score (range: 4-10), 
sex (male=0, female=1), NVIQ (<40=1, 40-54=2, 55-70=3, 71-100=4, >100=5), GID (no=0, yes=1), 
seizures (no=0, yes=1), and ancestry (1=non-Hispanic European, 2=Asian, 3=Hispanic European, 
4=African American). Analyses were performed by building models with no sleep problems versus sleep 
problems (mild or moderate/severe) as the outcome variable. Odds ratios with 95% confidence intervals 
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were used to measure the strength of associations between each variant and sleep patterns. Logistic 
regression was performed with the MASS package in the R suite. Level of significance was set at 
p<0.00023 (Bonferroni correction). 
1.4.5.2  Transmission disequilibrium test 
The transmission disequilibrium test (TDT) is one of several family-based association methods, a group 
of tests that examines how parental genotypes or alleles are transmitted to offspring affected by a disease 
or trait. The TDT tests Mendel’s law of segregation, which states that parental alleles are randomly and 
independently transmitted to offspring, with each allele having a probability of transmission = ½. 
According to the law of segregation, there should be no association between a marker allele and a disease-
susceptibility allele, because they will be transmitted independently. Transmission disequilibrium occurs 
when there is non-random or greater than expected transmission of a certain allele to offspring with a trait 
or disease (Laird & Lange, 2011). Alleles transmitted to offspring are viewed as “cases,” and alleles not 
transmitted as “controls,” and a significant TDT test statistic indicates both linkage and association 
between a marker and the disease susceptibility allele. One advantage of the TDT over traditional 
case/control studies, is that confounding variables are completely matched between cases and controls, 
since “case” and “control” alleles come from the same person. Thus, the test is robust to population 
stratification factors. The TDT also does not require the disease model to be identified, and the 
distribution of the trait or disease in the general population does not affect the validity of the test. A 
disadvantage is that only heterozygous parents provide the information necessary to perform the TDT, 
and thus information on homozygous parents is thrown away (Barmada, 2016). 
The TDT, performed with parent-child trios using McNemar’s test (McNemar, 1947), is a test of 
two binomial samples, in this case transmitted alleles and non-transmitted alleles. A contingency table is 
formed with transmitted and non-transmitted alleles, and a modified chi-square test assesses the null 
hypothesis that the probability that either allele will be transmitted is equal. A significant result would 
 38 
occur if one allele was transmitted significantly more often than would be expected by chance (Walker & 
Shostak, 2010). 
1.5 STRENGTHS, POTENTIAL LIMITATIONS, AND ALTERNATE APPROACHES 
1.5.1 Strengths 
The major strengths of the proposed project pertain to the study of ASD, and the innovative methods 
used. This study proposes to address a phenotype that is highly disruptive to families affected with ASD. 
It will be more efficient and cost-effective because of using secondary data from a large, well-phenotyped 
sample from across the United States. Since genotyping has already been performed, analysis of 
genotypes will be much less costly. This study made use of RNA-Seq and in situ genetic data to guide 
selection of the most valuable genetic variants. By performing factor analysis on the SSCSI, the research 
team endeavored to understand better its internal structure, sub-dimensions, and validity. While a partial 
genetic basis for sleep patterns is well-established, specific genetic variation and its effects are not well-
understood, especially in the context of ASD. Finally, this research was a good predoctoral training 
vehicle for the student to learn the tools of quantitative genetic analysis, which will provide the 
knowledge and skills required to become an independent researcher. Together, this study lays the 
groundwork to understand from a biological perspective why and how sleep patterns are abnormal in 
children with ASD. With this firm foundation, it should be possible to build further studies and 
interventions aimed at making sleep patterns more typical, thereby improving the quality of life for 
individuals with ASD and their families. 
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1.5.2  Limitations 
The first aim of the study has several limitations. The primary limitation of the factor analysis study was 
unequal sizes between early, middle, and late childhood groups. This may skew the ability to detect a 
similar factor structure in the SSC sample, and in the three groups. Although the sample is large and from 
sites across the United States, it is predominantly non-Hispanic Caucasian (74.5%), and had a slightly 
greater ratio of boys to girls (5.9:1) than that seen in the general ASD population (4.5:1). This could limit 
the ability to generalize results to other populations. However, this is the largest such sample in the world, 
and what we learn from it should have general value. Another limitation is that little was known about the 
origin and administration of the SSCSI, and no other sleep instruments were used, precluding the 
calculation of test-retest reliability, interrater reliability, and convergent validity. Without an objective 
measure of sleep, all items were based on parents’ report, and subject to reporting bias.  In addition, 
laying down with a child may be accepted in some cultures and families practicing co-bedding, and this 
was not taken into consideration. Finally, without also testing a control group of typically developing 
children, it is difficult to know what sleep problems are unique to ASD and which are common in all 
children of a certain age. 
Several factors related to the second aim have the potential to decrease the effect of the study. 
First, using secondary data precludes measuring levels of hormones related to sleep patterns, like 
melatonin and cortisol. Conversely, studies such as this one require large samples making it almost 
impossible to muster such a sample for which hormones were measured directly. Second, as neither the 
CMC nor GTEx collected samples with an eye to timing of circadian gene expression, the choice of 
eQTLs may not capture markers that were not expressed at the time of sample collection. The CMC used 
samples from the brains of adults, which may exhibit different gene expression patterns than the brains of 
children. Third, it is possible that melatonin/SCN genes are not key to driving sleep patterns. If this is the 
case, the student will evaluate the developing literature on the biology and genetics of sleep patterns, and 
investigate other genes for future analyses.  
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1.5.3 Alternate approaches 
An alternative approach may have been taken in performing the exploratory factor analysis on sleep 
questions that would become the SSCSI. Enuresis (“wet the bed”) and sleep disordered breathing 
(combined “difficulty breathing at night,” “sleep disordered breathing,” and “sleep apnea”) have been 
shown to disturb sleep in TD children. Based on this evidence, these two items may have been forced into 
the factor analysis model. This means that the items would be kept in the model despite poor associations 
with other items in the model, lower internal consistency (Cronbach’s α) with the items in the model, and 
low factor loading scores. The items “wet the bed,” “tonsils and adenoids present,” and “sleep disordered 
breathing,” all had small correlations with other sleep items (r ≤ 0.13). The communality—how much 
total variance in an item is explained by the extracted factors—was very low for “wet the bed” (0.031). 
When “wet the bed” and “sleep disordered breathing” were forced into the factor model, three factors 
emerged for early childhood (previously referred to as pre-pubertal) and two factors emerged for middle 
and late childhood (previously referred to as pubertal and post-pubertal respectively), making 
interpretation and generalized used of the instrument very difficult. It was concluded that, although 
enuresis and sleep disordered breathing affect sleep in other samples, they may not have strong effects on 
sleep patterns in the SSC sample and were allowed to drop out of the model as factor analysis proceeded.   
A second alternative approach that may have been taken when analyzing the SSCSI is to treat the 
SSCSI composite and subscale scores as continuous variables rather than categorizing them. This 
approach would have been less ideal than the categorical approach taken, as the scores are discrete—data 
may only take set, discrete values—rather than continuous data—data may take infinite small values 
between integers. This approach would also have been less ideal because the composite and subscale 
scores were very positively skewed.   
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1.6 PROTECTION OF HUMAN SUBJECTS 
This research analyzes existing genetic, phenotypic, and gene expression data. The genetic and 
phenotypic data are drawn from the Simons Foundation Autism Research Initiative (SFARI) database, an 
existing resource for autism research. This study was submitted, reviewed, and approved by the 
University of Pittsburgh Institutional Review Board (IRB) in October 2015 (PRO15050345, Appendix F). 
1.6.1 Potential risks for proposed secondary analysis 
The research team has received and analyzed de-identified data only. They do not have access to 
biological specimens or access to personal identifying information. The greatest risk to human subjects 
from data received by and analyzed at the University of Pittsburgh is theft. If the SFARI data were stolen, 
and if they were somehow associated with a specific person, this could cause embarrassment and 
discomfort to the subject who participated in the parent study.  
There are no direct benefits to participants in this study. The research team will consider each aim 
of the project complete when we have answered the specific scientific questions. Eventually, such 
knowledge could benefit mankind. In summary, the data to be analyzed are de-identified. Thus, the study 
presents very little risk to the subjects. The general knowledge gained by the study could benefit mankind. 
We believe the risk/benefit ratio is acceptable. 
1.6.2 Procedures for protection against risk 
Because the parent study involved risks greater than risks experienced in activities of daily living, 
informed consent was received from parents and assent was received from children as required by each 
site’s local IRB. In addition, each participant was assigned Global Unique Identifiers (GUID) produced 
from created from personal information using an algorithm. Each site maintained personal identifiers on 
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site, and only deidentified GUIDs were sent to the central database. At no times does the present research 
team have access to personal identifiers. Although it would be extremely difficult, it may be possible to 
deduce personal identities from demographic and genotype data. For this reason, all data will be retained 
behind the UPMC firewall, which is formidable, has tight limits on remote access, and is monitored for 
security at all times. Data is never shared with individuals outside the present research plan. 
The student has received exempt approval and will maintain approval from the University of 
Pittsburgh IRB for research on de-identified data from human subjects. She will report any data theft 
directly to the University of Pittsburgh IRB. 
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2.0  SUMMARY OF STUDY 
2.1 PRELIMINARY WORK ON DISSERTATION STUDY 
The purpose of this research was to: (1) examine the relationship between sleep patterns and 
characteristics of children with ASD—age, sex, ASD severity, IQ, and medical conditions.; and (2) 
determine if there are genetic associations between 27 melatonin/SCN genes and sleep patterns in 
children with ASD. Genetic variants were chosen for association analysis based on their impact on gene 
expression, as measured by RNA-Seq and SNP data. The results for the SSCSI psychometrics are 
presented in the instrumentation manuscript, “Psychometric properties of the Simons Simplex Collection 
Sleep Interview.” Results for Specific Aim 1 are presented in the data-based manuscript, “Characteristics 
of sleep in children with autism spectrum disorders from the Simons Simplex Collection.” Results for 
Specific Aim 2 are presented in the data-based manuscript, “Variations in genes related to sleep patterns 
in children with autism spectrum disorder.” 
2.2 PROPOSAL CHANGES 
An attempt was made to capture normal shifts in sleep patterns throughout childhood by exploring 
puberty stage as a predictor of sleep patterns.  Because the average age of puberty in the United States is 
between 8-13-years for girls (mean age of menarche is 12.2-12.8-years) and 9-14-years for boys (Al-
Sahab et al., 2012; Cabrera et al., 2014), children in the SSC sample were divided by age into three bands 
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called pre-pubescent (4-8-years), pubescent (9-13- years), and post-pubescent (14-18-years). The puberty 
development scale was developed by the parent study and relied on the opinion of the medical 
professional performing the exam. The scale measured 5 items in males (body hair, facial hair, growth 
spurt, skin changes, voice changes) and 4 in females (body hair, breast changes, growth spurt, skin 
changes) on a scale from 1 to 4 (1 = ”has not begun,” 2 = ”barely started,” 3 = ”definitely underway,” 4 = 
”seems complete”). Females also had one item, “begun period” measured on a two-point scale. Because 
the scale was ambiguous (ex. “seems complete”) and could be interpreted differently by each medical 
professional who used it, all children had data for age, but many did not have data for puberty, and 
because results using the scale will not be generalizable, it was decided to use age instead of puberty level 
in analyses. The instrumentation manuscript uses the terms “pre-pubertal,” “pubertal,” and “post-
pubertal” even though these groups were determined using age. The terms “early childhood,” “middle 
childhood,” and “late childhood” were used in the two subsequent manuscripts. 
After review of recent literature and consideration of other variables that may affect sleep 
patterns, GID and seizures were added as independent variables. Presence of GID was defined as parent 
reports of bloating/excess gas, celiac disease, constipation, diarrhea, ulcers, gastroesophageal reflux 
disease, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), irritable bowel syndrome, 
abdominal pain, unusual stools, vomiting, and/or other GID; and seizures as parent reports atonic drop, 
infantile spasms; or partial complex, grand mal, petit mal, simple partial, and/or other seizures. Presence 
or absence of GID and seizures was determined using data from the medical history interview conducted 
by the parent study at baseline. 
The transmission disequilibrium test was added to the Aim 2 analysis to reinforce results from the 
logistic regression from a different angle. The logistic regression analysis of genetic variants on SSCSI 
sleep scores looked at associations between the number of reference alleles possessed by the participant 
and their sleep score, while the TDT examined if there was over-transmission of one allele to children 
with sleep problems. 
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2.3 CONCLUSIONS, IMPLICATIONS FOR NURSING, AND FUTURE STUDIES 
Several conclusions may be drawn from this study. As expected, many sleep problems were most 
prevalent in early and middle childhood, suggesting that treatments may need to be tailored toward sleep 
problems evident in younger children. These included bedtime problems and the need for a parent to lay 
down with the child, difficulty falling asleep, and frequent/prolonged awakenings. However, children in 
middle childhood had more difficulty waking than those in early and late childhood, and children in late 
childhood had more excess daytime sleepiness than younger children, implying that treatments will need 
to evolve as children age.  
Using the SSC sample, this study confirmed numerous prior reports of sleep problems in children 
with ASD. These reports reinforce the need for health care professionals to screen for and discuss sleep 
problems with their ASD patients and families.  As recommended by Malow et al. (2014), parental 
education in proper sleep habits should be provided. Use of the SSCSI may be used to screen for sleep 
problems in children with ASD in primary care and sleep medicine clinics, as well as in a range of 
specialty clinics—neurology, pulmonology, cardiology, behavioral medicine, etc. This screening may aid 
in proper diagnosis and treatment of other symptoms, and contribute to holistic, multispecialty care. In 
addition, as sleep has been associated with behavioral, cognitive, and biological variables, the SSC 
provides a wealth of opportunities to incorporate sleep into research in this large, well-characterized 
sample of children with ASD. The SSCSI may be used by such researchers to incorporate sleep patterns 
into studies focusing on a wide range of variables. 
This study advances the understanding of sleep and ASD by showing that presence of GID, 
seizures, young age, and low NVIQ increase the odds of having sleep problems. As other studies have 
found, nearly half of children in this sample were reported to have GID, and these gastric symptoms were 
significantly related to sleep problems. The current study additionally found that rates of GID and its 
relationship to sleep problems were not different between age groups or sexes. Seizures were found to be 
significantly associated with composite sleep problems and nighttime problems, but not daytime problems 
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or sleep duration problems, which may imply that seizure activity impacts length, depth, and/or 
microarchitecture of sleep patterns.  That low NVIQ (more severe symptoms), but not ASD severity, is 
related to increased composite sleep problems is intriguing and will require more investigation to explain. 
These results, however, emphasize that practitioners and researchers from many specialties must be 
attentive for sleep problems in their ASD populations. 
The second aim of this study attempted to determine if there are genetic associations between 
melatonin/SCN genes and sleep patterns using association analysis and transmission disequilibrium tests.  
Variants were chosen because of their significant effect on expression of target genes, primarily in the 
brain. However, genetic analysis of the 72 eQTLs and SNPs did not demonstrate association with sleep 
problems in this sample, indicating that variation in expression, or transcription, of genes in the 
melatonin/SCN pathway is likely not a driver of sleep problems.  If transcription is not driving sleep 
problems, a number of research questions now follow, including the role of post-translational 
modification of melatonin/SCN proteins and epigenomic mechanisms in sleep problems, and the 
contribution of other sleep homeostasis gene pathways. In addition, the innovative methods used in these 
genetic analyses demonstrate a method that may be employed by other research groups interesting in the 
use of gene expression for association analyses.  
Future research could proceed in several directions. Use of a validated instrument adds a measure 
of confidence to a study and is essential for collection and interpretation of accurate patient data. 
However, due to the data available, a full description of the reliability and validity of the SSCSI was not 
possible. Before the SSCSI is used in full-scale studies, it must be tested in other samples of children and 
adolescents with ASD in order to establish test-retest reliability, inter-rater reliability, and to support our 
findings of internal consistency. The SSCSI must also be used along with validated sleep questionnaires 
such as the Children’s Sleep Habits Questionnaire, Modified Simmons and Parraga Sleep Questionnaire, 
or the Clinical Global Index-Sleep in order to establish convergent validity. In addition to refining the 
SSCSI, use of objective measures of sleep, such as actigraphy and polysomnography, would provide a 
strong foundation for association studies. As a next-step toward translation of research results into clinical 
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practice, evaluation of screening for sleep problems in various clinical settings may be performed to 
document how often healthcare providers address sleep problems.  
Continued research into the genomics of sleep problems in individuals with ASD are clearly 
needed. The lack of association found between expression of genes and sleep patterns in the present study 
does not imply that the melatonin synthesis and SCN pathway should be abandoned.  Although this study 
showed that transcription of these genes was not influencing sleep patterns, the effect of translation and 
post-translational modification on melatonin and SCN proteins cannot be dismissed. That a number of 
research studies have shown low melatonin or melatonin metabolite levels demonstrates this is still a 
valid research area.  Expanding on recent research suggesting that risk for ASD may lie in common 
variants acting additively, it may be informative to investigate risk haplotypes from melatonin-synthesis 
genes or SCN genes as guided by literature and well-thought out hypotheses.  However, as other gene 
pathways in the brain and body, such as glutamate, GABA, and serotonin are known to interact with 
melatonin and the SCN, inquiries should not be limited to the melatonin/SCN pathway.  In summary, 
future research into the biological basis of sleep problems in ASD—genetic, biochemical, comorbid 
conditions—and the effect of therapies on sleep problems may move this research into the realm of 
clinical interventions to improve quality of life for families affected by ASD and sleep problems.  
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3.0  INSTRUMENTATION MANUSCRIPT: PSYCHOMETRIC PROPERTIES OF 
THE SIMONS SIMPLEX COLLECTION SLEEP INTERVIEW 
3.1 ABSTRACT 
Background and Purpose: An estimated 40-80% of children with autism spectrum disorders (ASD) 
have sleep problems. The Simons Simplex Collection Sleep Interview (SSCSI) is a parent-report 
questionnaire assessing bedtime and nighttime sleep problems, and daytime function. The present study 
evaluated the factorial model of the SSCSI that best characterizes children 4-18 years with ASD. 
Methods: Exploratory factor analysis was performed using principal component analysis and promax 
rotation, beginning with 16 items and ending with 10 items. 
Results: Exploratory factor analysis concluded with ten dichotomous items, plus age and regular sleep 
duration, in three factors: nighttime problems, daytime problems, and sleep duration problems. The 
analysis was performed on the full sample, and on prepubertal (4-8-years), pubertal (9-13-years), and 
postpubertal (14-18-years) subgroups. 
Conclusion: Further refinement, including confirmatory factor analysis, test-retest reliability, and 
convergent validity testing are needed.  
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3.2 INTRODUCTION 
Autism spectrum disorder (ASD) encompasses a range of pervasive neurodevelopmental disabilities that 
begin early in childhood and last throughout life. Although all children require adequate sleep for normal 
growth and development (Hirshkowitz et al., 2015; Iglowstein, Jenni, Molinari, & Largo, 2003), an 
estimated 40-80% of children with ASD have comorbid sleep problems (May et al., 2015; Veatch et al., 
2016). These sleep problems may include increased sleep latency (time to fall asleep), decreased sleep 
efficiency (percentage of time asleep to time in bed), parasomnias (e.g. night terrors, sleep walking), and 
nighttime or early morning waking (Elia et al., 2000; Galli-Carminati, Deriaz, & Bertschy, 2009; 
Goldman et al., 2010; Liu et al., 2006; Malow et al., 2006).  
Nighttime behaviors and abnormal sleep duration in children with ASD can be very disruptive to 
the rest of the family, and often decrease the family’s quality of life (Giallo, Wood, Jellett, & Porter, 
2013; Johnson & Simpson, 2013; Schwichtenberg et al., 2013). Parents of children with ASD report 
significantly more and longer night wakings than parents of typically developing children (Krakowiak et 
al., 2008; Souders et al., 2009). Parents often must get up to help the child settle and fall asleep again, or 
to ensure the child is safe while awake. These wakings may also disrupt other siblings who sleep in the 
same room or near the child with ASD, possibly affecting their daytime function. Parental sleepiness 
during the day can affect family functioning, work productivity, and even public safety (Giallo et al., 
2013; Goldman, Bichell, Surdyka, & Malow, 2012; Tietze, Zernikow, Michel, & Blankenburg, 2014). 
Behavior problems in the child with ASD are exacerbated by their lack of quality sleep, and may disrupt 
classroom functioning at school (Allik et al., 2008; Schwichtenberg et al., 2013). 
Existing sleep instruments, originally designed for use with typically developing children, have 
been adapted for use in the ASD population. The most commonly used instrument is the Children’s Sleep 
Habits Questionnaire (CSHQ; Owens, Spirito, & McGuinn, 2000), a 45-item, parent-report measure of 
sleep behaviors that has been validated in children from preschool through school-age (Goodlin-Jones, 
Sitnick, Tang, Liu, & Anders, 2008; Markovich, Gendron, & Corkum, 2015). Eight subscales within the 
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CSHQ are bedtime resistance, sleep onset delay, sleep duration, sleep anxiety, night wakings, 
parasomnias, sleep disordered breathing, and daytime sleepiness. Items are scored on a three-point 
Likert-type scale with the behavior occurring in the previous week “usually” (5 to 7-times/week), 
“sometimes” (2 to 4-times/week), or “never” (zero to one-time/week). Internal consistency in a 
community sample of healthy, typically developing children 4 to 10-years-old was adequate for the full 
scale (ɑ=0.68), and acceptable for the subscales (ɑ=0.36-0.70). Test-retest reliability of subscales was 
satisfactory, ranging from r=0.62-0.79 (Owens et al., 2000). Internal consistency was similar in a sample 
of 2 to 16-year-old children with ASD (ɑ=0.68, Johnson, Turner, Foldes, Malow, & Wiggs, 2013). 
The Simonds and Parraga Sleep Questionnaire (Simonds & Parraga, 1982) is a similar instrument 
originally developed to screen for sleep problems in typically developing children 5-18-years-old, but 
modified and validated in children with ASD. The Modified Simonds and Parraga Sleep Questionnaire 
(MSPSQ; Johnson et al., 2013; Wiggs & Stores, 1996) is a 36-item, parent-report questionnaire consisting 
of 7 subscales scored on a 5-point Likert-type scale, with higher scores denoting more problems: bedtime 
resistance, sleep onset delay, sleep anxiety, night waking, parasomnia, sleep disordered breathing, and 
daytime sleepiness. In a sample of 345 children with ASD, the MSPSQ had good overall internal 
consistency (α=0.80), and test-retest reliability after 2 weeks (r=0.83; Maas et al., 2011).  However, in a 
follow-up study, internal consistency of subscales was lower, ranging from 0.19 to 0.66 (full scale 
α=0.67; Johnson et al., 2013).  
To complement parent-report instruments and objective measures, such as actigraphy (a 
movement sensor used to determine sleep and wake patterns) and polysomnography (in-laboratory sleep 
study), Malow et al. (2016) developed the clinician-report Pediatric Sleep Clinical Global Impressions 
Scale (CGI-S) for use in children with ASD. Based on components of insomnia criteria from the 
International Classification of Sleep Disorders (American Academy of Sleep Medicine, 2014), the CGI-S 
queries bedtime problems—ability to fall asleep and stay asleep independent of parents, bedtime 
resistance, sleep onset delay—night wakings, parents’ satisfaction with the child’s sleep patterns, and the 
clinician’s general opinion about the child’s sleep. Items are presented in two sections: current problems 
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and improvement from previous assessment. Responses are rated by the clinician on a 7-point Likert-type 
scale ranging from “no concerns” (1) to “highest level of concerns seen by the examiner” (Malow et al., 
2016, p. 371). In pilot testing, significant associations between the CGI-S and CSHQ were observed in 
sleep onset delay (r = 0.65, p <0.001), night wakings (r = 0.40, p < 0.001), and overall score (r = 0.29, p < 
0.001). Sleep onset delay score on the CGI-S was also significantly associated with objective actigraphic 
measure of sleep onset latency (time required to fall asleep; r = 0.75, p < 0.01). 
The Simons Foundation Autism Research Initiative began in 2003 with the goal of improving the 
scientific understanding of ASD. One of their major projects was the Simons Simplex Collection (SSC), a 
sample of approximately 2,750 simplex families (only one child with ASD, termed the proband) from 12 
sites in North America. A main goal of the SSC was to identify genetic variants associated with ASD risk 
(Fischbach & Lord, 2010). Its data have been used to study genomics of cognition and behavior in ASD 
(Frazier et al., 2014; Gamsiz et al., 2013; Green et al., 2016), the broad autism phenotype (Davidson et 
al., 2014), the impact of copy number variants on risk for ASD (Desachy et al., 2015; Sanders et al., 2015; 
Webb et al., 2016), and medical comorbidities with ASD (Gorrindo et al., 2012; Viscidi et al., 2013).   
More than thirty instruments were used with the SSC to collect a number of variables, including 
family health; psychiatric, developmental, and environmental exposure histories; proband medical, 
developmental, treatment, school, and ASD histories; and current proband comorbidities, intelligence, 
behavior, motor skills, and speech. Blood samples were taken from biological parents, the proband, and 
one sibling, if available, for genomic study. Probands were strictly phenotyped through parent interview, 
medical history, and multiple well-validated instruments (Fischbach & Lord, 2010).  
3.2.1 Study aims 
As one of the largest cohorts of children with ASD currently available, the SSC presented a good 
opportunity for the study of sleep throughout childhood in children with ASD. The Simons Simplex 
Collection Sleep Interview (SSCSI) originated as part of the full medical history performed upon entrance 
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to the study, and consisted of 18 questions about sleep habits, including bedtime behavior, nighttime sleep 
patterns, and daytime function. The SSCSI has not previously been evaluated for reliability and validity, 
or undergone factor analysis. The purpose of this study was to (1) evaluate the factor structure that best 
characterizes the SSC sample, and (2) establish validity and reliability of the SSCSI in this sample.  
3.3 METHODS 
3.3.1 Participants 
Families were recruited from clinics at academic medical centers serving children with ASD, as well as 
from service providers, parent and advocacy groups, web postings, and radio and television 
advertisements. Children were included if they were between 4- and 18-years-old; met the criteria for 
ASD based on the Autism Diagnostic Observation Schedule [ADOS], Autism Diagnostic Interview-
Revised [ADI-R], and Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revised [DSM-IV-
TR]; and had a non-verbal mental age of at least 24-months for probands 4- to 7-years-old, or 30-months 
for probands ≥7-years-old. Probands were excluded if they were born at less than 36-weeks and had a 
birth weight less than 2,000 grams; were born with a significant injury, abnormality, or disorder effecting 
the brain; had extended prenatal or birth complications; had fragile X or Downs syndrome; had sensory or 
motor disorders that would confound diagnostic measures; had a history of severe nutritional or 
psychological deficiency; were not fluent in English; or had another family member affected with ASD 
up to third degree relatives of the proband. One sibling was included in the study if available (Simons 
Foundation Autism Research Initiative, 2014). Because notable shifts in sleep patterns occur around 
puberty, the sample for the present study was divided into three age groups: prepubertal (4-8-years), 
pubertal (9-13- years), and post-pubertal (14-18-years).  
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3.3.2 Procedure 
This study was a secondary analysis of existing data from the Simons Foundation. Twelve study sites 
across the United States and Canada collaborated with the Simons Foundation Autism Research Initiative 
on the SSC. The SSCSI was completed at a clinic visit or by telephone interview of parents. Procedures 
of the parent study and characteristics of the SSC parent study sample have been described previously 
(Fischbach & Lord, 2010). 
Demographic data—age, ethnicity, family income, living situation, parental education—were 
collected at the time of initiation in the study, and the SSCSI was administered within three months of 
study initiation. Children with ASD were strictly phenotyped by trained clinicians using the Autism 
Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994), Autism Diagnostic 
Observation Schedule (ADOS; Lord et al., 2000), and multiple neurocognitive and behavioral measures 
described previously (Fischbach & Lord, 2010; Simons Foundation Autism Research Initiative, 2014). 
Phenotypic data was acquired for the present study from the Simons Foundation software platform, 
SFARI Base. Incentives were not offered to participants. For the parent study, informed consent was 
obtained from all parents or caregivers included in the study, and assent from children as required by local 
institutional review boards. Approval was obtained from the University of Pittsburgh (Pittsburgh, PA) 
Institutional Review Board for the present study.  
3.3.3 Survey instrument 
The original questionnaire included 18 items about going to bed and falling asleep; waking during the 
night; sleepwalking or nightmares; wetting the bed; breathing difficulties at night; waking in the morning; 
daytime sleepiness; regular bedtime, wake time and duration; age in months at questionnaire completion; 
and regular duration of sleep in hours. When a range of hours was given, the mean was taken for use in 
this analysis. Of the 18 items, 16 were dichotomous (yes/no) pairs inquiring if this sleep problem had ever 
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occurred, and if it is currently occurring. In considering if both “ever” and “currently” items should be 
retained, it was decided to only use “currently” items. One reason for this is that older children would 
have a much longer time to have had these sleep problems than younger children, and so may appear to 
have an inflated number of sleep problems. In addition, problems like wetting the bed or sleepwalking, 
which may be more developmentally typical at younger ages, are “currently” abnormal in older children.  
Only the 16 dichotomous items were analyzed in the present study. A continuous composite score is made 
by summing items as 0 for “no” and 1 for “yes,” and adding 1 point for sleep duration outside National 
Sleep Foundation recommendations for the child’s age (Hirshkowitz et al., 2015). Participants were 
excluded from the present study if more than two items were missing or coded as unknown. No 
information is available on the original writers or development process of the original sleep questions.   
3.3.4 Measures 
ASD severity was measured with the Autism Diagnostic Observation Schedule (ADOS), a semi-
structured observational instrument used with other instruments for diagnosis of ASD and classification 
of severity.  The measures that make up the ADOS total score are operationalized as characteristics of 
social responsiveness, communication, language delay, and spatial ability.  Four modules are available 
with developmentally appropriate tasks for testing individuals with different language abilities: (1) 
“Preverbal/single words/simple phrases,” (2) “Flexible phrase speech,” (3) “Fluent speech 
child/adolescent,” and (4) “Fluent speech adolescent/adult (Lord et al., 2000).” Items are scored on a 4-
point Likert-type scale from 0 (no abnormality) to 3 (moderate to severe abnormality), and fall into 
measures of either social affect or restricted repetitive behavior.  Calibrated severity scores (CSS), 
standardized for age and language level, are calculated and a total ADOS-CSS is the sum of these scores 
(Gotham et al., 2009; Gotham et al., 2008; Hus et al., 2014). ADOS-CSS was used in this study as an 
indicator of ASD severity. 
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Four instruments—Weschler Intelligence Scale for Children-IV, Weschler Abbreviated Scale of 
Intelligence, Differential Abilities Scales-II, and Mullen Scales of Early Learning—were used to quantify 
IQ in the SSC sample depending on chronologic and mental age.  Each scale produces standardized 
verbal IQ (VIQ), nonverbal IQ (NVIQ), and full-scale IQ (FSIQ) scores that can be used to measure and 
compare IQ across instruments.  The Differential Ability Scales-II (DAS-II) Early Years is divided into a 
lower level for children with mental age 2 years 6 months to 3 years 5 months, and an upper level for 
children with mental age 3 years 6 months to 6 years 11 months; and the DAS-II School Age is used for 
children with mental age 7 years to 17 years 11 months (Elliott, 2012; PsychCorp, 2016). The Weschler 
Intelligence Scale for Children-Fourth Edition (WISC-IV) is a standardized intelligence test used in 
children with mental age 6 years to 16 years 11 months (P. E. Williams et al., 2003).  The Wechsler 
Abbreviated Scale of Intelligence (WASI) is a standardized intelligence test used in individuals with 
mental age 6 years to 90 years 11 months (Axelrod, 2002; Canivez et al., 2009; Goldstein & Mazefsky, 
2013; McCrimmon & Smith, 2012). The Mullen Scales of Early Learning (MSEL) is a standardized 
cognitive test used with children from birth to a mental age of 5 years 8 months (Bradley-Johnson, 1997).  
3.3.5 Statistical analysis 
Descriptive statistics of the data were calculated, including frequencies of yes/no responses for the 16 
dichotomous items. Means with standard deviations, and ranges were computed for age and sleep 
duration. No ages were missing. Subjects missing regular sleep duration were retained (n=30), and other 
missing values were excluded pairwise. Histograms were generated for the continuous variables, 
including calculations of skewness and excess kurtosis, and the Shapiro-Wilkes test was performed to 
assess for normality. Because the questions, “regular bedtime and wake time,” “regular sleep duration,” 
and “sleep duration is enough” were worded positively (“yes” means no problem), these items were 
reverse coded to match the other dichotomous items.  
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Subsequently, the characteristics of the data were assessed, beginning with inter-item Spearman 
correlations and significance levels, and the presence of item clusters. Items were assessed for violation of 
factor analysis assumptions: redundancy of items, excessive inter-item correlations (r > 0.9), sampling 
inadequacy, and outliers (Tabachnick & Fidell, 2013a). Redundancy was explored particularly among the 
five breathing-related questions (“difficulty breathing at night,” “have the tonsils been removed,” “have 
the adenoids been removed,” “has a physician diagnosed obstructive sleep apnea,” and “child snores more 
than half the time”). Bartlett’s Test of Sphericity was performed to test the null hypothesis that there was 
no correlation between items (significance: p < 0.05). The overall Kaiser-Meyer-Olkin (KMO) test 
determined if the sample size was adequate relative to the number of items. The cutoff of KMO > 0.6 was 
used (Tabachnick & Fidell, 2013b). Measures of sampling adequacy (MSA) assessed the strength of 
correlations among individual items.  
Exploratory factor analysis was attempted with principle components analysis on the full scale 
and by age group. The Spearman correlation matrix was specified for the analysis, given the dichotomous 
nature of the items. Rotation was then attempted to improve factor loading. Factors were determined 
using percent of variance explained by the model and scree plots. Where cross loading (an item loading 
nearly equally on several factors) was present, the item was placed in the factor that best fit it 
conceptually. Scale reliability and validity were assessed using Cronbach’s alpha, inter-item correlations, 
and statistics if item deleted. The scale was not administered more than once with this sample, so that test-
retest reliability was not calculated. The families involved in the parent study did not complete any other 
sleep questionnaires, precluding the examination of criterion-related validity. SPSS version 23 was used 
for analysis, and significance was defined as a p-value < 0.05.  
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3.4 RESULTS 
3.4.1 Sample characteristics 
Table 2 provides sample characteristics. Of the full sample (N = 2,745), 2,737 children had sufficient data 
on the SSCSI to be used for the analysis. Those excluded were not significantly different in age, ADOS-
CSS, VIQ, NVIQ, FSIQ, regular sleep duration, or sex.  There were significant differences between those 
included and those excluded in the ADOS module used (Fisher’s exact test, p < 0.05). Among the 2,737 
children included in analyses, no significant difference was found in the number of males or ADOS-CSS 
score between age groups. As would be expected, sleep duration was significantly different between 
groups (prepubertal vs. pubertal d = 0.10, p < 0.01; pubertal vs. postpubertal d = 0.52, p < 0.01), with 
mean duration in hours decreasing from pre- to post-pubertal. Mean sleep duration for each age group 
was within the National Sleep Foundation’s recommendations for that age group (Hirshkowitz et al., 
2015). NVIQ, as measured on age appropriate scales, had a significant decrease from the prepubertal to 
pubertal age group (d = 0.01, p = 0.03). Scores in all age groups were low compared to the general 
population mean of 100 (SD = 15). Neither age nor sleep duration were normally distributed. The 
distribution of age was considerably positively skewed, with the majority of children in the younger age 
range (range 4-18 years; p < 0.01). The distribution of sleep duration was negatively skewed, with most 
children sleeping in the upper range of hours (range 3-13 hours per night; p < 0.01), and 12 outliers were 
present with regular sleep duration ranging from 3 to 5 hours per night. These cases were assessed for 
influence as analyses proceeded. 
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Table 2: SSCSI Sample Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prepubertal children were significantly more likely than pubertal children to need a parent to lay 
down with them, have frequent or long awakenings, wet the bed, and have tonsils and adenoids present; 
but less likely to have trouble falling asleep or difficulty waking. Pubertal children were significantly 
more likely than post-pubertal children to have trouble going to bed, need a parent to lay down with them, 
and wet the bed; and less likely to have sleep disordered breathing (all p < 0.05). 
3.4.2 Item reduction 
The characteristics of matrices—correlations, significance levels, and the determinant—describe how 
well individual items go together accounting or not accounting for the other items. Most dichotomous 
items had low to modest inter-item correlations (rs ≤ 0.286). An item cluster with moderate correlations 
 
Full Scale 
(4-18 years) 
N=2737 
Prepubertal 
(4-8 years) 
n=1533 
Pubertal 
(9-13 years) 
n=883 
Postpubertal 
(14-18 years) 
n=321 
Age [mean(SD)] 
       (years) 
9.0 (3.6) 6.4 (1.5)  11.1 (1.4)  15.8 (1.1)  
 
Male [n(%)] 
 
2302 (83.9) 
 
1285 (86.8) 
 
749 (87.2) 
 
268 (83.8) 
 
IQ [mean(SD)] 
     Full-scale 
     Verbal 
     Nonverbal 
 
 
81.2 (27.9) 
77.1 (31.0) 
84.1 (26.1) 
 
 
82.0 (25.7)             
79.0 (28.0)  
85.7 (24.2) a * 
 
 
80.1 (29.8)           
76.2 (33.7) 
83.0 (27.9) a * 
 
 
80.2 (32.2)      
69.1 (36.3) 
77.8 (29.4) 
 
ADOS  
calibrated 
severity 
score[mean(SD)] 
 
 
 
7.4 (1.7) 
 
 
 
7.5 (1.6)   
 
 
 
7.4 (1.8)  
 
 
 
7.3 (1.8)  
 
Sleep duration 
hours 
[mean(SD)] 
 
 
9.2 (1.3) 
 
 
9.6 (1.2) a ** 
 
 
9.0 (1.2) a **   
                      b ** 
 
 
8.4 (1.1) b ** 
 
ADOS: Autism Diagnostic Observation Scale (range: 1-10); a significant difference 
between prepubertal and pubertal groups; b significant difference between pubertal and 
postpubertal groups; * p < 0.05; ** p < 0.01 
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(0.340-0.517; p < 0.01) was seen between “difficulty going to bed,” “need to lay down with child,” and 
“difficulty falling asleep.” A second item cluster with more modest, but still significant, correlations (rs = 
0.267-0.302, p < 0.01) consisted of “difficulty waking,” “daytime sleepiness,” and “long/frequent naps.” 
These are items that were expected to cluster, and likely factor together. 
After examining correlations and their significance levels, it was determined that not all three 
items related to breathing problems were necessary. “Sleep apnea” had non-significant correlations with 
about half of the other items in the instrument; and “snoring” and “difficulty breathing” with about a 
quarter of items. Because sleep disordered breathing is an umbrella term that could describe sleep apnea, 
difficulty breathing at night and snoring, the three items were collapsed into a single combined “sleep 
disordered breathing” item. “Wet the bed,” “tonsils and adenoids present,” and “sleep disordered 
breathing,” each have small correlations with other items (rs ≤ 0.126). These items were carefully 
evaluated during factor analysis for retention in the model. 
3.4.3 Model 1 
Factor analysis was attempted in the full sample by principle components analysis. In this initial model, 
communalities—preliminary estimates of how much total variance in each item was explained by the 
factors to be extracted— ranged from 0.174 (“wet the bed”) to 0.607 (“difficulty falling asleep”). Four 
factors had eigenvalues greater than 1.0, and were obviously above the elbow on the scree plot (Figure 5). 
However, these four eigenvalues only explain 44% of total variance, and 10 factors were required to 
explain 80% of the total variance. There was an uneven distribution of items in the factor matrix, with two 
factors having only one item each, and another factor having 8 items. There were no items with factor 
loadings greater than 0.675, and “sleep walk/nightmares” did not achieve a factor loading > 0.4. Promax 
rotation did not result in much improvement, with “wet the bed” and “sleep walk/nightmares” cross-
loading on two factors, and “regular duration is not enough” and “frequent/prolonged awakenings” having 
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lower loading scores than unrotated items. Rotation does not change communalities or variance explained 
by factors, hence not improving these aspects of the model.  
 
 
 
Figure 4: Flowchart of Dichotomous Item Reduction 
 
3.4.4 Model 2 
Because of the less-than desirable factor loadings seen in Model 1, a second model was attempted, again 
specifying a Spearman correlation matrix. Items were removed from the model in a step-wise fashion 
based on low or non-significant correlations, communalities, strength of factor loadings, and if 
Cronbach’s α increased after deletion of the item (Table 3; Figure 4). For example, correlations between 
“wet the bed” and other items were very low (0.09) and non-significant for five items. Communality and 
factor loading were moderate, but Cronbach’s α increased by 0.17 when “wet the bed” was removed.   
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Before considering removal of this item, correlations were checked in the pre-pubertal age group, since 
this was the group most likely to experience wetting the bed. Correlations were found to be non-
significant for ten of the fourteen items, so “wet the bed” was removed from the model. In the same way, 
“tonsils and adenoids present,” “combined sleep disordered breathing,” and “sleepwalk/nightmares” were 
removed until all items loaded on factors, Cronbach’s α was no longer larger if items were deleted, and 
correlations were all significant, except for one pair (“awake frequently” and “irregular sleep duration;” 
p= 0.148). The largest correlation among items was modest--0.499 between “difficulty going to bed” and 
“difficulty falling asleep.”  
 
 
Table 3: Stepwise Removal of Questionnaire Items 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables 
removed KMO Cronbach’s α* α if item is deleted Factors in model 
 
[Full model] 
 
0.775 
 
0.671 
 
Wet the bed: 0.688 
Tonsils and adenoids 
present: 0.680 
 
4 
 
Wet the bed 
 
0.777 
 
0.687 
 
Tonsils and adenoids 
present: 0.698 
Sleepwalk/ 
nightmares: 0.688 
 
 
4 
Tonsils and 
adenoids present 
0.772 0.698 Sleep disordered 
breathing: 0.702 
Sleepwalk/ 
nightmares: 0.694 
3 
Sleep disordered 
breathing 
0.771 0.702 Sleepwalk/ 
nightmares: 0.700 
3 
 
Sleepwalk/ 
nightmares 
 
0.766 0.699 None higher than full 
scale α 
3 
Note: refinement of scale by removing variables one at a time; KMO=Kaiser-Meyer-Olkin 
test; * measure of internal consistency 
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As most bivariate correlations were significant with a 2-tail, 95% confidence interval, oblique 
rotation (Promax with Kaiser normalization) was attempted. In this second, rotated model, communalities 
were slightly better, ranging from 0.291 (“frequent/prolonged awakenings”) to 0.686 (“irregular sleep 
duration”). Three factors had eigenvalues greater than 1.0, and could explain just over 50% of the 
variance (Figure 6).  “Regular sleep duration is not enough” and “difficulty waking in the morning” 
switched factors when the model was rotated (Table 4). The factors will be known as night time 
problems, daytime problems, and sleep duration problems. Although “regular duration is not enough” 
seems like it should load with the other sleep duration problems, instead of with daytime problems, it may 
be that this item, conceptually, reflects the effect of not enough sleep on daytime function. 
Figures 7-11 show the distribution of the ten extracted items for the full scale, and three 
subscales. Cronbach’s alpha for the full, 10-item scale was α = 0.694 showing modest internal 
consistency, although internal consistency within the three factors (bedtime problems, daytime problems, 
sleep duration problems) was lower (α = 0.421-0.643; Table 4). Item-total correlations were low; the only 
correlations above r = 0.4 were between “difficulty going to bed” and “difficulty falling asleep” 
(rs=0.499). Because all age groups were together in one model, differences in frequency of sleep 
problems between groups may decrease correlations and consistency. 
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Figure 5: Model 1 Scree Plot 
 
 
Figure 6: Model 2 Scree Plot 
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Table 4: Factor Loadings of Principle Components Factor Analysis 
 
 
 
 
 Component (unrotated) matrix Pattern (rotated) matrix 
 Nighttime 
problems 
Daytime 
problems 
Sleep 
duration 
problems 
Nighttime 
problems 
Daytime 
problems 
Sleep 
duration 
problems 
Difficulty going to 
bed 0.664   0.777   
Need to lay down 
with child 0.534   0.679   
Difficulty going to 
sleep 0.689   0.767   
Frequent/prolonged 
awakenings 0.486   0.482   
Difficulty waking 
up in the morning 0.559    0.491  
 
Long/frequent naps 
 
 0.623   0.719  
Regular duration is 
not enough 0.562    0.436  
 
Daytime sleepiness 
 
 0.575   0.787  
Irregular sleep 
duration   0.761   0.841 
Irregular bedtime 
and wake time   0.622   0.723 
Cronbach’s α       
Full sample 0.6443 0.548 0.421    
     Prepubertal 0.649 0.518 0.454    
     Pubertal 0.650 0.572 0.456    
     Post-pubertal 0.576 0.610 0.177    
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3.4.5 Subgroup analysis 
In the pre-pubertal age group (4- to 8-years), 1,533 participants met eligibility requirements and were 
examined. Items loaded on the same factors as the full sample, with all items having a loading >0.40. The 
strongest factor loadings in this age group were “irregular sleep duration” (0.837) and “difficulty falling 
asleep” (0.803). Full-scale reliability was sufficient (α = 0.682; Table 4), and the removal of any one item 
did not impact the reliability. 
The pubertal group (9- to 13-years) had 883 eligible participants who were evaluated. Inter-item 
correlations were all significant. One item, “frequent/prolonged awakenings,” did not have a favorable 
factor loading above 0.4 (0.317). The strongest factor loadings were on “daytime sleepiness” (0.812) and 
“irregular sleep duration” (0.800), two elements expected to change during puberty (Crowley et al., 
2014).  Cronbach’s α was acceptable (α= 0.724), and would not increase if any items were deleted.  
In the post-pubertal group (14- to 18-years), 321 participants were eligible and were examined. 
Individual measures of sampling adequacy were more problematic, dipping down to 0.563; and the KMO 
(0.672) was just above the suggested threshold of 0.60. Many of the correlations between the ten items 
were not significant, particularly with “need to lay down with child” and “frequent/prolonged naps.” 
Factor analysis was attempted with these limitations in mind. PCA yielded four factors with eigenvalues 
greater than one. The fourth factor, although it was just above 1 (1.004) accounted for 10% of variance, 
making one wary to force it into another factor for the sake of a 3-factor full scale. “Irregular bedtime or 
wake time” loaded alone on the fourth factor with a strong loading (0.898). On the pattern matrix, “need 
to lay down with child” cross-loaded between factors 2 and 3 (“nighttime problems” and “sleep duration 
problems”), and “frequent/prolonged awakenings” did not achieve a unique loading above 0.4. The 
structure matrix better defined “need to lay down with child” as a member of factor 2 (“nighttime 
problems”), and raised factor loadings above 0.4 for “frequent/prolonged awakenings,” which then 
proceeded to cross-load on factors 2 and 4 (“nighttime problems” and the factor as yet undefined). When 
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three factors were forced, ‘irregular bedtime or wake time’ had a communality as low as 0.103, and did 
not have a factor loading greater than 0.4.  
3.5 DISCUSSION 
The results obtained from evaluating the SSCSI indicate three main concepts underlying sleep problems 
in children with ASD: night time problems, day time problems, and problems with sleep duration. Sixteen 
dichotomous items taken from the raw questionnaire were reduced through principle components analysis 
and reliability testing to ten items in three factors: nighttime problems, daytime problems, and sleep 
duration problems. The ten items are in addition to the continuous variables, age and regular sleep 
duration, yielding a twelve-item questionnaire. Items that were removed from the model, such as “sleep 
disordered breathing,” “wet the bed,” and “sleepwalking/nightmares” may not be as much a problem in 
this sample as some other sleep problems. The reliability of the SSCSI was modest (α = 0.694) indicating 
that additional refinement, perhaps in another ASD sample, is needed to further elucidate the concepts 
underlying sleep problems in children with ASD.  
The post-pubertal group was not well-characterized by the SSCSI, with low communalities and 
factor loadings. Evaluating this group with the instrument, however, may give important information 
about how sleep patterns and problems change from childhood through adolescence. For instance, some 
sleep habits or problems, such as needing to lay down with the child or frequent/prolonged naps, would 
developmentally be expected to resolve.  In addition, it is well-documented that the sleep period of post-
pubescent children shifts back to a later bedtime and wake time (Crowley et al., 2014; Tarokh & 
Carskadon, 2010), which may help to explain why “difficulty waking in the morning” and “daytime 
sleepiness” load well in the postpubertal model. One could presume that perhaps sleep duration has 
stabilized after puberty so that “irregular bedtime and wake time” may not be a problem according to the 
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SSCSI. Thought must be given to use of the instrument in this age group, and additional study may be 
needed to clarify these issues. 
Although no other instruments were administered in the SSC sample to allow for analysis of 
convergent validity, that many items on the SSCSI are represented in other well-validated questionnaires 
adds a measure of confidence in the SSCSI. Factor 1 of the SSCSI, nighttime problems, parallels the 
bedtime resistance, sleep onset delay, and night-waking subscales on the CSHQ and MSPSQ.  The latter 
two questionnaires have parasomnia and sleep disordered breathing subscales, though these items were 
not retained in the SSCSI. Factor 2 of the SSCSI, daytime problems, resembles the daytime sleepiness 
scales in the CSHQ and MSPSQ, although the MSQSQ does not address difficulty waking and neither 
questionnaires has a “regular sleep duration not enough”-type item in their daytime scale. Finally, factor 3 
of the SSCSI, sleep duration problems, corresponds to the sleep duration subscale of the CSHQ.  
3.5.1 Limitations 
The primary limitation of this study was unequal sizes between prepubertal, pubertal, and postpubertal 
groups. This may skew our ability to detect a similar factor structure in the SSC sample, and in the three 
groups. There was a slightly greater ratio of boys to girls (5.9:1) than that seen in the general ASD 
population (4.5:1). Another limitation was that little was known about the origin and administration of the 
SSCSI, and no other sleep instruments were used precluding the calculation of test-retest reliability, 
interrater reliability, and convergent validity. Without an objective measure of sleep, all items were based 
on parents’ report, and subject to reporting bias. In addition, laying down with a child may be accepted in 
some cultures and families practicing co-bedding, and this was not taken into consideration. Finally, 
without also testing a control group of typically developing children, it was difficult to know what sleep 
problems are unique to ASD and which are common in all children of a certain age.  
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3.5.2 Implications 
Several implications may be drawn from this analysis. First, myriad previous reports of sleep problems in 
children with ASD were confirmed using the SSC sample. This indicates the need for clinical screening 
by health care professionals of sleep habits and patterns in their ASD patient population, and as suggested 
by Malow et al. (2014), parent education in proper sleep habits should be provided. Nurses are in an 
optimal position to use the SSCSI for screening both in-patient and out-patient populations. Although 
sleep is often disturbed in the hospital, nurses working with in-patients may observe abnormal sleep 
patterns in their patients, and, guided by the SSCSI, bring these to the attention of the healthcare team.   
As well as in primary care and sleep medicine clinics, screening with the SSCSI could be employed in a 
range of specialty clinics—neurology, pulmonology, cardiology, behavioral medicine, etc. This screening 
may aid in proper diagnosis and treatment of other symptoms, and contribute to holistic, multispecialty 
care. Pediatric homecare nurses have an advantage in screening for sleep problems because they may 
have opportunities to witness first hand bedtime problems, abnormal sleep patterns, and sequela such as 
difficulty waking in the morning and excess daytime sleepiness. In addition, homecare nurses often have 
time that other nurses may not to counsel families about improving sleep habits, and to evaluate treatment 
interventions.  
Second, the SSCSI may be used by nurses and others utilizing the SSC sample for ASD research. 
As sleep problems in children with ASD have been correlated with gastrointestinal disorders, seizures 
(Aldinger et al., 2015), genes related to circadian rhythms (Melke et al., 2008; Yang et al., 2016), 
melatonin levels (Melke et al., 2008; Tordjman et al., 2005), cognitive performance (Elia et al., 2000; 
Limoges, Bolduc, Berthiaume, Mottron, & Godbout, 2013), behavior problems (Schwichtenberg et al., 
2013; Sikora, Johnson, Clemons, & Katz, 2012), and developmental regression (Flavia Giannotti et al., 
2011), the SSCSI may be used to evaluate sleep problems and patient outcomes in relation to many other 
variables in this large, well-characterized sample of children with ASD.  
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Use of a validated instrument adds a measure of confidence to a study, and is essential for 
collection and interpretation of accurate patient data. It is important to state that this study is the first to 
explore the psychometrics of the SSCSI, and due to the data available, a full description of the reliability 
and validity was not possible. Before the SSCSI is used in full-scale studies, it must be tested in other 
samples of children and adolescents with ASD in order to establish test-retest reliability, inter-rater 
reliability, and to support our findings of internal consistency. The SSCSI must also be used along with 
validated sleep questionnaires such as the CSHQ, MSPSQ, and CGI-S in order to establish convergent 
validity.  
3.5.3 Conclusion 
In conclusion, the SSCSI was found to have three factors with 10 dichotomous and 2 continuous items 
that describe sleep problems in a large sample of children with ASD, and has adequate reliability and 
validity. Relatively low internal consistencies and crossloading of several items point to the need for 
further refinement of the instrument. Similar factor loading of items in three age groups, indicates that 
many sleep problems continue from childhood through adolescence; and similarity to factors in other 
well-validated sleep instruments adds confidence in the SSCSI. This study adds to the current knowledge 
base of sleep patterns in children with ASD, and reinforces the need for nurses and other healthcare 
providers to screen for and address possible sleep problems in their practice.  The SSCSI also presents a 
means for other researchers using SSC data to integrate sleep pattern variables into their research, but 
must be further validated. 
 
 
 
 
 70 
4.0  DATA-BASED MANUSCRIPT: CHARACTERISTICS OF SLEEP IN CHILDREN WITH 
AUTISM SPECTRUM DISORDER FROM THE SIMONS SIMPLEX COLLECTION 
4.1 ABSTRACT 
Background: About 40-80% of children with ASD have sleep problems, including bedtime behavior 
problems, difficulty falling and staying asleep, decreased sleep time, and daytime sleepiness. This study 
aimed to examine relationships between sleep problems and characteristics of children with ASD in a 
large, nationwide sample.  
Methods: This secondary analysis of children 4- to 18-years explored sleep problems using the Simons 
Simplex Collection Sleep Interview (SSCSI), which includes Nighttime problems, Daytime problems, and 
Sleep duration problems subscales. Chi-square, Kruskal-Wallis, and Mann-Whitney U tests were 
performed to detect differences between age groups, sexes, and sleep problem severity groups. Odds 
ratios for variables associated with sleep problems were calculated using logistic regression. Two-way 
interaction effects were included in regression models, and stratified analyses performed for age groups. 
Results: Approximately 41% of children had SSCSI sleep problems. The most common items were in the 
nighttime problems subscale; difficulty falling asleep was most frequently reported. More than one-
quarter slept less than the hours recommended for their age. The odds of sleep problems were highest for 
gastrointestinal distress (GID) and age. Low nonverbal IQ (NVIQ) and seizures increased the odds of 
composite and Nighttime problems. Males were more likely to have composite and Daytime problems. 
ASD severity was not associated with sleep problems in this sample.  
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Conclusions: This study advances our understanding of sleep in ASD by showing that GID, NVIQ, age 
and seizures increased the odds of sleep problems in children with ASD. These results reinforce the need 
to screen for sleep problems in children with ASD, and suggest future lines of inquiry. 
4.2 INTRODUCTION 
4.2.1 Autism spectrum disorder 
Autism spectrum disorder (ASD) is a pervasive neurodevelopmental condition characterized by persistent 
difficulties in communication and social interaction, and restricted, repetitive behaviors, interests and 
activities. ASD is referred to as a “spectrum” because impairments may range from mild to severe, and 
may also include intellectual disability (American Psychiatric Association, 2013). The Autism and 
Developmental Disabilities Monitoring Network estimated that, in 2012, ASD affected 1 in 68 American 
children, and had a male-to-female ratio of 4.5:1 (Centers for Disease Control and Prevention, 2016). 
4.2.2 Sleep patterns in children with ASD 
An estimated 40-80% of children with ASD have comorbid sleep problems (Reviewed in Veatch, 
Maxwell-Horn, & Malow, 2015; Cortesi, Giannotti, Ivanenko, & Johnson, 2010), which have been 
recognized by researchers for decades (Ornitz et al., 1969; Tanguay et al., 1976).  Studies have observed 
that, compared with typically developing [TD] peers, children with ASD have significantly longer sleep 
onset latency (time to fall asleep; Giannotti, Cortesi, Cerquiglini, Vagnoni, & Valente, 2011, N=52; 
Goldman et al., 2017, N=41; Lambert et al., 2016, N=34), more frequent awakenings after sleep onset 
(Allik, Larsson, & Smedje, 2008, N=32; Souders et al., 2009, N=99), shorter total sleep time (sleep 
beginning to end– awakenings after sleep onset; Elrod & Hood, 2015, meta-analysis N=564; Goodlin-
 72 
Jones, Tang, Liu, & Anders, 2008, N=194; Miano et al., 2007, N=62), and poorer sleep efficiency (total 
sleep time/time in bed; all p < 0.05; Elrod & Hood, 2015; Fletcher et al., 2016, N=50; Giannotti et al., 
2011).  
It has been suggested that intellectual disability (ID; IQ < 70 with functional deficits; World 
Health Organisation, 1996) may alter sleep patterns in children with ASD. Two recent studies have noted 
that ASD with ID was associated with sleep anxiety in children 2- to 5-years-old (p < 0.001), bedtime 
resistance and night wakings in children 6- to 18-years-old (p < 0.05; Mazurek & Petroski, 2015), and 
short sleep duration in children 4- to 18-years-old (p < 0.001; Veatch et al., 2017). A meta-analysis of ten 
studies revealed that children with ASD and comorbid ID had significantly lower total sleep time than TD 
children (pooled difference of means = -45 minutes; 95% CI: -62.6 to -28.6, p < 0.001), while there was 
no significant difference in total sleep time between children with ASD and no ID compared to TD 
children (p = 0.316).  
Severity of ASD may also contribute to abnormal sleep patterns in children. In a population of 
1,224 children, those with parent-reported sleep problems (falling asleep and staying asleep) were 
observed to have higher ASD severity scores on the Autism Diagnostic Inventory-Revised social 
interaction, communication, and restricted, repetitive behavior subscales (Lord, Rutter, & Le Couteur, 
1994); and on the Vineland Adaptive Behavior Scale (Sparrow, Balla, Cicchetti, Harrison, & Doll, 1984) 
communication, socialization, daily living skills, and motor skills subscales than children without sleep 
problems (Zachor & Ben-Itzchak, 2016; p < 0.02). Using the Autism Diagnostic Observation Scale 
(ADOS; Hus, Gotham, & Lord, 2014; Lord et al., 1989) as an indicator of ASD severity, Veatch et al. 
(2017) observed that short sleep duration was significantly negatively correlated with ADOS social affect 
severity scores (ρ = -0.06, p < 0.02), though not with total ADOS severity score.  
Two medical comorbidities that have been associated with sleep problems in children with ASD 
are gastrointestinal disturbance (GID) and seizures. Presence of epilepsy and epileptiform EEG 
abnormalities have both been reported as predictors of sleep problems (Giannotti et al., 2008; p < 0.01). 
Aldinger, Lane, Veenstra-VanderWeele, and Levitt (2015) report that, among children with ASD and 
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sleep problems (defined as parent report yes/no any sleep problems) in the Simons Simplex Collection 
(SSC), the odds of having GID (23% of sample) were almost two times higher than for children without 
sleep problems (OR=1.8, 95% CI: 1.5-2.3), and the odds of having both GID and seizures (2.6% of 
sample) was twice as high as children without sleep problems (OR=2.0, 95% CI: 1.3-3.1).  In the Autism 
Genetic Resource Exchange, Aldinger et al. also report that children with sleep problems, seizures, and 
GID had a two-standard deviation lower Vineland Adaptive Behavior Scale composite score than children 
with none of the three comorbidities.  
 To date, most studies examining sleep problems in children with ASD have had small sample 
sizes and restricted age ranges, or look only at a single or select few sleep problems. The aim of this study 
is to examine the relationship between the presence of sleep problems and characteristics of children with 
ASD, such as age, sex, nonverbal IQ (NVIQ), ASD severity, and medical conditions in a large, 
nationwide sample of children 4- to 18-years-old. We hypothesize that the number of children with 
bedtime and nighttime sleep problems will decrease as children age; that children with GID and/or 
seizures will have more sleep problems; and that children with severe ASD and/or NVIQ will have more 
sleep problems. 
4.3 METHODS 
4.3.1 Participants 
4.3.1.1 Simons Simplex Collection 
The Simons Foundation Autism Research Initiative began in 2003 with the goal of improving the 
scientific understanding of ASD. One of their major projects was the Simons Simplex Collection [SSC], a 
sample of approximately 2,750 simplex families (only one child with ASD) from 12 sites in the United 
States and Canada. Two studies have examined sleep patterns in children from the SSC. Veatch et al. 
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(2017) examined short sleep duration in relation to intellectual and behavioral comorbidities of ASD, and 
Aldinger et al. (2015) studied risk for fourteen medical conditions, including presence of any sleep 
problem (yes/no), in children with ASD. The present study will examine ten sleep problems, including 
short sleep duration, and how these relate to demographic, medical, and behavioral characteristics.  
 Procedures of the parent study, inclusion and exclusion criteria, and characteristics of the SSC 
study sample have been described previously (Fischbach & Lord, 2010; Frazier et al., 2014; Lord et al., 
2012). Briefly, children, aged 4- to 18-years-old (N=2,745, M=9.0, SD=0.07 years), were strictly 
phenotyped through parent interview, medical history, and multiple well-validated instruments. Children 
were given a clinical best estimate diagnosis of ASD based on observation, medical history and chart 
review, and Autism Diagnostic Observation Schedule [ADOS] and Autism Diagnostic Interview-Revised 
[ADI-R] scores. Diagnoses were based on the Diagnostic and Statistical Manual of Mental Disorders-IV-
Text Revised [DSM-IV-TR] (Simons Foundation Autism Research Initiative, 2014).  
4.3.2 Procedure 
This study was a secondary analysis of existing data from the Simons Foundation.  For the parent study, 
informed consent was obtained from all parents or caregivers included in the study, and assent from 
children as required by local institutional review boards. Approval was obtained from the University of 
Pittsburgh Institutional Review Board for the present study. Data were de-identified by the Simons 
Foundation prior to receipt by the present researchers. 
Demographic data (age, sex, etc.) were collected at the time of initiation in the parent study. In 
the current study, an attempt was made to capture normal shifts in sleep patterns throughout childhood by 
exploring the association of age with sleep patterns.  Therefore, children in the SSC sample were divided 
by age into three age groups called early (4-8-years), middle (9-13- years), and late (14-18-years) 
childhood. Presence or absence of GID and seizures was determined using data from the medical history 
interview conducted by the parent study at baseline.  
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4.3.3 Measures 
Simons Simplex Collection Sleep Interview (SSCSI), an 11-item parent-report questionnaire, was used for 
assessing bedtime and nighttime sleep problems, daytime function, and sleep duration (Table 10). 
Questions were asked at a clinic visit or by telephone interview of parents within three months of study 
initiation.  The scoring rubric consists of individual items that are scored as 0 for “no” and 1 for “yes”.  A 
continuous composite score is made by summing 10 dichotomous items, and adding 1 point for sleep 
duration that was outside the National Sleep Foundation recommendations for the child’s age 
(Hirshkowitz et al., 2015). Composite scores range from 0 to 11, with higher scores indicating worse 
sleep.  Scores for the nighttime problems and daytime problems subscales range from 0 to 4, and scores 
for the sleep duration problems subscale range from 0 to 2 (reviewed in Johansson, Feeley, Chasens, in 
press).  Participants were excluded from the present study if more than two items were missing or coded 
as unknown.  
Autism Diagnostic Observation Schedule (ADOS) was used to measure ASD severity. The ADOS 
is a semi-structured observational instrument used with other instruments for diagnosis of ASD and 
classification of severity.  The measures that make up the ADOS total score are operationalized as 
characteristics of social responsiveness, communication, language delay, and spatial ability.  Four 
modules are available with developmentally appropriate tasks for testing individuals with different 
language abilities (Lord et al., 2000). Items are scored on a 4-point Likert-type scale from 0 (no 
abnormality) to 3 (moderate to severe abnormality), and fall into measures of either social affect or 
restricted repetitive behavior.  Calibrated severity scores standardized for age and language level are 
calculated for social affect and restricted, repetitive behavior items, and a total ADOS severity score is the 
sum of these scores. Children with a total ADOS severity score from four to five are classified as having 
“autism spectrum,” and those with a score of six or more are classified as having “autism”  (Gotham, 
Pickles, & Lord, 2009; Gotham et al., 2008; Hus, Gotham, & Lord, 2014). Standardization of module 4 
scores to match prior standardization of modules 1-3 was performed by the present research team by 
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mapping raw social affect and restricted, repetitive behavior scores onto total, social affect, and restricted 
repetitive behavior severity scores (V. Hus Bal, personal communication, March 24, 2017). 
Four norm-referenced instruments were used by the parent study to quantify IQ in the SSC 
sample depending on chronologic and mental age: the Differential Ability Scales-II (DAS-II; Elliott, 2012; 
PsychCorp, 2016), Weschler Intelligence Scale for Children-Fourth Edition (WISC-IV; Weschler, 2003), 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 2011), and Mullen Scales of Early 
Learning (MSEL; Bradley-Johnson, 1997). Scales have been standardized so that each scale produces a 
common verbal IQ (VIQ), nonverbal IQ (NVIQ), and full-scale IQ (FSIQ) score that can be used to 
quantify and compare IQ across instruments.  The WISC-IV (Khor et al., 2014; Oliveras-Rentas et al., 
2013; P. E. Williams et al., 2003) and MSEL (Akshoomoff, 2006; Bishop, Guthrie,  Coffing, & Lord, 
2011) have been previously used in ASD samples. Discrepencies also often occur between nonverbal and 
verbal IQ scores in individuals with ASD, and tests that rely on language skills may not accurately reflect 
the child’s actual intelligence and functional abilities. Thus, NVIQ scores will be utilized in the present 
study. Children were excluded from the present study if they were missing NVIQ and ADOS data. 
Children were classified as having GID if they were reported (yes/no) to have bloating/excess 
gas, celiac disease, constipation, diarrhea, ulcers, gastroesophageal reflux disease, inflammatory bowel 
disease (Crohn’s disease, ulcerative colitis), irritable bowel syndrome, abdominal pain, unusual stools, 
vomiting, and/or other GID; and classified as having seizures if they were reported to have atonic drop, 
infantile spasms; or partial complex, grand mal, petit mal, simple partial, and/or other seizures. GID and 
seizures were dichotomized as 0 (none reported) or 1 (one or more reported). 
4.3.4 Analysis 
Phenotypic data was acquired from the Simons Foundation software platform, SFARI Base. The ten 
dichotomous SSCSI items, SSCSI composite score and subscale scores, NVIQ, ADOS severity score, and 
sex were described using frequency counts and percentages. Regular sleep duration in hours per night and 
 77 
age in years were described using mean, standard deviation, and range. Outliers in regular sleep 
duration—reported sleep duration less than 3 standard deviations below the population mean—were 
replaced with the 3rd standard deviation below the mean (4.85 hours). Differences in NVIQ, ADOS 
severity score between age groups, sexes, and sleep problem groups (none/minimal, mild, 
moderate/severe) were explored with Mann-Whitney U or Kruskal-Wallis analyses; and differences in 
presence of GID and seizures between these groups were explored with chi-square analyses. Descriptive 
analyses were performed with SPSS version 23 (SPSS Inc., Chicago, IL). 
SSCSI composite sleep scores have been categorized into three levels of sleep problems: 
none/minimal (scores 0-1), mild (2-3), moderate/severe (> 4). Baseline and adjacent category logistic 
regression analyses were performed to explore and compare the association between SSCSI composite 
and factor scores, and child characteristics. This method uses maximum likelihood estimation to compare 
the log odds of being in one group versus another. Six independent child characteristics variables were 
included: age, ADOS severity score (range: 4-10), sex (male=0, female=1), NVIQ (<40=1, 40-54=2, 55-
70=3, 71-100=4, >100=5), GID (no=0, yes=1), and seizures (no=0, yes=1). Nonverbal IQs above 70 were 
split into 2 groups: those above and those below or equal to the population mean of 100. Those 70 and 
below were split into 3 groups using the population standard deviation (SD=15). The groups were 0 to 1 
SD below 70 (NVIQ = 55-70), 1 to 2 SD (NVIQ=40-54), and >2 SD (NVIQ < 40). Based on 
recommendations from the American Association of Intellectual and Developmental Disabilities (Tasse, 
Luckasson, & Nygren, 2013), NVIQ scores below 40 were condensed into one category. Where total 
ADOS severity score was significant, social affect and restricted, repetitive behavior severity scores were 
analyzed. Analyses were performed by building models with no/minimal sleep problems versus sleep 
problems (mild and moderate/severe) as the outcome variable, and then looking between sleep problem 
severities (none/minimal vs. mild, none/minimal vs. moderate/severe, mild vs. moderate/severe). The 
most parsimonious model in each case was chosen using the Akaike information criterion (AIC). Because 
of small proportions of children in the female, middle and late childhood, or seizure groups, only baseline 
(none/minimal sleep problems vs. sleep problems) analyses were performed in subgroups. Logistic 
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regression analyses were done with the full sample. Two-way interactions between child characteristics 
were requested; and significant interactions between age or sex and the other child characteristics were 
reported. When there were interactions with age or sex, the sample was stratified by the significant 
variable (age or sex) and logistic regression analyses were run in the subgroups.  Logistic regression was 
performed with the MASS package in the R suite (R Core Team, 2016). Level of significance was set at 
p<0.05. 
4.4 RESULTS 
4.4.1 Sample characteristics 
Of the full sample (N=2,745), 2,619 children had sufficient data on the SSCSI, NVIQ, and ADOS 
measures to be used for the analysis (Table 5; see Table 13 for sample characteristics by SSCSI sleep 
score severity). One hundred twenty-six children were excluded from analysis: 22 because of missing 
more than 2 SSCSI items, and 104 because of not having SSCSI, NVIQ, and ADOS data. There were no 
significant differences between those included and excluded. All children had GID and seizure data. 
Among the variables used in this study, the SSCSI item, irregular bedtime/waketime, was the only 
variable missing in more than 5% of participants (missing n=449, 17.1%). Children missing this item 
were significantly older (mean=9.5(3.4) vs. 8.9(3.6) years, p<0.01), and had significantly higher NVIQ 
(mean=90.2(25.1) vs. 83.3(26.2), p<0.01).  
Mean age at study inclusion was approximately 9-years-old (range: 4-18-years-old).  Overall, 
there was a male-to-female ratio of 6.5:1. Half of all children were reported to have GID, a rate that was 
not significantly different between age groups. Significantly more children with moderate/severe sleep 
problems had GID than those with mild or none/minimal sleep problems; and significantly more children 
with mild sleep problems have GID than those with none/minimal sleep problems (moderate/severe: 
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60.9%, mild: 52.5%, and none/minimal: 44.8% p<0.05). Approximately 5% of children were reported to 
have a seizure condition. Significantly fewer children in early childhood had seizures than in middle and 
late childhood (early: 4.2%, middle: 6.1%, late: 7.3% respectively, p<0.05); and significantly fewer 
children with none/minimal sleep problems had seizures than those with moderate/severe sleep problems 
(4.3% vs. 7.1%, p<0.05). 
In the current sample, over one-quarter (26.6%) of children had a NVIQ ≤ 70. The proportion of 
children with NVIQ ≤ 70 was not different between age groups, but was significantly higher in girls than 
boys (38.0% vs. 24.8%, p<0.001), in children diagnosed with autism than ASD (28.5% vs. 9.9%, 
p<0.001), and in children with moderate/severe than none/minimal sleep problems (31.2% vs. 24.8%, 
p<0.05). Total ADOS severity score and number of children with ASD (ADOS=4-5) versus autism 
(ADOS=6-10) were not found to be significantly different between girls and boys (p>0.05). Significantly 
more children with none/minimal vs. mild sleep problems had ASD (12.1% vs. 9.2%, p<0.05). 
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Table 5: SSC Sample Characteristics 
  
Age Groups 
 
Sex 
 
Full Sample 
N=2,619 
Early 
Childhood 
n=1,464 
Middle 
Childhood 
n=841 
Late 
Childhood 
n=314 
Males 
n=2,272 
Females 
n=347 
Age (yrs.) [mean(SD)] 9.0 (3.6) 6.4 (1.5) 11.1 (1.5) 15.9 (1.1) 9.0 (3.6) 9.0 (3.7) 
Male  2,272 (86.8) 1,274 (87.0) 732 (87.3) 266 (84.4) - - 
ADOS severity score* 
[mean(SD)] 7.5 (1.7) 7.5 (1.6) 7.5 (1.7) 7.5 (1.7) 7.5 (1.7) 7.4 (1.7) 
     Social affect 7.2 (1.7) 7.2 (1.7) 7.3 (1.7) 7.4 (1.7) 7.2 (1.7) 7.2 (1.8) 
     RRB 7.8 (1.8) a 8.0 (1.7) 7.8 (1.9) 7.3 (2.0) c 7.9 (1.8) 7.7 (2.0) 
Diagnosis:  
     ASD  
     AD  
289 (11.0) 
2,330 (89.0) 
135 (9.2) b  
1,329 (90.8) 
102 (12.1)  
739 (87.9) 
52 (16.6) 
262 (83.4) 
 
247 (10.9) 
2,025 (89.1) 
 
42 (12.1) 
305 (87.9) 
NVIQ ≤ 70 695 (26.6) 364 (24.8) 236 (28.0) 95 (30.2) 563 (24.8) 132 (38.0) d 
Seizures 135 (5.2) 61 (4.2) b 51 (6.1)  23 (7.3) 111 (4.9) 24 (6.9) 
GI disturbance 1,307 (49.9) 741 (50.7) 412 (48.9) 154 (49.0) 1,128 (49.6) 179 (51.6) 
Regular sleep duration 
(hours) [mean(SD)] 9.2 (1.3) 
a 9.6 (1.3) b 8.9 (1.2)  8.3 (1.1) c 9.2 (1.5) 9.2 (1.4) 
Duration less than NSF 
recommendations  741 (28.3) 392 (26.8) 
b 285 (33.9)  64 (20.4) c 640 (28.5) 101 (29.4) 
Note: data presented as n (%) unless otherwise specified; *ADOS=Autism Diagnostic Observation Scale, range 4-10; 
ASD=autism spectrum disorder (ADOS score 4-5); AD=autism disorder (ADOS score 6-10); GI= gastrointestinal; 
NSF=National Sleep Foundation; NVIQ=nonverbal IQ; RRB=restricted and repetitive behavior ;a Difference between early, 
middle, and late childhood, Kruskal-Wallis, p<0.05; b Difference between early and middle childhood, p<0.05; c Difference 
between middle and late childhood, p<0.05; d Difference between males and females, p<0.05 
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4.4.2 SSCSI items 
Table 6 displays the number and proportion of children whose parents responded “yes” to each SSCSI 
item, indicating that the item was problematic for the child (see Table 14 for distribution of SSCSI sleep 
score categories). In the total sample of 2,619 children, 1,623 (62%) of parents responded “yes” to one or 
more SSCSI items. The most commonly reported SSCSI items were in the nighttime problems subscale, 
with up to 32% of parents reporting “yes” to at least one item. Similarly, parents reported that up to one-
sixth of children had at least one problem item on the SSCSI daytime problems subscale. Significantly 
more females than males were reported to have regular sleep duration that was not enough (26.4% vs. 
20.6%, p<0.02), difficulty waking in the morning (19.3% vs. 12.5%, p<0.01), long/frequent naps (5.8% 
vs. 3.5%, p<0.04), and excess daytime sleepiness (17.1% vs. 12.9%, p < 0.04). Few children were 
reported to have all items for nighttime problems (3.1%), daytime problems (0.7%), or sleep duration 
problems (2.7%) subscales, and only one child had the maximum SSCSI composite score of 11.  Mean 
sleep duration was just over 9 hours (range: 4.9-13 hours), and steadily declined as children aged 
(correlation between age and sleep duration r= -0.361, p<0.01). About one-quarter of children (28.7%) 
slept less than the number of hours recommended for their age by the National Sleep Foundation (NSF; 
Hirshkowitz et al., 2015). The proportion of children with regular sleep duration less than that 
recommended by the NSF increased from early (27.8%) to middle childhood, (33.9%) and then decreased 
from middle to late childhood (20.1%).  
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Table 6: SSCSI Reported Item Frequencies 
  
Age groups 
 
Sex 
 Total Sample 
N=2,619 
Early 
Childhood 
n=1,464 
Middle 
Childhood 
n=841 
Late 
Childhood 
n=314 
Males 
n=2,272 
Females 
n=347 
Nighttime problems 
       
Bedtime problems       465 (17.8) a 280 (19.1) 146 (17.4)  39 (12.4) c 396 (17.4) 69 (19.9) 
 
Need to lay down with 
child 
   498 (19.1) a 363 (24.9) b 121 (14.5)  14 (4.5) c 433 (19.1) 65 (18.9) 
 
Difficulty falling asleep    829 (31.8) a 437 (30.0) b 296 (35.4)  96 (30.6) 706 (31.2) 123 (35.7)  
 
Frequent/prolonged 
awakenings 
 
   489 (18.8) a 300 (20.5) b 143 (17.1) 46 (14.7) 416 (18.4) 73 (21.2) 
Daytime problems          
 
Difficulty waking    351 (13.4) 178 (12.2) 
 132 (15.7)  41 (13.1)  284 (12.5) d 67 (19.3) 
 
Excess daytime sleepiness    350 (13.4) 182 (12.5) 117 (14.0) 51 (16.3) 291 (12.9) 
d 59 (17.1) 
 
Long/ frequent naps    99 (3.8) 56 (3.8) 26 (3.1) 17 (5.4) 79 (3.5) 
d 20 (5.8) 
 
Regular duration is not 
   enough 
 
   537 (21.4) 293 (20.8) 183 (22.6) 61 (20.5) 449 (20.6) d 88 (26.4) 
Sleep duration problems            
 
Irregular bedtime and/or 
   waketime * 
 
   425 (19.6) 235 (18.9) 133 (19.8) 57 (22.1) 361 (19.2)  64 (22.2) 
No regular duration 
 
   146 (5.6) 80 (5.5) 44 (5.2) 22 (7.1) 123 (5.4) 23 (6.6) 
All n (%); * missing 17.1%; a Difference between early, middle, and late childhood, p<0.05; b Difference between early and 
middle childhood, p<0.05; c Difference between middle and late childhood, p<0.05; d Difference between males and 
females, p<0.05 
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4.4.3 SSCSI composite and subscale scores 
Approximately 41% of children were categorized as having a mild (SSCSI composite score 2-3) or 
moderate/severe (SSCSI composite score ≥ 4) sleep problem (Table 7; Table 15 for SSCSI composite and 
subscale frequencies by sleep score categories). The proportion of children with sleep problems was 
significantly less in the late childhood group (34.1%) than the early and middle childhood groups (47.4% 
vs. 46.3% respectively, p<0.001). The distribution of SSCSI composite and subscale scores were not 
different between those with ASD (ADOS CSS 4-5) versus autism (ADOS CSS ≥ 6). Mean SSCSI 
composite score was significantly greater in children with NVIQ ≤ 70 compared to those with NVIQ >70 
(2.1(2.1) vs. 1.8(1.9), p<0.01).  In addition, children with NVIQ < 55 had significantly more need for a 
parent to lay down with them (28.0% vs. 18.2%, p<0.01), more frequent/prolonged awakenings (29.2% 
vs. 22.1%, p<0.05), and irregular bedtime/waketime than children with NVIQ 55-70 (30.0% vs. 22.7%, 
p<0.05).  
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Table 7: SSCSI Composite and Subscale Frequencies Among Children with Sleep Problems 
  Age groups 
 
Sex 
 
Full Sample 
N=2,619 
Early 
Childhood 
n=1,464 
Middle 
Childhood 
n=841 
Late 
Childhood 
n=314 
Males 
n=2,272 
Females 
n=347 
Composite 1,073 (41.0) a 635 (43.4) d 331 (39.4) 107 (34.1) 900 (39.6) e 173 (49.9) 
   Nighttime 
   problems 
675 (25.8) a 406 (27.7) b, d 213 (25.3) 56 (17.8)  577 (25.4) 98 (28.2) 
   Daytime 
   problems 
348 (13.3)  192 (13.1) 115 (13.7) 41 (13.1) 726 (32.0) e 147 (42.4) 
   Sleep 
   duration 
   problems 
72 (2.7)   45 (3.1) 21 (2.5) 6 (1.9) 60 (2.6)  12 (3.5) 
Note: “Sleep problems” considered SSCSI score ≥ 2; a Difference between early, middle, and late childhood, 
p<0.05; b Difference between early and middle childhood, p<0.05; c Difference between middle and late 
childhood, p<0.05; d Difference between early and late childhood, p<0.05; e Difference between males and 
females, p<0.05 
 
4.4.4 Full sample associations with SSCSI sleep problems 
Odds ratios, 95% confidence intervals, and p-values reflecting the association between child 
characteristics (age, sex, NVIQ, ADOS severity score, GID, and seizures) and SSCSI scores for the full 
sample can be found in Table 8. When examining the odds of a child having SSCSI composite sleep 
problems (mild-moderate/severe) as opposed to none/minimal sleep problems, GID was the strongest risk 
factor (OR=2.79, 95% CI: 1.59-4.92, p<0.01), followed lower NVIQ (OR=0.73, 95% CI: 0.59-0.90, 
p<0.01) and younger age (OR=0.76, 95% CI: 0.66-0.87, p<0.01) controlling for sex and ADOS severity 
score. An interaction was present between age and NVIQ for composite vs. none/minimal sleep problems 
(OR=1.04, 95% CI 1.02-1.06, p<0.01). Seizures had a significant, large OR, but an extremely wide 95% 
CI (OR=7.38, 95% CI: 1.34-43.18, p=0.02), likely due to the small number of children with seizures. Of 
those who had sleep problems, the odds of having mild sleep problems (vs. none/minimal) was associated 
with GID (OR=2.63, 95% CI: 1.29-5.40, p=0.01), male sex (OR=1.66, 95% CI: 1.26-2.18, p<0.01), 
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younger age (OR=0.87, 95% CI: 0.79-0.96, p<0.01), and higher ADOS severity score (OR=1.07, 95% CI: 
1.01-1.13, p=0.03) and ADOS social affect severity score (OR=1.09, 95% CI: 1.03-1.15, p<0.01). A 
significant interaction was present between age and NVIQ for mild vs. none/minimal problems 
(OR=1.03, 95% CI: 1.01-1.06, p=0.02). The odds of moderate/severe sleep problems were significantly 
greater as NVIQ decreased (vs. none/minimal: OR=0.62, 0.48-0.79; or mild: OR=0.80, 95% CI: 0.68-
0.95, all p≤0.01), as age increased (vs. none/minimal: OR=0.84, 95% CI: 0.75-0.92, p<0.01), and with the 
presence of GID (OR=1.88, 95% CI: 1.51-2.34, p<0.01). The odds of moderate/severe composite sleep 
problems increased as ADOS total severity score and social affect severity score decreased (vs. mild; total 
ADOS: OR=0.91, 95% CI: 0.84-0.98; social affect: OR=0.89, 95% CI: 0.82-0.96, all p≤0.02). Restricted, 
repetitive behavior severity score was not significantly associated with the SSCSI composite sleep score. 
A significant interaction was found between age and NVIQ in those with moderate/severe composite 
sleep problems (OR=1.04, 95% CI: 1.01-1.07, p<0.01). 
 The odds of nighttime problems (mild-moderate/severe vs. none/minimal) were significantly 
greater in younger children (OR=0.85, 95% CI: 0.78-0.93, p<0.01), those with lower NVIQ (OR=0.70, 
95% CI: 0.57-0.86, p<0.01), and those with seizures (OR=1.47, 95% CI: 1.01-2.14, p=0.04). A significant 
interaction was present between age and NVIQ (OR=1.02, 95% CI: 1.01-1.05, p=0.03). The odds of mild 
nighttime problems (vs. none/minimal problems) and moderate/severe nighttime problems (vs. 
none/minimal and mild problems) were significantly greater in younger children (mild vs. none/minimal: 
OR=0.89, 95% CI: 0.81-0.96; moderate/severe vs. none/minimal: OR=0.81, 95% CI: 0.69-0.96; 
moderate/severe vs. mild: OR=0.85, 95% CI: 0.73-0.97; all p≤0.03). Children with GID were 
significantly more likely to have mild (vs. none/minimal) nighttime problems (OR=2.68, 95% CI: 1.14-
6.34, p=0.02). Lower NVIQ also increased the likelihood of mild (vs. none/minimal) nighttime problems 
(OR=0.71, 95% CI: 0.57-0.88, p<0.01), and a significant interaction was found between age and NVIQ in 
children with mild (vs. none/minimal) nighttime problems (OR=1.02, 95% CI: >1.00-1.05, p=0.04).    
 The odds of daytime problems (mild-moderate/severe vs. none/minimal) were more than three 
times greater for males and those with GID (male: OR=3.37, 95% CI: 1.50-7.63; GID: OR=3.17, 95% CI: 
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1.72-5.88, all p<0.01). The odds of composite (vs. mild-moderate/severe problems) and mild (vs. 
none/minimal) daytime problems were significantly greater in younger children (composite: OR=0.90, 
95% CI: 0.83-0.98; mild vs. none/minimal: OR=0.88, 95% CI: 0.79-0.996; all p<0.05). However, the 
odds of moderate/severe problems were significantly greater in older children (vs. none/minimal: 
OR=1.80, 95% CI: 1.08-2.93; vs. mild: OR=1.79, 95% CI: 1.03-3.19; all p<0.05). A significant 
interaction was found for children with daytime problems between age and NVIQ (mild-moderate/severe 
vs. none/minimal: OR=1.03, 95% CI: 1.01-1.05, p<0.01), and between age and ADOS (moderate/severe 
vs. none/minimal: OR=0.93, 95% CI: 0.87-0.99, p=0.03). There were no associations between odds of 
sleep duration problems (mild-moderate/severe vs. none/minimal) and any child characteristics. 
4.4.5 Subgroup associations with SSCSI sleep problems 
Since there were numerous interactions between age and other covariates, the sample was stratified by 
age group (early, middle, and late childhood) and associations between sleep problems and child 
characteristics were further explored (Tables 18-20). Examining only the early childhood group (4-8-
years-old), low NVIQ was significantly associated with increased odds of composite sleep problems 
(OR=0.82, 95% CI: 0.74-0.90; p<0.01), nighttime problems (OR=0.80, 95% CI: 0.72-0.89; p<0.01), and 
sleep duration problems (OR=0.65, 95% CI: 0.52-0.82, p<0.01). Presence of GID significantly increased 
the odds of composite sleep problems (OR=1.61, 95% CI: 1.31-1.99, p<0.01), nighttime problems 
(OR=1.37, 95% CI: 1.09-1.73, p<0.01) and daytime problems (OR=2.19, 95% CI: 1.60-3.04, p<0.01). 
Males in the early childhood group were significantly more likely to experience daytime problems than 
females (OR=1.59, 95% CI: 1.05-2.37, p=0.02).  
 Children in the middle childhood group (8-13-years-old) had significant associations between age 
and the odds of composite problems (OR=1.15, 95% CI: 1.04-1.27, p<0.01) and daytime problems 
(OR=1.18, 95% CI: 1.03-1.36, p<0.01).  Males were significantly more likely than females to have 
composite sleep problems (OR=1.86, 95% CI: 1.23-2.83, p<0.01). Presence of GID significantly 
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increased the odds of composite problems, nighttime problems, and daytime problems (composite: 
OR=1.56, 95% CI: 1.18-2.06; nighttime problems: OR=1.63, 95% CI: 1.19-2.24, p<0.01). As NVIQ 
decreased, the odds of sleep duration problems significantly increased (OR=0.73, 95% CI: 0.54-0.99, 
p=0.04). Presence of GID also increased the odds of nighttime problems two-fold in the late-childhood 
group (OR=2.08, 95% CI: 1.15-3.85, p=0.02).  
 
 
 
 
 88 
Table 8: Associations Between Child Characteristics and SSCSI Sleep Problems 
  None/minimal vs.  
Mild-severe 
None/minimal vs.  
Mild 
None/minimal vs. 
Moderate/severe 
Mild  
vs. Moderate/severe 
  OR CI p OR CI p OR CI p OR CI p 
SSCSI 
composite 
sleep score 
Age 0.97 0.95-0.99 <0.01 0.97  
0.95-
0.99 0.04 0.96 
0.93-
0.99 <0.01 0.99 
0.96-
1.03 0.72 
Sex * 1.47 1.17-1.85 <0.01 1.58 
1.22-
2.06 <0.01 1.35 
0.98-
1.79 0.07 0.84 
0.61-
1.16 0.30 
NVIQ 0.88 0.81-0.95 0.08 0.98 
0.90-
1.07 0.66 0.88 
0.81-
0.96 <0.01 0.89 
0.81-
0.98 0.02 
ADOS  1.02 0.97-1.07 0.40 1.05 
0.99-
1.12 0.05 0.97 
0.91-
1.04 0.40 0.92 
0.86-
0.99 0.02 
     SA t - - - - - - - - - 0.93 0.86-0.99 0.03 
     RRB t - - - - - - - - - 0.97 0.91-1.03 0.35 
GID 1.53 1.30-1.78 <0.01 1.34 
1.12-
1.61 <0.01 1.84 
1.50-
2.28 <0.01 1.38 
1.09-
1.75 <0.01 
Seizures 1.33 0.93-1.90 0.12 1.26 
0.82-
1.93 0.28 1.41 
0.90-
2.18 0.13 1.16 
0.72-
1.88 0.54 
Subscales             
     Nighttime 
     problems 
      
Age 0.95 0.93-0.98 <0.01 0.96 
0.94-
0.99 <0.01 0.90 
0.84-
0.96 <0.01 0.94 
0.87-
1.004 0.07 
Sex * 1.10 0.85-1.43 0.45 1.12 
0.86-
1.46 0.40 0.99 
0.51-
1.91 0.98 0.91 
0.46-
1.80 0.78 
NVIQ 0.88 0.81-0.95 <0.01 0.88  
0.81-
0.95 <0.01 0.84 
0.70-
1.02 0.08 0.99 
0.82-
1.19 0.89 
ADOS 0.99 0.94-1.05 0.73 0.99 
0.93-
1.04 0.66 1.01 
0.88-
1.16 0.86 1.03 
0.90-
1.20 0.60 
     SA t - - - - - - - - - - - - 
     RRB t - - - - - - - - - - - - 
GID 1.49 1.25-1.78 <0.01 1.43 
1.19-
1.73 <0.01 1.94 
1.23-
3.12 <0.01 1.39 
0.86-
2.26 0.18 
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Seizures 1.33 0.91-1.93 0.14 1.35 
0.91-
1.99 0.13 1.19 
0.46-
3.10 0.72 0.86 
0.32-
2.29 
0.76 
     Daytime 
    problems  
Age 0.98 0.79-1.21 0.84 0.98 
0.79-
1.22 0.85 0.97 
0.40-
2.32 0.94 1.03 
0.90-
1.17 0.64 
Sex * 1.57 1.15-2.12 <0.01 1.63 
1.19-
2.20 <0.01 0.80 
0.18-
3.50 0.77 0.41 
0.09-
1.92 0.26 
NVIQ 1.08 0.98-1.20 1.13 1.09 
0.98-
1.21 0.12 1.03 
0.70-
1.52 0.89 1.05 
0.70-
1.56 0.83 
ADOS 1.00 0.93-1.07 0.94 1.00 
0.93-
1.07 0.97 0.93 
0.71-
1.21 0.59 1.11 
0.81-
1.50 0.52 
     SA t - - - - - - - - - - - - 
     RRB t - - - - - - - - - - - - 
GID 1.98 1.57-2.51 <0.01 1.98 
1.56-
2.53 <0.01 1.90 
0.75-
4.85 0.18 0.83 
0.31-
2.24 
0.71 
Seizures 1.16 0.73-1.86 0.53 1.00 
0.60-
1.67 0.99 5.13  
1.45-
14.41 <0.01 4.35 
1.16-
13.42 0.02 
     Sleep 
     duration 
     problems  
Age 0.95 0.88-1.02 0.14   
 
  
 
  
 
Sex * 1.32 
0.70-
2.48 0.39 
Bold results denote statistical significance; Note: Sleep duration problems sample too 
small to examine differences between none vs. mild, none vs. moderate/severe, or mild 
vs. moderate/severe; * Reference group=females;      t only tested if ADOS severity 
score significant; ADOS=ADOS severity score; CI=95% confidence interval; 
GID=gastrointestinal disturbance; NVIQ=non-verbal IQ; OR=odds ratio; SA=ADOS 
social affect severity score; RRB=ADOS restricted, repetitive behavior severity score 
NVIQ 0.69 
0.58-
0.82 <0.01 
ADOS 1.00 
0.87-
1.15 0.97 
     SA t - - - 
     RRB t - - - 
GID 1.11 0.69-1.78 0.66 
Seizures 2.07 0.92-4.64 0.08 
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4.5 DISCUSSION 
The aim of this study was to examine the relationship between sleep patterns and characteristics of 
children with ASD ranging from early to late childhood. More than 60% of children in the SSC sample 
had a parent identify at least one item on the SSCSI as problematic, and about 40% were classified as 
having a mild or moderate/severe sleep problem on the SSCSI composite or subscales. The nighttime 
problems subscale had the highest occurrence of sleep problems, with difficulty falling asleep being the 
most frequently reported problem. A considerable proportion of the sample did not get the sleep duration 
recommended by the National Sleep Foundation for their age (20-34%), although only a very small 
proportion were reported by parents as having problems on the SSCSI sleep duration problems subscale 
(3%). The number of children with mild or moderate/severe scores on the nighttime problems subscale 
did not decrease significantly between early and middle childhood groups, but did decrease between 
middle and late childhood groups.  In the full sample, and in sex and age subgroups, GID and age were 
the variables most frequently most significantly associated with sleep problems in the SSC sample. A 
significantly higher mean SSCSI composite score was seen in children with NVIQ ≤ 70. In addition, 
NVIQ was significantly associated with composite and nighttime problems subscales; and small 
interactions between age and NVIQ were present for composite problems, and nighttime problems and 
daytime problems subscales.  Seizures were significantly correlated with increased composite and 
nighttime problems scores. Lower total ADOS and social affect severity scores were associated with 
increased odds of moderate/severe (versus mild) sleep problems on the SSCSI composite, but higher total 
ADOS and social affect severity scores were associated with increased odds of mild (versus 
none/minimal) sleep problems.  However, these associations were small, had incongruous directions, and 
there was no significant difference in the distribution of SSCSI scores between children with low (4-5) 
and high (6-10) ADOS severity scores in this sample. In addition, although an interaction between age 
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and total ADOS severity score was indicated, ADOS severity score was not significantly associated with 
sleep problems in any of the stratified groups. These inconsistencies suggest that the associations are 
likely false positives.  
That GID was found to be frequently associated with sleep problems is consistent with results 
found in other studies. Comparable to Kang et al. (2014), the present study found that almost 50% of 
children studied had at least one chronic GID, that rates of GID were not significantly different among 
age groups, and that GID was associated with sleep disturbance in children with ASD. A link between 
sleep problems and GID has been previously reported in the medical and ASD specific literature, with 
attempts to further understand this phenomenon. The first theory is that abdominal pain or discomfort is 
likely to make it difficult to fall asleep, stay asleep, or maintain deep sleep. Fass et al. (2000) found in 
their study of 505 patients with functional bowel disease and/or irritable bowel syndrome that up to 71% 
report sleep disturbance such as waking during the night or waking unrefreshed in the morning. In 
addition, individuals with ASD may have heightened pain sensitivity, compounding the effect of 
abdominal discomfort on sleep (Riquelme, Hatem, & Montoya, 2016).  More specifically for this 
population, GID in children with ASD may be due to neurobehavioral factors such as food selectivity or 
stool-holding behavior (Ibrahim, Voigt, Katusic, Weaver, & William, 2009). In addition to the effect of 
these behaviorally-influenced GID symptoms on sleep, children who are particularly prone to restrictive, 
ritualistic behaviors may also exhibit bedtime problems like bedtime resistance or insistence on having a 
parent in the room when falling asleep.   
Age was observed to be associated with sleep patterns in the way expected: negatively associated 
with SSCSI composite and nighttime problems subscale scores. This indicates that as children aged, the 
number of sleep problems reported by parents decreased.  Conversely, age was significantly positively 
associated with moderate/severe daytime problems. Studies of sleep patterns through adolescence have 
shown that postpubertal children naturally tend to fall asleep and wake later than prepubertal children, and 
are more likely to experience difficulty waking and daytime sleepiness (M. Carskadon et al., 1979; 
Crowley et al., 2014; Jenni et al., 2005). Discrepancies between when adolescents naturally fall asleep, 
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and when they must wake in the morning for school or work may contribute to parents reporting their 
older child not getting enough sleep duration. Of note, age was only associated with composite sleep 
problems and daytime problems in the middle childhood group, indicating that sleep patterns are changing 
between 9- and 13-years-old in this sample.  
Lower total ADOS and social affect severity scores were found to be associated with lesser odds 
of mild composite sleep problems (vs. none/minimal), but greater odds of moderate/severe composite 
sleep problems (vs. mild). However, these associations may represent false positive results based on the 
size and direction of associations. First, odds ratios were small (mild: total ADOS OR = 1.07, social affect 
OR = 1.09; moderate/severe: total ADOS OR = 0.92, social affect OR = 0.93), translating to only a 7-9% 
change in problems for each unit increase in ADOS severity score. That the direction of the mild vs. 
none/minimal and moderate vs. mild results are incongruent is concerning, as well. Second, the 
implication that children with less severe ASD symptoms have more reported sleep problems also does 
not support our hypothesis that children with more severe ASD would have more sleep problems. Indeed, 
there are mixed positive and negative associations between non-significant total ADOS severity score and 
total sleep problems (mild-severe; vs. none/minimal), mild and moderate/severe sleep problems (vs. 
none/minimal), and SSCSI subscale scores. Third, that total ADOS severity score was not significantly 
associated with sleep duration problems (irregular bedtime/waketime and no regular sleep duration) 
agrees with the Malow et al. (2006) finding that total ADOS is not associated parent-reported sleep 
duration, but does not agree with the Veatch et al. (2017) finding that shorter sleep duration was 
associated with more severe social impairment. Other studies, such as Zachor and Ben-Itzchak (2016) 
using the Autism Diagnostic Inventory-Revised (Lord et al., 1994) and the Vineland Adaptive Behavior 
Scales (Sparrow, Balla, Cicchetti, Harrison, & Doll, 1984), and Hirata, Mohri, Kato-Nishimura, & 
Tachibana (2016)  using the Child Behavior Checklist (Achenbach, 2001) have found that children with 
parent-reported sleep problems had higher autism severity scores. Overall, the uncertainty surrounding the 
size, direction, and validity of the significant association between sleep problems and ASD severity in the 
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present study and other studies indicate that more investigation into this complex relationship is 
warranted. 
Unlike Elrod and Hood (2015), who observed that children with ASD and mild ID (FSIQ 55-70) 
had more trouble falling asleep than those with ASD and moderate to severe ID (FSIQ < 55), the present 
study did not confirm these results. The present study showed that children with NVIQ 55-70 did not 
have significantly more difficulty falling asleep than those with NVIQ < 55, and they had significantly 
less nighttime and sleep duration problems than those with NVIQ < 55. In fact, most of the results 
reported here indicated more reported sleep problems in children with lower NVIQ. Analyses showed that 
SSCSI composite, and nighttime problems and sleep duration problems subscale scores, were negatively 
associated with NVIQ. This indicates that as NVIQ decreases, the frequency of reported sleep problems 
increases. The present study did confirm the results of Gail-Williams et al. (2004) which showed that 
children with concurrent ID were found to have a greater frequency of night wakings than those with 
ASD and no ID. 
Interactions between age and NVIQ were observed in analyses of SSCSI composite, nighttime 
problems, and daytime problems scores. Although the association between these interaction effects and 
sleep problems were small (OR=1.02-1.04), their frequency in the regression models may warrant further 
investigation. The positive direction of the interactions implies that, in the SSC sample, as age increased 
the effect of NVIQ on the odds of sleep problems increases. However, it is possible that the use of 
different IQ measures based on mental age may be creating an artificial interaction between age and 
NVIQ. In addition, it is becoming more evident that the genetic and environmental causes ASD and ID 
are varied, it is possible that there are subgroups within the SSC sample that are not accounted for in this 
study. 
A confounding factor in the measurement and analysis of IQ in the SSC sample is the effect of 
ASD severity on the IQ testing process.  If a child was unable to participate in part of the IQ testing 
because of communication or behavior difficulties, SSC researchers recorded the IQ with what they were 
able to measure.  Consequently, some IQ scores were extremely low (NVIQ reported range: 9-152), and 
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not reflective of children who would have fit the inclusion criteria for the SSC sample. Because IQ scores 
may be artificially low and correlated with ADOS scores, they may be creating false correlations with 
SSCSI scores, and in turn masking a true correlation between sleep scores and ADOS severity scores or 
preventing ADOS severity scores from entering the regression model. Because of this, we cannot say 
conclusively that ADOS severity score is or is not associated with sleep scores.  
4.5.1 Limitations 
This study has several limitations. First, little is known about administration of the SSCSI, and other sleep 
instruments were not used so that test-retest reliability, interrater reliability, and convergent validity 
cannot be calculated. Also, without an objective measure of sleep, the SSCSI was based on parents’ 
report, and thus is subject to reporting bias.  For instance, some parents may not be aware that their child 
is waking multiple times in the night if the child does not wake them; or children with GID or other 
medical comorbidities may wake their parents more often with complaints of discomfort. In addition, 
some parents may view symptoms such as difficulty waking in the morning or daytime sleepiness as 
normal for their child’s developmental level, and thus not report these symptoms as problems on the 
SSCSI.  Second, although this is one of the largest groups of children with ASD available, subgroups of 
the sample varied considerably in size. Because of small sample size in comparison to the full sample, 
females and the late childhood group did not yield reliable regression results. Also, a greater ratio of boys 
to girls was seen in this group (6.5:1) than that seen in the broader ASD population (4.5:1). Third, without 
also testing a typically developing control group, it is difficult to surmise what sleep problems are unique 
to ASD versus are typical in children of a certain age.  
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4.5.2 Implications 
This study advances the understanding of sleep and ASD by showing that age, and presence of GID and 
low NVIQ increase the risk of sleep problems in a large, well-phenotyped sample of children with ASD. 
Several implications may be drawn from this investigation. First, as expected, sleep problems were most 
prevalent in early and middle childhood, suggesting that treatments may need to focus on the sleep 
problems evident in younger children. However, adolescents had more daytime problems while younger 
children presented with more nighttime problems, indicating that treatments will need to evolve as 
children age. Second, using the SSC sample, this study confirmed the many prior reports of sleep 
problems in children with ASD. These numerous reports reinforce the need for health care professionals 
to screen for and discuss sleep problems with their ASD patients and families.  As recommended by 
Malow et al. (2014), parental education in proper sleep habits should be provided. Third, since sleep 
problems in ASD have been associated with gastrointestinal disorders, seizures (Aldinger et al., 2015), 
circadian genes (Melke et al., 2008; Yang et al., 2016) and melatonin levels (Melke et al., 2008; 
Tordjman et al., 2005), cognitive performance (Elia et al., 2000; Limoges et al., 2013), behavior problems 
(Schwichtenberg et al., 2013; Sikora et al., 2012), and developmental regression (Flavia Giannotti et al., 
2011), the SSC provides a wealth of opportunities to incorporate sleep into research in this large, well-
characterized sample of children with ASD.  
Several future lines of inquiry may be proposed from these results to further the understanding of 
sleep problems in ASD. Based on the associations found between sleep problems and GID in the present 
study, a next step would be to explore types of GID—constipation, diarrhea, reflux, abdominal pain, etc. 
It is possible that different types of GID may have distinct influences on sleep problems. In the same way, 
associations between various types of seizures and sleep problems may also be investigated. Additionally, 
the potential influence of medications on sleep problems, and on comorbidities such as GID and seizures, 
should be considered in future studies. The current study was not able to take into consideration the 
effects of medications in the current study because pertinent details, such as dose, administration time and 
 96 
frequency were not available from the parent study. To fully address the influence of medications on 
expression of sleep problems, variables to be collected and considered in future studies should include for 
each medication, the type of medication (primary mechanism of action), dose and frequency of doses, 
time of administration in relation to sleep time, interactions with other medications taken, and potential 
side effects that may themselves disturb sleep, seizure patterns, or cause GID. As age was found to be 
significantly associated with sleep problems, and particularly sleep problems in middle childhood, further 
investigation into the effect of puberty on sleep patterns in ASD is warranted. An objective measure of 
puberty, such as the Tanner stages, would greatly enhance our understanding of the interaction between 
puberty and sleep patterns.   
4.5.3 Conclusions 
In conclusion, approximately 41% of children in the SSC were categorized as having mild or 
moderate/severe sleep problems based on the SSCSI. Most sleep problems were seen in early and middle 
childhood, and the most frequent problems were in the nighttime problems subscale—bedtime problems, 
difficulty falling asleep, need for a parent to lay with the child, and frequent/prolonged awakenings during 
the night. Almost one-third of children had a reported sleep duration less than NSF recommendations. 
GID and age were the most frequent variables associated with of sleep problems, followed by NVIQ, sex, 
and age. Presence of seizures was associated with composite problems and nighttime problems. ADOS 
severity score is likely not associated with sleep problems in this sample. Future research into the 
biological basis of sleep problems and comorbidities affecting sleep, changes in sleep during puberty, and 
the influence of pharmacologic therapies on sleep problems may move this research into the realm of 
clinical interventions to improve quality of life for families affected by ASD and sleep problems. 
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5.0  DATA-BASED MANUSCRIPT: VARIATIONS IN GENES RELATED TO SLEEP 
PATTERNS IN CHILDREN WITH AUTISM SPECTRUM DISORDERS 
5.1 ABSTRACT 
Background: Sleep disturbance is a frequent comorbidity in children with autism spectrum disorder 
(ASD), estimated to affect 40-80% of cases. Previous reports have shown relationships between several 
circadian rhythm-related genes and sleep problems in ASD. The purpose of this study is to relate variation 
in and around melatonin-synthesis and suprachiasmatic nucleus genes to sleep problems in a large sample 
of children with ASD.  
Methods: This secondary analysis used existing genotypic and phenotypic data on 2,065 children aged 4-
18-years from the Simons Simplex Collection. Sleep problems were measured with the Simons Simplex 
Collection Sleep Interview. Expression quantitative trait loci and single nucleotide polymorphisms in 25 
circadian genes were chosen primarily for their impact on expression levels of target genes in the brain. 
Associations between composite sleep problems, nighttime problems, daytime problems, and sleep 
duration problems, and variants were calculated using logistic regression analysis. Age, sex, nonverbal 
IQ, ASD severity, gastrointestinal distress, seizures, and ancestry were included as covariates. 
Transmission disequilibrium tests were performed to test for over-transmission of alleles in the same 
variants.  
Results: No significant associations or transmission disequilibrium were found between gene variants and 
sleep problems in this sample of children with ASD.  
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Conclusion: Variation in expression of investigated genes in the melatonin synthesis and suprachiasmatic 
nucleus pathway do not have notable impacts on sleep problems in this large sample of children with 
ASD. Future research may explore translational and post-translational effects of these genes, or the effects 
of genes in other sleep-homeostasis pathways on sleep patterns. 
5.2 INTRODUCTION 
5.2.1 Autism spectrum disorder 
Autism spectrum disorder (ASD) is a pervasive developmental disorder characterized by deficits in social 
communication, and restricted, repetitive interests and behaviors (American Psychiatric Association, 
2013). ASD presents early in life, persisting through the lifespan, and is termed a spectrum because 
symptoms of the disorder vary widely in severity. In addition to core communication and behavior 
difficulties, children with ASD may suffer from a range of other medical and behavioral comorbidities, 
such as anxiety, gastrointestinal disorders, seizures, and sleep problems. Sleep problems are estimated to 
affect 40-80% of children with ASD, and include difficulty falling asleep (Giannotti, Cortesi, Cerquiglini, 
Vagnoni, & Valente, 2011; Goldman et al., 2017; Lambert et al., 2016) and staying asleep (Allik, 
Larsson, & Smedje, 2008; Souders et al., 2009), shorter total sleep time (sleep beginning to end– 
awakenings after sleep onset; Elrod & Hood, 2015; Goodlin-Jones, Tang, Liu, & Anders, 2008; Miano et 
al., 2007), poorer sleep efficiency (total sleep time/time in bed; Elrod & Hood, 2015; Fletcher et al., 2016; 
Giannotti et al., 2011).  
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5.2.2 Genetics of sleep patterns 
Recent studies have suggested that disrupted levels of melatonin, a neurotransmitter vital in regulation of 
circadian rhythm, may play a role in sleep problems in ASD (Nir, Meir, Zilber, Knobler, & Hadjez, 1995; 
Pagan et al., 2014; Pagan et al., 2017; Tordjman, Anderson, Pichard, Charbuy, & Touitou, 2005). Spurred 
by these reports of abnormal melatonin levels in individuals with ASD, Melke et al.(2008) examined 
variations in ASMT in 250 individuals with ASD, and 255 controls.  Two promoter polymorphisms were 
found significantly more frequently in individuals with ASD (rs4446909 and rs5989681, p<0.000) 
leading to a substantial decrease in ASMT activity (p = 2x10-12) and melatonin level (p = 3x10-11).  In 
addition, a splice-site mutation (IVS5+2T > C) was correlated in ASD with decreased sleep efficiency 
(70-82% vs. >85% in controls) and increased night wakings (17-22 times/hr vs. <10 times/hr in controls).  
More recently, Veatch et al. (2015) confirmed a high frequency of two ASMT polymorphisms previously 
reported by Melke et al. (rs4446909 and rs5989681) in a group of fifteen unrelated children with ASD 
and sleep onset delay.  
Although a number of studies have investigated links between SCN genes and risk for ASD 
(Chaste et al., 2011; Goto, Mizuno, Matsumoto, Yang, & Jimbo, 2017; Hu, Sarachana, Sherrard, & 
Kocher, 2015; Nicholas et al., 2007), only one study to date has examined multiple SCN genes in relation 
to sleep patterns in individuals with ASD. Yang et al. (2015) examined 18 genes in individuals with ASD 
with and without abnormal sleep patterns, and in controls.  Six missense changes found exclusively in 
individuals with ASD and abnormal sleep problems were observed in CLOCK (c.2551A>G), MTNR1B 
(c.974G>A), PER3 (c.1447C>T, c.1361G>A), NIR1D1 (c.58A>C), and TIMELESS (c.1493T>C).  
However, mutations were also identified in ARNTL, MTNR1A, MTNR1B, PER1, PER2, PER3, and 
TIMELESS in individuals with ASD without sleep problems, and in PER2 in healthy controls.   
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5.2.3 Study aims 
To our knowledge, no study has examined the genes of the melatonin synthesis pathway and core SCN 
pathway together with characteristics of a large sample of children with ASD. Using data from the 
Simons Simplex Collection (SSC), a large, national ASD consortium genome-wide association study 
(GWAS) that also collected information about sleep patterns, the proposed study seeks to fill this gap in 
knowledge by relate variation in and around 25 melatonin synthesis and SCN genes to their influence on 
sleep problems in children with ASD. Genetic variants have been chosen for association analysis based on 
their impact on gene expression, as measured by RNA-Seq and single nucleotide polymorphism (SNP) 
data.  
5.3 METHODS 
5.3.1 Participants 
The Simons Foundation Autism Research Initiative began the Simons Simplex Collection [SSC] with the 
primary goal of identifying genetic variants that contribute to ASD risk. The sample of approximately 
2,750 simplex families (only one child with ASD) was recruited from 12 academic medical centers in the 
United States and Canada. Procedures of the original SSC study, and characteristics of the sample have 
been described previously. Strict phenotyping was performed on children 4- to 18-years-old with ASD 
using parent interview, medical history, and multiple well-validated instruments. Clinical best estimate 
diagnoses of autism or ASD were given based on medical history and chart review, the Autism 
Diagnostic Observation Schedule (ADOS; Lord et al., 1989) and Autism Diagnostic Interview-Revised 
(ADI-R; Lord, Rutter, & Le Couteur, 1994) scores, and the Diagnostic and Statistical Manual of Mental 
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Disorders-IV-Text Revised (DSM-IV-TR; American Psychiatric Association, 2013; Simons Foundation 
Autism Research Initiative, 2014).  
5.3.2 Procedures 
Procedures of the parent study, inclusion and exclusion criteria, and characteristics of the SSC study 
sample have been described previously (Fischbach & Lord, 2010; Frazier et al., 2014; Johansson, Feeley, 
et al., n.d.; Lord et al., 2012). The current study was a secondary analysis of existing genotypic and 
phenotypic data from the Simons Foundation.  Informed consent was obtained for the SSC study from 
parents or caregivers, and assent was obtained from children as required by local institutional review 
boards. Approval was obtained from the University of Pittsburgh Institutional Review Board for the 
current study. Data was de-identified by the Simons Foundation prior to receipt by the present 
researchers. 
Phenotypic data was obtained from the Simons Foundation software platform, SFARI Base. 
Demographic data (age, sex, etc.) were collected when families entered the SSC study. As previous 
analysis of the sample (Johansson et al., n.d.), revealed associations between sleep problems and presence 
or absence of gastrointestinal distress (GID), non-verbal IQ (NVIQ), and Autism Diagnostic Observation 
Scale (ADOS) total score, these variables, with the addition of seizures, sex, age, and ancestry, will be 
used as covariates in analyses. GID was defined as parent reports of bloating/excess gas, celiac disease, 
constipation, diarrhea, ulcers, gastroesophageal reflux disease, inflammatory bowel disease (Crohn’s 
disease, ulcerative colitis), irritable bowel syndrome, abdominal pain, unusual stools, vomiting, and/or 
other GID; and seizures as parent reports atonic drop, infantile spasms; or partial complex, grand mal, 
petit mal, simple partial, and/or other seizures. Presence or absence of GID and seizures was determined 
using data from the medical history interview conducted by the parent study at baseline. Four norm-
referenced instruments were used to measure NVIQ in the SSC sample based on chronologic and mental 
age: the Differential Ability Scales-II (DAS-II; Elliott, 2012; PsychCorp, 2016), Weschler Intelligence 
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Scale for Children-Fourth Edition (WISC-IV; Weschler, 2003), Wechsler Abbreviated Scale of 
Intelligence (WASI; Wechsler, 2011), and Mullen Scales of Early Learning (MSEL; Bradley-Johnson, 
1997). The ADOS (Gotham, Pickles, & Lord, 2009; Lord et al., 1989) is a semi-structured observational 
instrument used with other instruments for diagnosis of ASD and classification of severity, and measures 
social responsiveness, communication, language delay, and spatial ability.   
5.3.3 Instruments 
Simons Simplex Collection Sleep Interview (SSCSI): The SSCSI (Johansson, Rohay, & Chasens, in press) 
is an 11-item cross-sectional, parent-report questionnaire evaluating nighttime and daytime sleep 
problems, and sleep duration problems (Table 10).  Items are scored as 0 for “no” and 1 for “yes”.  A 
continuous composite score is made by summing the 10 dichotomous items, plus 1 point for reported 
sleep duration outside National Sleep Foundation recommendations based on the child’s age (Hirshkowitz 
et al., 2015). Composite scores range from 0 to 11, with higher scores indicating worse sleep.  Subscale 
scores are determined by summing the items within the subscale (Nighttime problems and Daytime 
problems range = 0–4; Sleep duration problems range = 0-2.  Participants were excluded from the present 
study if more than two items were missing or coded as unknown.   
5.3.4 Gene variant selection 
Expression quantitative trait loci (eQTLs), or genomic variants that influence the expression of one or 
more genes, were chosen primarily using gene expression data from the CommonMind Consortium 
(CMC; Fromer et al., 2016). The CMC used RNA-Seq data from dorsolateral prefrontal (DLPFC) brain 
tissue from adults with and without neuropsychiatric disorders (Albert & Kruglyak, 2015). Variants were 
also taken from the Genotype-Tissue Expression project (GTEx; The GTEx Consortium, 2015), 
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HaploReg v.4 (Ward & Kellis, 2016), and variants identified by other groups as affecting sleep patterns in 
individuals with ASD (Melke et al., 2008; Veatch et al., 2015; Yang et al., 2016).  
For the current study, gene expression was analyzed in cis- (within 1Mb of gene) variants with a 
false discovery rate threshold FDR ≤ 0.05, revealing that 16 of the 25 genes were expressed in substantial 
quantities in the CMC DLPFC data (TPH2, CLOCK, ARNTL, PER1/2/3, BHLHE40/41, DBP, GAD1/2, 
NR1D2, RORA/B, CSNK1D/E). Data was used from the GTEx project (The GTEx Consortium, 2015) to 
identify eQTLs for 6 of the 7 remaining genes (MTNR1B, CRY1, DDC, AANAT, PROK2, CIART, 
CRY1/2, TIMELESS). For MTNR1A, 2,149 variants were found in the Haploreg v.4 program using the 
location of the gene plus 50KB on each side (chr4:187404809-187526537). Of these, 12 variants had data 
for expression. Those eQTLs with a p-value < 0.001 were chosen, and the independent pairwise function 
in Plink was used to prune the list based on linkage disequilibrium (LD) and an r2 = 0.5. Proxy eQTLs 
were required for some eQTLs that were not available in the SSC. SNAP Proxy Search was used to find 
proxy eQTLs (Broad Institute, 2015). These processes resulted in 73 eQTLs from the CMC; 49 were 
available in SSC data (32 proxy eQTL in significant LD were substituted for eQTLs not in SSC data). Of 
the 40 eQTLs from GTEx, 16 were available in the SSC data (12 proxy eQTLs were substituted). 
Haploreg identified 8 eQTLs; 3 were available in SSC data (1 proxy eQTL was used). Of 26 variants 
identified by previous literature in 10 genes (ASMT, CLOCK, CSNK1D/E, MTNR1A/B, NR1D1, 
PER1/2/3, TIMELESS), 4 were available in the SSC data (2 proxies were used): ASMT rs4446909 was 
identified by Melke et al. (2008) and Veatch et al. (2015); PER2 rs934945, PER3 rs10462020 (proxy: 
rs10462021), and PER3 rs228697 (proxy: rs228690) were identified by Yang et al. (2016). In all, 73 
independent eQTLs or variants were identified (CMC= 50, GTEx= 16, Haploreg= 3, literature= 4; Table 
12).  
Individuals in the SSC sample were genotyped using either Illumina 1Mv1 (approximately 325 
families), Illumina 1Mv3 Duo (approximately 1,160 families), or Illumina HumanOMNI 2.5 
(approximately 625 families) arrays. The same array version was used to analyze all members of a family. 
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5.3.5 Statistical analyses 
SSCSI items, composite and subscale scores, and sex were described using frequency counts and 
percentages. Parent reported regular sleep duration (hours per night) and age (years) were described using 
mean, standard deviation, and range. Regular sleep duration less than 3 standard deviations below the 
population mean, were replaced with the 3rd standard deviation below the mean (4.85 hours). Mann-
Whitney U was used to compare SSCSI composite and subscale scores between age groups, and chi-
square analyses to compare between sexes. Descriptive and correlational analyses were performed with 
SPSS version 23 (SPSS Inc., Chicago, IL). 
Power analysis was conducted using the Genetic Power Calculator (Purcell, Cherny, & Sham, 
2003).  Power to detect factors associated with sleep patterns was calculated assuming 72 independent 
tests, resulting in a Bonferroni corrected significance level of 0.05/72 or p=0.0007. Given the large size of 
the SSC database, the present study was well-powered (≥ 80%) to detect an OR of 1.2 for a common 
variant (risk allele frequency=0.5) or a less common variant (risk allele frequency=0.25; p-value=0.0007). 
5.3.5.1 Logistic regression analysis 
SSCSI composite and subscale scores were dichotomized into none/minimal (scores 0-1) or sleep 
problems present (≥ 2). Logistic regression analyses were performed to estimate associations between 
SSCSI composite and factor scores, and individual variant reference allele dosage (0, 1, 2 alleles). Hardy-
Weinberg equilibrium (HWE) was assessed in participants of non-Hispanic European Ancestry using the 
HardyWeinberg package in the R suite (R Core Team, 2016) and a p < 0.0007 (Bonferroni correction).  
All variants were in HWE. All models were adjusted for age (years), ADOS severity score (range: 4-10), 
sex (male=0, female=1), NVIQ (<40=1, 40-54=2, 55-70=3, 71-100=4, >100=5), GID (no=0, yes=1), 
seizures (no=0, yes=1), and ancestry (1=non-Hispanic European, 2=Asian, 3=Hispanic European, 
4=African American), and were performed under the additive genetic model ((0, 1, 2 alleles). Analyses 
were performed by building models with no sleep problems versus sleep problems (mild or 
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moderate/severe) as the outcome variable. Odds ratios with 95% confidence intervals were used to 
measure the strength of associations between each gene variant and sleep patterns. Logistic regression 
was performed with the MASS package in the R Suite. Level of significance was set at p<0.0007 
(Bonferroni correction). 
5.3.5.2 Transmission disequilibrium test 
The transmission disequilibrium test (TDT), one of several family-based association methods, examines 
expected and observed transmission of parental genotypes or alleles to offspring affected by a disease or 
trait. Transmission disequilibrium occurs when there is non-random or greater than expected transmission 
of a certain allele to offspring with a trait or disease (Laird & Lange, 2011). The TDT was performed with 
parent-child trios in which the child had SSCSI composite and subscale sleep problems present using 
Bioconductor trio package in the R Suite (Schwender et al., 2015).  Level of significance was set at 
p<0.0007 (Bonferroni correction). Only variants in which more than 100 trios were tested are reported. 
5.4 RESULTS 
5.4.1 Sample characteristics 
Characteristics of the sample are presented in Table 9. Of the full sample of children with genetic data 
available (N=2,200), 135 were excluded for missing sleep data. Three-quarters of these (78-80%) were 
also missing descriptive data (age, ancestry, diagnosis, ADOS severity score, NVIQ, sleep duration) so 
that comparisons between children included and excluded from the sample were not feasible. There was 
no significant difference in sex between those included and excluded (p=0.42). The sample was 
predominantly male (87%), Non-Hispanic European (78%), did not have seizures (95%), and had NVIQ 
above 70 (75%). Exactly half of the sample had GID. The mean age of the sample was approximately 9-
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years (range: 4-18-years). Children below the mean age were significantly more likely than children over 
the mean age to have a NVIQ<70 (40.2% vs. 33.0%, p<0.05), to have seizures (6.9% vs. 4.3%, p<0.01), 
and to have sleep problems on the SSCSI composite (76.3% vs. 61.6%, p<0.01) and nighttime sleep 
problem subscale (38.2% vs. 30.7%, p<0.05). Younger children also had significantly longer sleep 
duration than older children (mean = 9.5(1.3)hrs vs. 8.8(1.2)hrs, p<0.01). In addition, no significant 
differences were found between males and females in regular sleep duration, age, proportion of children 
with GID, seizures, NVIQ≤ 70, or sleep duration less than recommended for age. Significantly more 
females had NVIQ≤ 70 (37.6% vs. 23.7%, p<0.01).  
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Table 9: Sample Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4.2 Genotype associations with SSCSI sleep problems 
While no genetic associations remained significant after applying correction for multiple testing, due to 
the hypothesis-generating nature of the study, results that meet the conventional p<0.05 cut-off will be 
discussed. Those eQTLs associated (p<0.05) with sleep problems (mild or moderate/severe vs. none) 
based on SSCSI composite and subscale scores are listed in Table 15. Composite sleep problems were 
  
N=2065 
 
 
Age (yrs.) [mean(SD)] 
 
8.91 (3.5) 
 
Male  
 
1,794 (86.9) 
 
Ancestry 
     Non-Hispanic European 
     Hispanic European 
     African American 
     Asian 
 
            
 
1578 (77.9) 
153 (7.6) 
147 (7.2) 
148 (7.3) 
ADOS severity score [mean(SD)] 
 
7.44 (1.7)  
NVIQ ≤ 70 
 
528 (25.6) 
Seizures 
 
107 (5.2) 
GI disturbance 
 
1,033 (50.0) 
Regular sleep duration (hours) 
[mean(SD)] 
 
9.2 (1.3) 
Sleep duration less than 
recommended  
for age * 
 
583 (28.5) 
Note: data presented as n (%) unless otherwise specified; 
ADOS=Autism Diagnostic Observation Scale, range 4-10; NVIQ = non-
verbal IQ * Based on National Sleep Foundation recommendations 
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most highly associated with the CRY1 eQTL, rs1035768 (reference allele: A, OR = 1.58, 95% CI: 1.07-
2.34); and also with RORA rs8038644 (reference allele: A, OR = 1.23, 95% CI: 1.07-1.42) and the GAD1 
eQTL rs16857804 (reference allele: A, OR = 1.15, 95% CI: 1.00-1.31). Nighttime sleep problems were 
most highly associated with the MTNR1B eQTL, rs1962041 (reference allele: G, OR= 1.44, 95% CI: 
1.09-1.89); and also associated with PER2 eQTLs rs6431588 (reference allele: A, OR=1.26, 95% CI: 
1.05-1.52) and rs934945 (reference allele: G, OR = 1.25, 95% CI: 1.04-1.50), and the RORA eQTL 
rs8038664 (reference allele: A, OR = 1.23, 95% CI: 1.04-1.44). Daytime problems were most highly 
associated with the MTNR1B eQTL, rs11598 (reference allele: G, OR = 1.59, 95% CI: 1.17-2.17); and 
also associated with the GAD1 rs16857804 (reference allele: A, OR = 1.16, 95% CI: 1.00-1.33) and the 
CLOCK eQTL rs11943456 (reference allele: G, OR = 1.14, 95% CI: 1.00-1.30). Sleep duration problems 
were most highly associated with the GAD2 eQTL, rs11014824 (reference allele: G, OR = 4.47, 95% CI: 
1.08-18.56); and also associated with the DDC rs3735274 (reference allele: G, OR = 3.14, 95% CI: 1.06-
9.31) and the GAD2 eQTL rs7077123 (reference allele: G, OR = 1.96, 95% CI: 1.04-3.69).  
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Table 10: Genotype Associations with SSCSI Composite and Subscale Sleep Problems 
 
Variant Gene Reference allele     b OR 
95% 
CI 
lower 
95% 
CI 
upper 
p-value* 
         
Composite 
sleep problems 
rs1035768 CRY1 A 0.458 1.58 1.07 2.34 0.022 
rs8038664 RORA A 0.208 1.23 1.07 1.42 0.004 
rs16857804 GAD1 A 0.137 1.15 1.00 1.31 0.049 
         
Nighttime 
problems 
rs1962041 MTNR1B G 0.363 1.44 1.09 1.89 0.009 
rs6431588 PER2 A 0.235 1.26 1.05 1.52 0.011 
rs934945 PER2 G 0.222 1.25 1.04 1.50 0.017 
rs8038664 RORA A 0.204 1.23 1.04 1.44 0.013 
         
Daytime 
problems 
rs11598 MTNR1B G 0.466 1.59 1.17 2.17 0.003 
rs16857804 GAD1 A 0.146 1.16 1.00 1.33 0.044 
rs11943456 CLOCK G 0.133 1.14 1.00 1.30 0.048 
         
Sleep duration 
problems 
rs11014824 GAD2 G 1.498 4.47 1.08 18.56 0.039 
rs3735274 DDC G 1.143 3.14 1.06 9.31 0.039 
rs7077123  GAD2 G 0.673 1.96 1.04 3.69 0.037 
* No statistically significant results after Bonferroni correction (p < 0.0007); Top results among the 
variants tested are displayed. OR = odds ratio 
 
5.4.3 Transmission disequilibrium test 
No variants showed statistically significant over-transmission of alleles from parents to children with 
sleep problems after adjustment for multiple testing (p<0.0007; Table 16). Sleep duration problems did 
not have any variants with >100 trios. The variant associated with the highest odds of sleep problems in 
the TDT analysis was CIART rs28730724, which displayed over-transmission of the A allele in children 
with composite sleep problems (OR=1.71, 95% CI: 1.16-2.52, p=0.012). RORA rs4775351 displayed 
over-transmission of the A allele in children with composite and daytime problems (OR=1.20, 95% CI: 
1.01-1.42, p=0.038; OR=1.23, 95% CI: 1.01-1.48, p=0.037). Over-transmission of the A allele was shown 
in two variants of CSNK1E: rs135721 with composite sleep problems (OR=1.17, 95% CI: 1.01-1.37, 
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p=0.041) and rs4296527 with daytime problems (OR=1.24, 95% CI: 1.03-1.49, p=0.023).  Two CLOCK 
variants were associated with transmission of alleles to children with daytime problems: rs693367 showed 
over-transmission of the A allele (OR=1.21, 95% CI: 1.03-1.43, p=0.019), and rs11943456 of the G allele 
(OR=1.23, 95% CI: 1.05-1.43, p=0.009). GAD1 rs13395562 and MTNR1B rs11598 also showed over-
transmission of the G allele in children with daytime problems (OR=1.21, 95% CI: 1.03-1.42, p=0.018; 
OR=1.55, 95% CI: 1.08-2.24, p=0.019, respectively). Only one variant, PER2 rs6431588, showed over-
transmission to children with nighttime problems (A allele, OR=1.36, 95% CI: 1.09-1.71, p=0.007). 
5.5 DISCUSSION 
This study represents the first analysis of relationships between variation in genes of both the melatonin 
synthesis and core SCN pathways and sleep problems in children with ASD from the SSC. To investigate 
these associations, logistic regression was performed on 72 variants (68 eQTLs and 4 SNPs) in 25 genes 
and sleep problems—SSCSI composite problems, nighttime problems, daytime problems, and sleep 
duration problems—controlling for age, sex, total ADOS severity score, NVIQ, presence of 
gastrointestinal distress and seizures, and ancestry.  To corroborate association findings, transmission 
disequilibrium was investigated between parents and children affected by sleep problems. The analysis 
revealed no variants significantly associated with sleep problems, and no evidence was found for over-
transmission of alleles from parents to children with ASD affected by sleep problems. It can be said with 
some confidence that eQTLs and SNPs for the investigated genes in the melatonin synthesis pathway and 
core SCN pathways do not have a notable impact on sleep problems in children with ASD. 
 A number of strengths lend credence to the results of this study. While many previous studies 
have been limited in their ability to identify meaningful associations between genomic and biochemical 
variants and sleep patterns by small sample sizes and choice of only one or two gene, the present study 
presents a comprehensive analysis of 25 genes with more than 2,000 strictly phenotyped children. A 
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unique aspect of this study is the a priori selection of eQTLs that affect transcription of these genes in the 
brain. A majority of eQTLs chosen came from the CMC, which mined gene expression data from the 
brain tissue, including tissue from individuals with schizophrenia, a neurobehavioral disorder with genetic 
similarities to ASD (O’Connell, Mcgregor, Lochner, Emsley, & Warnich, 2018; The Autism Spectrum 
Disorders Working Group of The Psychiatric Genomics Consortium, 2017).  The innovative use of RNA-
Seq data to select gene variants affecting target gene expression may help to explain the divergent results 
from those of other groups who chose variants based on previous literature (Veatch, Pendergast, et al., 
2015) or whole exome sequencing (Chaste et al., 2010; Melke et al., 2008; Yang et al., 2016). While these 
groups looked at associations with structural mutations in the genes or post-translational melatonin levels, 
the present study investigated associations with variation in transcription, or gene expression. The size of 
the SSC sample was also a key strength of this study, even with a large number of tests performed. This 
study was powered to detect effects of approximately 1% of variability in sleep problems yet did not 
detect significant effects of gene variants after correction for multiple testing. The use of TDT also 
augments power by eliminating the problem of population stratification. 
The present study had several limitations. As neither the CMC nor GTEx collected samples with 
consideration to timing of circadian gene expression, the choice of eQTLs may not capture markers that 
were not expressed at the time of sample collection. The CMC used samples from the brains of adults, 
which may exhibit different gene expression patterns than the brains of children. In addition, using 
secondary data precludes the use of different sleep questionnaires or measuring levels of hormones related 
to sleep patterns, like melatonin and cortisol. Conversely, studies such as this one require large samples 
making it almost impossible to muster such a sample for which hormones were measured directly. The 
present study had a large sample, but if the effects of the variants were small, the current sample size 
might not be adequate to detect them. Finally, the SSCSI was developed for use with the SSC, and has not 
been independently validated or used with other samples of children with ASD. The SSCSI was also 
based on parents’ report, and thus may be subject to reporting bias. 
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5.5.1 Implications 
Continued research into the genomics of sleep problems in individuals with ASD is necessary. The lack 
of association found between expression of genes and sleep patterns in the present study does not imply 
that the melatonin synthesis and SCN pathway should be abandoned.  Although this study showed that 
transcription of these genes was not influencing sleep patterns, the effect of translational and post-
translational modification on melatonin and SCN proteins cannot be dismissed. That a number of research 
studies have shown low melatonin or melatonin metabolite levels (Leu et al., 2011; Melke et al., 2008; 
Tordjman et al., 2005), and success with melatonin supplementation (Cuomo et al., 2017; Gringras et al., 
2017; Wright et al., 2011) demonstrates this is still a valid research area.  However, as other gene 
pathways in the brain and body, such as glutamate, GABA, and serotonin are known to interact with 
melatonin and the SCN, inquiries should not be limited to the melatonin/SCN pathway.   
5.5.2 Conclusion 
Variation in the expression of core genes in the melatonin synthesis and SCN pathway were not found to 
have notable impacts on sleep problems in this large sample of children with ASD based on logistic 
regression and transmission disequilibrium tests. The results of this study may differ from previous 
investigations of the genetics of sleep problems in ASD due to the innovative use of expression data to 
guide gene variant selection, and because of the much larger size of the current sample. This study may be 
of use in clarifying genomic mechanisms related to the melatonin/SCN pathway and sleep problems in 
ASD, and in proposing further lines of inquiry.  Future research may explore translational and post-
translational effects of these genes, the effects of genes in other sleep-homeostasis pathways on sleep 
patterns, and the use of objective measures of sleep. 
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APPENDIX A 
COMPARISON OF SLEEP PATTERNS IN CHILDREN WITH ASD AND TYPICALLY 
DEVELOPING CHILDREN 
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Table 11: Comparison of Sleep Patterns in Children with ASD and Typically Developing Children 
Author/Title Populations Age Range Sleep Instrument(s) Results 
Goldman et al. 
(2017). 
Characterizing 
sleep in 
adolescents and 
adults with autism 
spectrum 
disorders.  
ASD (n=28), 
TD (n=13) 
11 to 30 
years 
(post-
pubertal) 
Sleep history, 
Adolescent 
Sleep-Wake 
Scale, 
Adolescent 
Sleep-Hygiene 
Scale, 
actigraphy 
Adolescent Sleep-Wake Scale 
> problems with going to bed, falling asleep, and total problems* than TD 
 
Actigraphy 
> SOL** and < sleep efficiency* than TD 
Lambert et al.  
(2016). Poor sleep 
affects daytime 
functioning in 
typically 
developing and 
autistic children 
not complaining 
of sleep problems: 
A questionnaire-
based and 
polysomnographic 
study.  
ASD (n=11), 
TD (n=13) 
6 to 13 
years 
CSHQ, sleep 
diary, PSG 
CSHQ 
No significant differences 
 
Sleep diary 
> SOL than TD* 
< parent-report sleep quality than TD* 
 
PSG 
> SOL than TD* 
< SWS % than TD* 
Fletcher et al. 
(2016). The 
development 
trajectory of 
parent-report and 
objective sleep 
profiles in autism 
spectrum 
disorder: 
Associations with 
anxiety and 
ASD (n=21), 
TD (n=29) 
Time 1: 6 
to 12 years 
Time 2: 7 
to 13 years 
actigraphy, 
CSHQ 
> % of parents report a sleep problem in the past year than TD** 
> % had a sleep problem at times 1 and 2 than TD* 
 
CSHQ 
> total score at times 1 and 2 than TD;** greater difference in total score 
     between ASD and TD at baseline than follow-up* 
> reduction (time 1 to time 2) in total sleep problems than TD* 
 
Actigraphy 
Group by time interaction in bedtime resistance and sleep anxiety 
     subscales** 
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bedtime routines.  < average (times 1 and 2) SE % than TD** 
> variability (time 1 to time 2) WASO (decreased)** and SE (decreased)* 
     than TD  
May et al. (2015). 
Sleep in high-
functioning 
children with 
autism: 
Longitudinal 
developmental 
change and 
associations with 
behavior 
problems.  
ASD (n=46), 
TD (n=38) 
7 to 12 
years 
CSHQ > total score a at baseline and 1 year later** than TD 
> bedtime resistance,* sleep onset delay,** sleep duration,** sleep 
     anxiety,* parasomnia,* daytime sleepiness** subscales than TD 
Elrod and Hood 
(2015; meta-
analysis). Sleep 
differences among 
children with 
autism spectrum 
disorders and 
typically 
developing peers: 
A meta-analysis.  
ASD 
(n=343), TD 
(n=221) 
(10 papers) 
2 to 19 
years 
actigraphy, 
PSG 
Relationship between ASD and: TST moderated by ID,** SE by 
     medications,* SE by method (actigraphy, PSG)*  
Pooled difference in means, ASD vs. TD: TST = -32.8 minutes, 95% CI:  
     -49.0 to -16.6), SL = 10.9 minutes (95% CI: 6.7 to 15.0), SE = -1.9% 
     (95% CI: -3.1 to -0.7) 
 
Hodge et al.  
(2014). Sleep 
patterns in 
children with and 
without autism 
spectrum 
disorders: 
Developmental 
comparisons.  
ASD 
(n=108), TD 
(n=108) 
3 to 17 
years 
CSHQ, sleep 
diary 
CSHQ 
> total score;** and bedtime resistance,** sleep onset delay,** sleep 
     duration,** sleep anxiety,** night waking,** sleep disordered 
     breathing* subscales than TD 
> total score than TD in children 6-9 years* and 10-17 years* 
 
Sleep diary 
< sleep duration than TD* 
> minutes awake after sleep onset than TD* 
Giannotti et al.  
(2011). Sleep in 
children with 
ASD 
(regressive 
n=18, 
5 to 10 
years 
Sleep diary, 
CSHQ, PSG 
Sleep diary 
Regressive: later bedtime and earlier rise time, < sleep time, > SOL than 
     TD;** later bedtime, < sleep time,** > SOL than non-regressed* 
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autism with and 
without autistic 
regression.  
nonregressive 
n=22) TD 
(n=12) 
Non-regressive: later bedtime, < sleep time, > SOL than TD** 
 
CSHQ 
Regressive: > total score; and bedtime resistance, sleep onset delay, sleep 
     duration, night waking subscales than TD** and non-regressed** 
Non-regressive: > total score; and bedtime resistance, sleep onset delay, 
     sleep duration, night waking subscales than TD** 
 
PSG 
Regressive: < TST, SE than TD and non-regressive;* < SWS %, REM % 
     than TD** > SOL, WASO %, REM % than TD and non-regressive;* 
     >awakenings/hr, REM latency, stage 2 % than TD* 
Non-regressive: < TST, SE than TD;* > SOL, WASO %, awakenings/hr, 
     REM latency than TD 
Cotton and 
Richdale (2010). 
Sleep patterns and 
behaviour in 
typically 
developing 
children and 
children with 
autism, Down 
syndrome, 
Prader-Willi 
syndrome and 
intellectual 
disability.  
ASD (n=34), 
TD (n=33)  
3 to 16 
years 
Sleep diary Daytime problems 
Behavior problems: > than TD** 
 
Nighttime problems 
Level of bedtime sleepiness: < than TD** 
Bedtime behavioral problems: > than TD** 
 
Buckley et al.  
(2010). REM 
sleep percentage 
in children in 
autism compared 
with 
developmental 
delay and typical 
ASD (n=60), 
TD (n=15) 
2 to 13 
years 
PSG < TST, SWS percentage, REM percentage than TD**  
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development.  
Souders et al.  
(2009). Sleep 
behaviors and 
sleep quality in 
children with 
autism spectrum 
disorders.  
ASD (n=59: 
AD n=26, 
PDD-NOS 
n=21, AS 
n=12), TD 
(n=40) 
4 to 10 
years 
CSHQ, 
actigraphy 
CSHQ 
> total score;** and sleep-onset delay,* sleep duration,** sleep anxiety* 
     (sleep terrors,** bed wetting,* bruxism** items), night waking,** and 
     parasomnia** subscales than TD 
 
Actigraphy 
AD,** PDD,* AS** > sleep onset latency than TD  
AD* and PDD* > number of WASO* and AD longer WASO than TD**  
> activity during night than TD** 
Krakowiak et al. 
(2008). Sleep 
problems in 
children with 
autism spectrum 
disorders, 
developmental 
delays, and 
typical 
development: A 
population-based 
study.  
ASD 
(n=303), 
TD (n=163) 
2 to 5 years CHARGE 
Sleep History 
(study specific 
instrument) 
At least one sleep problem frequently/ always: > frequent than TD* 
Sleep onset problems frequently: > frequent than TD* 
Night waking problems frequently: > frequent than TD* 
No sig differences between ASD  
Goodlin-Jones et 
al.  (2008). Sleep 
patterns in 
preschool-age 
children with 
autism, 
developmental 
delay, and typical 
development.  
ASD (n=68), 
TD (n=69) 
2 to 5.5 
years 
Actigraphy, 
sleep diary, 
CSHQ 
Frequency of parent-report of sleep problems: > than TD* 
 
Actigraphy 
24-hour sleep duration: ASD < than TD** 
Time in bed: < than TD** 
WASO number: < than TD** 
Nap duration: < than TD* 
 
CSHQ 
Total score and subscale scores not sig different between ASD and TD 
Allik et al. (2008). 
Sleep patterns in 
school-age 
children with 
ASD 
(AS/HFA 
n=16), TD 
(n=16) 
Time 2: 
11.7 to 
15.5 years 
Actigraphy Actigraphy 
> duration of weekend night waking than TD** 
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Asperger 
syndrome or high-
functioning 
autism: A follow-
up study.  
Giannotti et al. 
(2008). An 
investigation of 
sleep 
characteristics, 
EEG 
abnormalities and 
epilepsy in 
developmentally 
regressed and 
non-regressed 
children with 
autism.  
ASD 
(regressive 
n=70, non-
regressive 
n=34), TD 
(n=162) 
2.5 to 8 
years 
CSHQ, sleep 
diary, sleep 
history 
Sleep diary 
Regressive: later bedtime, earlier rise time, < TST, > SOL than TD** and 
     non-regressive;** > SOL than non-regressed* 
Non-regressive: later bedtime, <TST, > SOL than TD** 
 
CSHQ 
Regressive: > bedtime resistance, sleep onset delay, sleep duration, night 
     wakings subscale scores than TD** and non-regressive;** > sleep 
     anxiety, parasomnia,** daytime sleepiness* subscale scores than TD 
Non-regressive: > bedtime resistance, sleep onset delay, sleep duration, 
     sleep anxiety, night-wakings, parasomnia,** daytime sleepiness* 
     subscale scores than TD 
 
Sleep history 
Regressive: > percent sleep problems before age 2, mean age at onset of 
     sleep problems, % behavioral insomnia of childhood diagnosis, % 
     circadian rhythm sleep disorder-delayed sleep phase type and irregular 
     sleep/wake type, % seasonal sleep variations than TD;** > mean age at 
     onset of sleep problems,** % circadian rhythm sleep disorder-delayed 
     sleep phase type and irregular sleep/wake type, unclassified sleepiness 
     than non-regressive*   
Non-regressive: > % sleep problems before age 2, mean age at onset of 
     sleep problems, % behavioral insomnia of childhood, % circadian 
     rhythm sleep disorder-delayed sleep phase type and irregular 
     sleep/wake type, % seasonal sleep variations than TD**  
Bruni et al. 
(2007). Sleep 
architecture and 
NREM alterations 
in children and 
adolescents with 
ASD (n=10), 
AS (n=8), TD 
(n=12) 
7 to 15 
years 
PSG, sleep 
questionnaire 
AS: > sleep stage shifts than ASD* and TD* 
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Asperger 
syndrome.  
Miano et al. 
(2007). Sleep in 
children with 
autistic spectrum 
disorder: A 
questionnaire and 
polysomnographic 
study.  
ASD (n=31), 
TD (n=31) 
3.7 to 19 
years 
Sleep 
Disturbance 
Scale for 
Children, PSG 
Sleep Disturbance Scale for Children 
> sleeps less than 8hrs, difficulty getting to bed, more than 2 WASO/night, 
     daytime sleepiness* movements in sleep/hypnic jerks, SOL, fluids or 
     drugs needed to sleep, poor sleep quality, enuresis, waking to drink or 
     eat in the night, difficulty falling asleep after WASO** than TD 
 
PSG 
< TST,** time in bed, sleep period time, REM latency* than TD 
 
DD=developmental disability; TD=typical development; AS=Asperger syndrome; AD=autistic disorder; HFA=high-functioning autism; 
CSHQ=Children’s Sleep Habits Questionnaire; PSG=polysomnography; SWS=slow wave sleep; TST=total sleep time; SOL=sleep onset latency; 
PSG=polysomnography; WASO=wake after sleep onset; SE=sleep efficiency; ano significant difference between ASD and TD on second night of 
in-lab PSG; * p < 0.05, ** p < 0.01; a greater score indicates worse sleep dysfunction 
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Figure 7: Distribution of SSCSI Item Scores 
 
 
 
 
 
Figure 8: Distribution of SSCSI Nighttime Problems Item Scores 
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Figure 9: Distribution of SSCSI Daytime Problems Item Scores 
 
 
 
Figure 10: Distribution of Sleep Duration Problems Item Scores 
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APPENDIX C 
SIMONS SIMPLEX COLLECTION SLEEP INTERVIEW (SSCSI) 
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Table 12. Simons Simplex Collection Sleep Interview (SSCSI) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subscales 
 
Does your child currently have: 
 
Nighttime         
problems         
 
1.   difficulty going to bed? 
2.   difficulty falling asleep? 
3.   need for a parent to lay down with them to fall asleep? 
4.   frequent or prolonged awakenings at night? 
Day time          
problems          
 
5.    difficulty waking up in the morning? 
6.    long or frequent naps? 
7.    sleepiness during the day? 
8.    enough sleep? 
Sleep duration  
problems         
9.    an irregular bedtime and waketime? 
10.  a regular sleep duration? 
 11.  What is your child’s regular sleep duration in hours? 
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APPENDIX D 
IQ AND AUTISM SEVERITY MEASURE PSYCHOMETRICS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 126 
Table 13: IQ and Autism Severity Measure Psychometrics 
Weschler Intelligence Scale for 
Children-IV 
Reliability: full scale        r = 0.97 
         “Special” groups     r = 0.82 - 0.93 
Test-retest: full scale        r = 0.93 
Weschler Abbreviated Scale of 
Intelligence 
Reliability: full scale        r = 0.87 – 0.91 
         Subscales                 r = 0.92-0.96 
         Psychiatric sample  r = 0.96-0.98 
Test-retest: full scale        r = 0.87 – 0.95 
         Subscales                 r = 0.79-0.90 
Mullen Scale of Early Learning Reliability: full scale        r = 0.83 – 0.95 Test-retest: subscales       r = 0.85-0.96 
Differential Ability Scale-II Reliability: full scale        r = 0.94-0.96          Subscales                 r = 0.87-0.96 
Autism Diagnostic Observation 
Scale 
Internal consistency: 
         Social affect             α = 0.87 – 0.92 
         Repetitive behavior  α = 0.51-0.66 
Sensitivity:                        91 - 98% 
Specificity:                        84 – 94% 
Test-retest:                        r = 0.59-0.82 
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VARIANTS INCLUDED IN GENETIC REGRESSION ANALYSIS 
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Table 14: Variants Included in Genetic Regression Analysis 
Variant Proxy for Variant* 
Allele 
Frequency  
[n (%)] 
HWE Gene Source 
rs12939873 
   n = 2055  
AA     807 (39.1) 
AG     939 (45.5) 
GG     309 (15.0) 
p=0.5793 AANAT GTEx 
rs3760138 
 
rs1000821 
   n=2065 
AA   695 (33.7) 
AG  1016 (49.2) 
GG   354 (17.1) 
p=0.2627 AANAT GTEx 
rs59467367 
 
rs4788926 
   n=613 
AA   255 (41.6) 
AG   286 (46.7) 
GG    72 (11.7) 
p=0.3773 AANAT GTEx 
rs10832178 
 
rs11023081 
   n=2064 
AA    968 (46.9) 
AG    903 (43.7) 
GG    193 (9.3) 
p=0.1745 ARNTL CMC 
rs4446909 
   n = 1152  
AA    666 (57.8) 
AG    411 (35.7) 
GG      75 (6.5) 
p=0.2982 ASMT Melke, 2008 
rs11710676 
 
rs12629173 
   n=2063 
GG     528 (25.6) 
GA   1004 (48.6) 
AA     531 (25.7) 
p=0.4501 BHLHE40 CMC 
rs36126004 
 
rs6786132 
   n=1451 
AA     965 (66.5) 
AG     433 (29.8) 
GG       53 (3.7) 
p=0.773 BHLHE40 CMC 
rs4685806 
 
rs7651990 
   n=2065 
GG   1330 (64.4) 
GA     625 (30.3) 
AA     110 (5.3) 
p=0.4157 BHLHE40 CMC 
rs931503 
   n=2060  
GG   1544 (74.8) 
GA     469 (22.7) 
AA       47 (2.3) 
p=0.3342 BHLHE40 CMC 
rs4246238 
 
rs4963647 
   n=2062 
GG   1838 (89.0) 
GA     217 (10.5) 
AA         7 (0.3) 
p=0.6351 BHLHE41 CMC 
rs28730724 
   n=1451  
AA   1290 (88.9) 
AG     158 (10.9) 
GG         3 (0.2) 
p=0.6182 CIART GTEx 
rs4549456 
 
rs11943456 
   n=2065 
GG    538 (26.1) 
GA  1033 (50.0) 
AA    494 (23.9) 
p=0.7625 CLOCK CMC 
rs482114 
 
rs693367  
   n=2056 
GG    973 (47.1) 
GA    879 (42.6) 
AA    204 (9.9) 
p=0.8602 CLOCK CMC 
rs12298001 
 
rs4964521 
   n=2063 
AA    723 (35.0) 
AG    950 (46.0) 
GG    390 (18.9) 
p=0.157 CRY1 GTEx 
rs4964471 
 
rs1035768 
   n=613 
AA    467 (76.2) 
AG    136 (22.2) 
GG      10 (1.6) 
p=0.9999 CRY1 GTEx 
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rs57707013 
 
rs11150805 
   n=2064 
AA   1453 (70.4) 
AG    560 (27.1) 
GG      51 (2.5) 
p=0.7862 CSNK1D CMC 
rs135729 
 
rs135721 
   n=2064 
AA   1078 (52.2) 
AG     811 (39.3) 
GG     175 (8.5) 
p=0.2057 CSNK1E CMC 
rs11089862 
   n=2064  
AA    619 (30.0) 
AG    992 (48.0) 
GG    453 (21.9) 
p=0.9596 CSNK1E CMC 
rs4296527 
   n=1451  
GG   392 (27.0) 
GA   727 (50.1) 
AA   332 (22.9) 
p=0.8093 CSNK1E CMC 
rs5756931 
   n=2060  
GG   781 (37.8) 
GA   963 (46.6) 
AA   316 (15.3) 
p=0.8752 CSNK1E CMC 
rs526744 
 
rs837642 
   n=2064 
GG   1094 (53.0) 
GA     828 (40.1) 
AA    142 (6.9) 
p=0.0961 DBP CMC 
rs11575281 
   n=2063  
CC    1937 (93.8) 
CA     126 (6.1) 
AA        0 
p=0.2593 DDC GTEx 
rs2122817 
 
rs11575548 
   n=2065 
AA   1645 (79.7) 
AC     407 (19.7) 
CC       13 (0.6) 
p=0.039 DDC GTEx 
rs1157375 
 
rs7809758 
   n=2064 
GG    853 (41.3) 
GA    971 (47.0) 
AA    240 (11.6) 
p=0.0672 DDC GTEx 
rs58129743 
 
rs3807553 
   n=2062 
AA   1671 (80.9) 
AG     379 (18.4) 
GG       12 (0.6) 
p=0.2090 DDC GTEx 
rs6952023 
 
rs3735274 
   n=1451 
GG     804 (55.4) 
GA     551 (38.0) 
AA       96 (6.6) 
p=0.8696 DDC GTEx 
rs6963996 
 
rs3807558 
   n=2065 
AA   1253 (60.7) 
AG     710 (34.4) 
GG     102 (4.9) 
p=0.8812 DDC GTEx 
rs10930411 
 
rs10930412 
   n=2065 
CC  1629 (78.9) 
CA   404 (19.6) 
AA     32 (1.5) 
p=0.883 GAD1 CMC 
rs11684294 
 
rs11903215 
   n=1451 
AA   410 (28.3) 
AC   711 (49.0) 
CC   330 (22.7) 
p=0.589 GAD1 CMC 
rs13014896 
   n=2065  
CC   876 (42.4) 
CA  928 (44.9) 
AA  261 (12.6) 
p=0.9569 GAD1 CMC 
rs13395562 
   n=2063  
GG  906 (43.9) 
GA  908 (44.0) 
AA  249 (12.1) 
p=0.9543 GAD1 CMC 
rs13414831 rs16857804
 
   n=2063 
GG  986 (47.7) 
GA  869 (42.1) p=0.6356 GAD1 CMC 
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AA  208 (10.1) 
rs17607321 
   n=2062  
CC  1731 (83.8) 
CA   310 (15.0) 
AA     21 (1.0) 
p=0.8295 GAD1 CMC 
rs34375966 
 
rs7568852 
   n=2064 
CC  761 (36.9) 
CA  985 (47.7) 
AA  318 (15.4) 
p=0.6011 GAD1 CMC 
rs56851249 
 
rs13384194 
   n=2060 
CC  902 (43.7) 
CA  920 (44.6) 
AA  238 (11.5) 
p=0.8659 GAD1 CMC 
rs62170724 
 
rs4668263 
   n=2064 
AA  1302 (63.1) 
AG    663 (32.1) 
GG      99 (4.8) 
p=0.1277 GAD1 CMC 
rs6759322 
 
rs1364529 
   n=2064 
AA  698 (33.8) 
AG  980 (47.5) 
GG  386 (18.7) 
p=0.232 GAD1 CMC 
rs7564575 
   n = 2065  
AA  1560 (75.5) 
AG    464 (22.5) 
GG      41 (2.0) 
p=0.412 GAD1 CMC 
rs11014816 
 
rs11014824 
   n=2061 
AA   1713 (83.0) 
AG     328 (15.9) 
GG       20 (1.0) 
p=0.149 GAD2 CMC 
rs11015040 
 
rs7077123 
   n=2060 
AA     887 (43.0) 
AG     926 (44.8) 
GG     247 (12.0) 
p=0.822 GAD2 CMC 
rs2442858 
 
rs2442861 
   n=1150 
CC     878 (76.3) 
CA     258 (22.4) 
AA       14 (1.2) 
p=0.4713 GAD2 CMC 
rs787041 
 
rs787033  
   n=2064 
GG     740 (35.8) 
GA     959 (46.4) 
AA     365 (17.7) 
p=0.9562 GAD2 CMC 
rs9299827 
 
rs2252096 
   n=2062 
GG     982 (47.6) 
GA     890 (43.1) 
AA     190 (9.2) 
p=0.3029 GAD2 CMC 
rs10013543 
   n=2063  
AA    584 (28.3) 
AC    972 (47.1) 
CC    507 (24.6) 
p=0.0869 MTNR1A Haploreg 
rs1317237  
   n=1450  
GG    802 (55.3) 
GA    544 (37.5) 
AA    104 (7.2) 
p=0.3939 MTNR1A Haploreg 
rs767168 
 
rs7675885 
   n=2064 
CC    513 (24.8) 
CA  1046 (50.7) 
AA    505 (24.5) 
p=0.1904 MTNR1A Haploreg 
rs7950811 
 
rs11598 
   n=2053 
GG   1871 (90.6) 
GA     178 (8.6) 
AA         4 (0.2) 
p=0.7919 MTNR1B GTEx 
rs16919041 
 
rs1962041 
   n=2064 
AA   1722 (83.4)     
AG     327 (15.8) 
GG       15 (0.7) 
p=0.7431 MTNR1B GTEx 
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rs11714673 
 
rs2043581 
   n=2062 
AA    657 (31.8) 
AC    982 (47.6) 
CC    423 (20.5) 
p=0.877 NR1D2 CMC 
rs7619728 
   n = 2061  
AA  1824 (88.3) 
AG    230 (11.1) 
GG        7 (0.3) 
p=0.8145 NR1D2 CMC 
rs55739732 
 
rs1294525 
   n=1150 
GG     756 (65.7) 
GA     354 (30.8) 
AA       40 (3.5) 
p=0.8355 PER1 CMC 
rs6729088 
 
rs6431588 
   n=2065 
AA   1397 (67.7) 
AG     608 (29.4) 
GG       60 (2.9) 
p=0.5591 PER2 CMC 
rs934945 
   n=2062  
AA   1302 (63.1) 
AG     681 (33.0) 
GG       79 (3.8) 
p=0.5251 PER2 Yang et al, 2015 
rs10462020 
 
rs10462021 
   n=2062 
GG   1398 (67.7) 
GA     613 (29.7) 
AA       51 (2.5) 
p=0.0789 PER3 Yang et al, 2015 
rs228697 
 
rs228690 
   n=2064 
AA   1749 (84.7) 
AG     303 (14.7) 
GG       12 (0.6) 
p=0.9999 PER3 Yang et al, 2015 
rs58654499 
 
rs9310221  
   n=2063 
AA     704 (34.1) 
AG     995 (48.2) 
GG     364 (17.6) 
p=0.599 PROK2 GTEx 
rs10519085 
   n=2064  
GG     633 (30.7) 
GA     963 (46.6) 
AA     468 (22.7) 
p=0.1303 RORA CMC 
rs28868703 
 
rs8038513  
   n=2041 
GG   1198 (58.0) 
GA    759 (36.8) 
AA      84 (4.1) 
p=0.0168 RORA CMC 
rs17204945 
   n=2063  
AA   1452 (70.3) 
AG    558 (27.0) 
GG      53 (2.6) 
p=0.5147 RORA CMC 
rs34088848 
 
rs4419005 
   n=2065 
AA   1230 (59.6) 
AG   719 (34.8) 
GG   116 (5.6) 
p=0.6684 RORA CMC 
rs4775351 
   n=2064  
GG 1347 (65.2) 
GA   622 (30.1) 
AA     95 (4.6) 
p=0.851 RORA CMC 
rs55870008 
 
rs10851691 
   n=2065 
AA    522 (25.3) 
AG   1033 (50.0) 
GG   510 (24.7) 
p=0.4191 RORA CMC 
rs7162913 
 
rs8038664 
   n=2062 
GG   1011 (49.0) 
GA     869 (42.1) 
AA     182 (8.8) 
p=0.8597 RORA CMC 
rs9888726 
   n=2065  
GG    995 (48.2) 
GA    890 (43.1) 
AA    180 (8.7) 
p=0.1521 RORA CMC 
rs9989351 
   n=1746  
CC   1249 (71.5) 
CA     461 (26.4) p=0.1946 RORA CMC 
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AA       36 (2.1) 
rs10869497 
 
rs10869495 
   n=613 
GG  182 (29.7) 
GA  309 (50.4) 
AA  122 (19.9) 
p=0.6494 RORB CMC 
rs35752149 
 
rs1323368 
   n=2064 
AA   1440 (69.7) 
GA     573 (27.7) 
GG       51 (2.5) 
p=0.2631 RORB CMC 
rs3752955 
   n=2064  
AA     671 (32.5) 
AC   1040 (50.4) 
CC     353 (17.1) 
p=0.8696 RORB CMC 
rs73524533 
 
rs11143948 
   n=2065 
AA   1186 (57.4) 
AG     740 (35.8) 
GG     139 (6.7) 
p=0.2857 RORB CMC 
rs2291738 
 
rs774047 
   n=2063 
AA     577 (27.9) 
AG   1013 (49.1) 
GG     473 (22.9) 
p=0.685 TIMELESS GTEx 
rs17110451 
 
rs4131348 
   n=1451 
GG   1060 (73.1) 
GA     357 (24.6) 
AA       34 (2.3) 
p=0.3225 TPH2 CMC 
rs4760820 
   n=1756  
CC     713 (40.6) 
CA     791 (45.0) 
AA     252 (14.4) 
p=0.8211 TPH2 CMC 
 
* Proxy eQTLs used when original eQTLs not available in Simons Simplex Collection data;  
HWE = Hardy-Weinberg equilibrium, p > 0.00023 
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Figure 11: Distribution of SSCSI Composite Sleep Score Categories 
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Table 15: Sample characteristics by SSCSI Sleep Score Categories 
 
Full Sample 
N=2,619 
None/minimal 
n=1429 
Mild 
n=684 
Moderate/severe 
n=506 
Age (yrs.) [mean(SD)] 9.0 (3.6) a 9.2 (3.6) b,d 8.8 (3.5) 8.7 (3.5) 
Male  2,272 (86.8) a 1,270 (88.9) b,d 571 (83.5) 431 (85.2) 
ADOS severity score 
[mean(SD)] 7.4 (1.7) 7.4 (1.7) 7.6 (1.6) 7.4 (1.6) 
     SA severity score 
     [mean(SD)] 7.2 (1.7)
 7.2 (1.8) 7.4 (1.7) 7.2 (1.7) 
     RRB severity score  
     [mean(SD)] 7.8 (1.8) 7.8 (1.9) 7.9 (1.8) 7.8 (1.7) 
Diagnosis:  
     ASD  
     AD  
 
274 (10.5) 
2,345 (89.5) 
173 (12.1) b 
1,256 (87.9) 
63 (9.2) 
621 (90.8) 
53 (10.5) 
453 (89.5) 
NVIQ ≤ 70 695 (26.6) a 355 (24.8) d 182 (26.6) 158 (31.2) 
Seizures 135 (5.2) a 61 (4.3) d 38 (5.6) 36 (7.1) 
GI disturbance 1,307 (49.9) a 640 (44.8) b,d 359 (52.5) 308 (60.9) c 
Regular sleep duration 
(hours) [mean(SD)] 9.2 (1.3) 
a 9.5 (1.1) b,d 9.2 (1.3) 8.3 (1.6) c 
Duration less than NSF 
recommendations  741 (28.3) 
a 297 (19.3) b,d 214 (34.4) 230 (53.9) c 
Note: data presented as n (%) unless otherwise specified; ADOS=Autism Diagnostic Observation 
Scale, range 4-10; ASD=autism spectrum disorder (ADOS score 4-5); AD=autism disorder (ADOS 
score 6-10); NVIQ=nonverbal IQ; NSF=National Sleep Foundation; RRB=restricted, repetitive 
behavior; SA=social affect; aDifference between none/minimal, mild, and moderate/severe, Kruskal-
Wallis, p < 0.05; b Difference between none/minimal and mild, p < 0.05; c Difference between mild and 
moderate/severe, p < 0.05; dDifference between none/minimal and moderate/severe, p < 0.05 
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Table 16: Reported SSCSI Item Frequencies by Sleep Score Categories 
 Total Sample N=2,619 
Mild 
n=684 
Moderate/severe 
n=506 
Nighttime problems 
    
Bedtime problems       466 (17.8) 135 (19.8) 318 (62.8) 
 
Need to lay down with 
   child 
   500 (19.1) 173 (25.4) 283 (56.3) 
 
Difficulty falling asleep    833 (31.8) 325 (47.6) 420 (83.7) 
 
Frequent/prolonged 
   awakenings 
 
   492 (18.8) 172 (25.4) 264 (52.5) 
Daytime problems       
 
Difficulty waking    351 (13.4) 104 (15.2) 222 (43.9) 
 
Excess daytime 
sleepiness 
   351 (13.4) 116 (17.1) 196 (39.0) 
 
Long/ frequent naps    100 (3.8) 31 (4.5) 64 (12.7) 
 
Regular duration is not 
   enough 
 
   560 (21.4) 184 (28.0) 289 (60.6) 
Sleep duration 
problems         
 
Irregular bedtime and/or 
   waketime * 
 
   513 (19.6) 130 (23.6) 202 (47.1) 
No regular duration    149 (5.7) 37 (5.4) 90 (18.0) 
All n (%); * missing 17.1%; a Difference between mild and moderate/severe 
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Table 17: SSCSI Composite and Subscale Frequencies by Sleep Score Categories 
 Full 
Sample 
N=2,619 
Mild 
n=684 
Moderate/ 
severe 
n=506  
Children with sleep 
problems * 
     Composite 
     Nighttime problems 
     Daytime problems 
     Sleep duration 
     problems 
 
1,073 (41.0) 
   675 (25.8) 
   348 (13.3) 
     72 (2.7) 
 
 
238 (34.8) 
89 (13.0) 
8 (1.2) 
 
 
437 (86.4) 
259 (51.2) 
64 (12.6) 
 
* SSCSI score ≥ 2 
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Table 18: Associations Between Child Characteristics and SSCSI Sleep Problems in Early 
Childhood 
  None/minimal vs.  
Mild-severe 
  OR CI p 
SSCSI 
composite 
sleep score 
Age 0.84 0.63-1.12 0.23 
Sex * 1.25 0,92-1.71 0.15 
NVIQ 0.82 0.74-0.90 
<0.0
1 
ADOS 1.03 0.96-1.09 0.41 
     SA t - - - 
     RRB t - - - 
GID 1.61 1.31-1.99 
<0.0
1 
Seizures 1.19 0.71-2.01 0.28 
Subscales     
     Nighttime 
     problems 
      
Age 0.94 0.86-1.01 0.10 
Sex * 1.05 0.75-1.48 0.76 
NVIQ 0.80 0.72-0.89 
<0.0
1 
ADOS 0.98 0.91-1.05 0.60 
     SA t - - - 
     RRB t - - - 
GID 1.37 1.09-1.73 
<0.0
1 
Seizures 1.46 0.85-2.50 0.17 
     Daytime 
    problems  
Age 0.95 0.66-1.38 0.80 
Sex * 1.59 1.05-2.37 0.02 
NVIQ 1.01 0.87-1.16 0.92 
ADOS 1.03 0.94-1.13 0.56 
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     SA t - - - 
     RRB t - - - 
GID 2.19 1.60-3.04 
<0.0
1 
Seizures 0.89 0.41-1.91 0.76 
     Sleep 
     duration 
     problems  
Age 0.67 0.42-1.09 0.11 
Sex * 1.23 0.54-2.79 0.62 
NVIQ 0.65 0.52-0.82 
<0.0
1 
ADOS 1.01 0.84-1.21 0.93 
     SA t - - - 
     RRB t - - - 
GID 1.01 0.56-1.84 0.97 
Seizures 1.74 0.52-5.80 0.37 
Bold results denote statistical significance; * Reference group=females; t 
Only tested if ADOS severity score significant, ADOS=ADOS severity 
score; CI=95% confidence interval; GID=gastrointestinal disturbance; 
NVIQ=non-verbal IQ; OR=odds ratio; SA=ADOS social affect severity 
score; RRB=ADOS restricted, repetitive behavior severity score 
 
 
 
 
 
 
 
 
 
 
 148 
Table 19: Associations Between Child Characteristics and SSCSI Sleep Problems in Middle 
Childhood 
  None/minimal vs.  
Mild-severe 
  OR CI p 
SSCSI 
composite 
sleep score 
Age 1.15 1.04-1.27 
<0.0
1 
Sex * 1.86 1.23-2.83 
<0.0
1 
NVIQ 1.07 0.95-1.19 0.27 
ADOS 1.01 0.94-1.10 0.72 
     SA t - - - 
     RRB t - - - 
GID 1.56 1.18-2.06 
<0.0
1 
Seizures 1.74 0.97-3.22 0.07 
Subscales     
     Nighttime 
     problems 
      
Age 0.80 0.55-1.17 0.25 
Sex * 1.46 0.93-2.26 0.09 
NVIQ 0.96 0.85-1.09 0.54 
ADOS 1.05 0.96-1.15 0.29 
     SA t - - - 
     RRB t - - - 
GID 1.63 1.19-2.24 
<0.0
1 
Seizures 1.60 0.86-2.88 0.13 
     Daytime 
    problems  
Age 1.18 1.03-1.36 0.02 
Sex * 1.31 0.75-2.28 0.35 
NVIQ 1.11 0.94-1.31 0.22 
ADOS 0.97 0.86-1.09 0.61 
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     SA t - - - 
     RRB t - - - 
GID 1.98 1.32-3.01 
<0.0
1 
Seizures 1.72 0.83-3.35 0.12 
     Sleep 
     duration 
     problems  
Age 0.80 0.33-1.93 0.61 
Sex * 1.60 0.53-4.86 0.40 
NVIQ 0.73 0.54-0.99 0.04 
ADOS 1.03 0.80-1.32 0.84 
     SA t - - - 
     RRB t - - - 
GID 1.44 0.60-3.46 0.42 
Seizures 3.00 0.81-8.82 0.06 
Bold results denote statistical significance; * Reference group=females; t 
Only tested if ADOS severity score significant, ADOS=ADOS severity 
score; CI=95% confidence interval; GID=gastrointestinal disturbance; 
NVIQ=non-verbal IQ; OR=odds ratio; SA=ADOS social affect severity 
score; RRB=ADOS restricted, repetitive behavior severity score 
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Table 20: Associations Between Child Characteristics and SSCSI Sleep Problems in Late 
Childhood 
  None/minimal vs.  
Mild-severe 
  OR CI p 
SSCSI 
composite 
sleep score 
Age 1.17 0.86-1.59 0.31 
Sex * 1.70 0.90-3.19 0.10 
NVIQ 1.06 0.87-1.28 0.57 
ADOS 1.06 0.92-1.23 0.40 
     SA t - - - 
     RRB t - - - 
GID 1.23 0.76-1.97 0.39 
Seizures 0.94 0.38-2.33 0.89 
Subscales     
     Nighttime 
     problems 
      
Age 1.23 0.87-1.74 0.25 
Sex * 0.87 0.38-2.00 0.74 
NVIQ 0.99 0.78-1.25 0.94 
ADOS 0.98 0.82-1.16 0.78 
     SA t - - - 
     RRB t - - - 
GID 2.08 1.15-3.85 0.02 
Seizures 1.11 0.39-3.18 0.85 
     Daytime 
    problems  
Age 1.14 0.78-1.66 0.50 
Sex * 2.23 0.96-4.90 0.05 
NVIQ 1.36 1.01-1.90 0.06 
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ADOS 0.97 0.79-1.18 0.73 
     SA t - - - 
     RRB t - - - 
GID 1.07 0.55-2.07 0.85 
Seizures 0.91 0.25-3.30 0.89 
     Sleep 
     duration 
     problems  
Age 1.09 0.06-20.42 0.95 
Sex * 1.14 0.13-10.18 0.91 
NVIQ 0.98 0.51-1.90 0.96 
ADOS 0.87 0.53-1.42 0.57 
     SA t - - - 
     RRB t - - - 
GID 0.92 0.18-4.75 0.92 
Seizures <0.00 0 - 
Bold results denote statistical significance; * Reference group=females; t 
Only tested if ADOS severity score significant, ADOS=ADOS severity 
score; CI=95% confidence interval; GID=gastrointestinal disturbance; 
NVIQ=non-verbal IQ; OR=odds ratio; SA=ADOS social affect severity 
score; RRB=ADOS restricted, repetitive behavior severity score 
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Table 21: Transmission Disequilibrium Test Results 
 
 
Variant Gene 
Reference 
allele b OR 
95% 
CI 
lower 
95% 
CI 
upper 
Trios 
(n) 
p-
value* 
          
Composite 
sleep problems 
rs28730724 CIART A 0.487 1.63 1.11 2.38 110 0.012 
rs4775351 RORA A 0.180 1.20 1.01 1.42 461 0.038 
rs135721 CSNK1E A 0.161 1.17 1.01 1.37 508 0.041 
          
Nighttime 
problems rs6431588 PER2 A 0.311 1.36 1.09 1.71 262 0.007 
          
Daytime 
problems 
rs11598 MTNR1B G 0.440 1.55 1.08 2.24 113 0.019 
rs4296527 CSNK1E A 0.212 1.24 1.03 1.49 354 0.023 
rs11943456 CLOCK G 0.204 1.23 1.05 1.43 506 0.009 
rs4775351 RORA A 0.203 1.23 1.01 1.48 362 0.037 
rs13395562 GAD1 G 0.192 1.21 1.03 1.42 477 0.018 
rs693367 CLOCK A 0.194 1.21 1.03 1.43 453 0.019 
Note: Results with p < 0.05 and trios with n > 100 are displayed. No trios with n > 100 for sleep duration 
problems subscale. * No significant results after Bonferroni correction (p < 0.0007). OR = odds ratio 
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